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Chronic Kidney Disease (CKD) has been characterised into five stages with CKD5 
defined as an estimated glomerular filtration rate (eGFR) of < 15ml/min/1.73m2 and 
includes those receiving renal replacement therapy (RRT) (dialysis and transplantation) 
or those who are eligible for RRT but are not receiving treatment. In New Zealand (NZ) 
approximately 1000 individuals commence dialysis each year, with the majority aged 
between 65-74 years. Māori experience a two-fold higher rate of CKD5 compared to 
non-Māori. CKD5 has a potential to have a negative effect on an individual’s health-
related quality of life (HRQoL). CKD5 is associated with disability. Little research has 
been completed to understand the impact of HRQoL on disability in people aged ≥65 
years with CKD5.  
Aims 
The aims of the Health and Disability Study (H&D Study) presented in this thesis are to 
describe cross-sectional associations between HRQoL and disability among a cohort of 
older New Zealanders with CKD5, and to determine which factors at recruitment, 
including HRQoL, have the potential predict disability outcomes 12 months later; and 
to describe the HRQoL and disability outcomes for an older Māori cohort with CKD5.  
Methods 
A rapid review was completed to identify important models of HRQoL and disability, 
with a scoping review completed to identify existing research investigating HRQoL and 
disability in CKD patients. The dialysis outcomes in those aged ≥65 study (DOS65+ 
Study) was an “accelerated longitudinal” cohort which aimed to determine the HRQoL 
of those aged ≥65 years with CKD5, to aid in developing evidence-based guidelines for 
the management of CKD5 in older adults. This study analysed the baseline 
characteristics of the 225 participants in the DOS65+ Study to determine associations 
between HRQoL (EQ-5D-3L) and disability (WHODAS 2.0). Participants who were 
followed to 12 months (n=156) were analysed using modified Poisson regression with 
robust standard errors to identify which factors at recruitment, including HRQoL, 
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predict disability outcomes 12 months later. Descriptive analyses were used to describe 
the Māori cohort (n=49) and their outcomes.  
Results 
Of the 223 participants analysed at baseline, those with 3 or more comorbidities were 
more likely to be disabled as were those with moderate-severe problems with the EQ-
5D-3L dimensions of mobility, self-care, usual activities and anxiety/depression. The 
multivariable analyses indicate that those disabled at baseline were at an 86% higher 
risk of being disabled at 12 months. The HRQoL dimensions of self-care and mobility 
at baseline predicted disability at 12 months by 31% and 38% respectively. Dialysis 
vintage of ≥2 years was associated with lower disability. Within the Māori cohort, 
HRQoL and disability at baseline appear important in predicting disability at 12 
months, however this result is limited due to small sample size.  
Discussion and Conclusion  
Issues with EQ-5D-3L mobility, self-care and disability at baseline predict disability at 
12 months in this cohort. The EQ-5D-3L and WHODAS 2.0 allow for patients to 
determine how they perceive their HRQoL and disability which may be important in 
improving patients’ clinical experiences and therefore outcomes. Patient participation 
in assessing these HRQoL components and baseline disability could help with CKD5 










Key words: Health-related quality of life, disability, chronic kidney disease stage five, 




I would like to thank all the DOS65+ participants who allowed this research to be 
completed. Without their time and insight this research would not have been possible. 
Additionally, I would like to express my gratitude to the DOS65+ research team for 
completing this research and graciously allowing me access to the data.  
I wish to acknowledge those who form the Department of Preventive and Social 
Medicine for providing me with a warm, diverse and interesting learning environment. 
Supervision, support, and expertise provided by Professor Sarah Derrett, Dr Ari 
Samaranayaka, Dr Emma Wyeth, and Professor Robert Walker was invaluable.  
I would like to express my very great appreciation to all who offered words of 
encouragement, a listening ear and supportive smiles. To those whom I was fortunate 
enough to share an office space with, those whom I lived with during this journey and 
all my other supporters and cheerleaders, thank-you.  
I would like to thank my families (both the family I was born into and the family I have 
had the privilege of marrying into) for all their love and support. Thank-you to Mum 
for your thorough proof reading and willingness to do so.  
I am particularly grateful to Marc, who at the start of this journey was my boyfriend, 
then became my fiancé and is now my husband. I love you and really appreciate your 
calm, stable presence and your willingness to provide support for me in all things.  
Lastly all glory goes to God, whom my inner peace comes from.  




Table of Contents 
Abstract…………………………………………………………………………………..i 
Acknowledgements…………………………………………………………………… iii 
List of Tables ..................................................................................................................vii 
List of Figures............................................................................................................... viii 
1 Chapter One: Introduction and Background ............................................................. 1 
1.1 Introduction to CKD Globally and in New Zealand .......................................... 1 
1.2 Introduction to the Dialysis Outcomes in those aged ≥65 years Study 
(DOS65+) ..................................................................................................................... 3 
1.3 Health-Related Quality of Life (HRQoL) and Disability .................................. 3 
1.4 Chronic Kidney Disease Stage Five (CKD5) .................................................... 4 
1.5 Importance of this Research for Māori .............................................................. 5 
1.5.1 Te Whare Tapa Whā ................................................................................... 5 
1.6 Overall Aim ....................................................................................................... 6 
1.7 Research Approach ............................................................................................ 6 
1.8 Overview of the Thesis ...................................................................................... 7 
1.9 Summary ............................................................................................................ 7 
2 Chapter Two: Rapid Review .................................................................................... 8 
2.1 Review Methods ................................................................................................ 8 
2.2 Rapid Review Results and Source Selection ..................................................... 9 
2.3 HRQoL History................................................................................................ 10 
2.3.1 Key Frameworks, Models and Theories of HRQoL ................................ 10 
2.3.2 Applications of HRQoL ........................................................................... 13 
2.3.3 HRQoL Measures ..................................................................................... 14 
2.3.4 Māori Perspectives of HRQoL ................................................................. 16 
2.3.5 HRQoL in this Thesis ............................................................................... 17 
2.4 Disability .......................................................................................................... 18 
2.4.1 Key Frameworks, Models and Theories of Disability.............................. 18 
2.4.2 Disability is Important .............................................................................. 21 
2.4.3 Disability Measures .................................................................................. 22 
2.4.4 Disability for Māori .................................................................................. 22 
2.4.5 Māori Models of Disability ...................................................................... 23 
2.4.6 Disability in this Thesis ............................................................................ 25 
2.5 HRQoL and Disability ..................................................................................... 26 
2.6 Conclusion ....................................................................................................... 27 
v 
 
3 Chapter Three: Scoping Review ............................................................................. 28 
3.1 Methods ........................................................................................................... 28 
3.1.1 Results and Source Selection.................................................................... 30 
3.2 HRQoL and CKD Scoping Review ................................................................. 36 
3.3 HRQoL Defined ............................................................................................... 36 
3.4 HRQoL and CKD ............................................................................................ 37 
3.4.1 HRQoL and CKD in Cross-Sectional Studies .......................................... 37 
3.4.2 HRQoL and CKD in Longitudinal Cohort Studies .................................. 38 
3.4.3 HRQoL and CKD in Review Studies ....................................................... 41 
3.4.4 HRQoL and CKD in Systematic Reviews................................................ 42 
3.4.5 Summary of HRQoL and CKD ................................................................ 42 
3.5 Disability and CKD Scoping Review .............................................................. 43 
3.6 Disability Defined ............................................................................................ 43 
3.7 Disability and CKD ......................................................................................... 44 
3.7.1 Disability and CKD in Cross-Sectional Studies ....................................... 44 
3.7.2 Disability and CKD in Cohort Studies ..................................................... 45 
3.7.3 Disability and CKD in Review Studies .................................................... 47 
3.7.4 Disability and CKD in Systematic Reviews ............................................. 49 
3.7.5 Summary of Disability and CKD ............................................................. 49 
3.8 HRQoL and Disability in CKD ....................................................................... 50 
3.9 Sources that Discussed Either HRQoL or Disability in Māori CKD Patients . 51 
3.10 Conclusion.................................................................................................... 52 
4 Chapter Four: Methods ........................................................................................... 53 
4.1 The Dialysis Outcomes in those aged ≥65 Study (DOS65+) .......................... 53 
4.1.1 Ethical Approval ....................................................................................... 54 
4.1.2 DOS65+ Methods in Brief ....................................................................... 54 
4.1.3 Inclusion/Exclusion Criteria ..................................................................... 54 
4.2 H&D Study ...................................................................................................... 55 
4.2.1 H&D Study Participants ........................................................................... 55 
4.3 Predictor, Outcome and Explanatory Variables .............................................. 56 
4.3.1 Predictor Variables ................................................................................... 57 
4.3.2 Outcome Variable ..................................................................................... 58 
4.3.3 Explanatory Variables .............................................................................. 59 
4.4 Statistical Analyses .......................................................................................... 61 
4.5 Analysis of the Māori Cohort .......................................................................... 63 
vi 
 
4.6 Summary .......................................................................................................... 63 
5 Chapter Five: Results ............................................................................................. 64 
5.1 Study Participants ............................................................................................ 64 
5.2 Participant’s Characteristics at Baseline .......................................................... 65 
5.2.1 Disability at Baseline ................................................................................ 67 
5.3 Predictors of Disability at 12 Months .............................................................. 69 
5.3.1 Univariate Analyses.................................................................................. 69 
5.3.2 Multivariable Analyses ............................................................................. 71 
5.4 Outcomes for Older people on Dialysis ........................................................... 73 
5.4.1 Descriptive Analyses ................................................................................ 73 
5.4.2 Multivariable Analysis of Disability Outcomes among Dialysis Patients 
(HD or PD) only ..................................................................................................... 75 
5.5 Analyses Māori Cohort .................................................................................... 76 
5.5.1 Māori Descriptive Analyses ..................................................................... 76 
5.5.2 Univariate Analyses.................................................................................. 78 
5.6 Comparison of Participants Remaining in the Study at 12 months to Baseline 
only Participants ......................................................................................................... 81 
5.7 Conclusion ....................................................................................................... 83 
6 Chapter Six: Discussion ......................................................................................... 84 
6.1 Results .............................................................................................................. 84 
6.1.1 Objective One ........................................................................................... 84 
6.1.2 Objective Two .......................................................................................... 85 
6.1.3 Objective Three ........................................................................................ 88 
6.2 H&D Study Strengths and Limitations ............................................................ 89 
6.2.1 Strengths ................................................................................................... 89 
6.2.2 Limitations ................................................................................................ 90 
6.3 Implications ..................................................................................................... 92 
6.4 Future Research ............................................................................................... 94 
6.5 Final Conclusions ............................................................................................ 95 
References……………………………………………………………………………...97 
Appendix I: Tables to Support the Rapid Review ........................................................ 115 
Appendix II: Tables to Support the Scoping Review ................................................... 141 





List of Tables 
Table 2.1 Search terms used to identify HRQoL literature .............................................. 8 
Table 2.2 Search terms used to identify disability literature ............................................ 8 
Table 2.3 Summary of the key definitions, frameworks, models and theories of HRQoL
 ........................................................................................................................................ 12 
Table 3.1 Search terms used to identify HRQoL in literature ........................................ 29 
Table 3.2 Search terms used to identify disability in literature ...................................... 30 
Table 3.3 Search terms used to identify CKD in literature ............................................ 30 
Table 3.4 CKD status of the 24 papers regarding ‘HRQoL and CKD’ .......................... 35 
Table 3.5 CKD status of the 14 papers about ‘disability and CKD’ .............................. 35 
Table 4.1 Variables investigated in the multivariable prospective model ...................... 62 
Table 5.1 Baseline descriptive characteristics of the 223 participants ........................... 66 
Table 5.2 Disability described at baseline (n=223) ........................................................ 68 
Table 5.3 Univariate analysis of risk of WHODAS 2.0 ≥10 representing ‘considerable 
disability’ after 12 months follow-up according to characteristics of the participants 
(n=157) ........................................................................................................................... 70 
Table 5.4 Multivariable analysis of variables predicting WHODAS 2.0 ≥10 
representing ‘considerable disability’ at 12 months (n=156) ......................................... 72 
Table 5.5 Baseline descriptive statistics of HD (n=108) and PD (n=60) ....................... 74 
Table 5.6 Multivariable analyses of variables predicting WHODAS 2.0 ≥10 
representing ‘considerable disability’ at 12 months, among older dialysis patients (HD 
and PD) only (n=116) ..................................................................................................... 75 
Table 5.7 Baseline characteristics of the Māori cohort (n=49) ...................................... 77 
Table 5.8 Disability described at baseline in the Māori participants (n=49).................. 79 
Table 5.9 Baseline characteristics of Māori participants who had ‘lesser/no disability’ 
compared to those who were disabled at 12 months (n=37) .......................................... 80 
Table 5.10 Characteristics of participants followed-up at 12 months (n=156) compared 





List of Figures 
Figure 2.1 Flow diagram of source selection ................................................................... 9 
Figure 2.2 HRQoL depicted for this thesis ..................................................................... 18 
Figure 2.3 Disability depicted for this thesis (building on the WHO ICF model (114) . 26 
Figure 3.1 Diagram demonstrating the search strategy .................................................. 29 
Figure 3.2 Flow diagram of scoping review for HRQoL and CKD in those aged ≥65 
years. ............................................................................................................................... 32 
Figure 3.3 Flow diagram of scoping review for disability and CKD in those aged ≥65 
years ................................................................................................................................ 33 
Figure 4.1 Diagram of the DOS65+ illustrating the clinical mortality and interview data 
collection points. ............................................................................................................ 53 
Figure 4.2 Diagram of the H&D Study in relation to the DOS65+ Study, indicating the 
numbers of participants at each data collection points ................................................... 56 
Figure 5.1 H&D Study participants ................................................................................ 64 





List of Abbreviations and Acronyms 
ANZDATA Australian and New Zealand Dialysis Transplantation registry  
BMI Body Mass Index  
CI Confidence Interval  
CKD Chronic Kidney Disease 
CKD5 Chronic Kidney Disease Stage Five  
DHB District Health Board  
DOS65+ Study Dialysis outcomes in those aged ≥65 years study  
ESKD End Stage Kidney Disease  
eGFR Estimated Glomerular Filtration Rate 
GFR Glomerular Filtration Rate  
HALex Health and Activities Limitations Index 
HD Haemodialysis  
H&D Study  DOS65+ Health and Disability Outcomes Study 
HRQoL  Health-related Quality of Life  
ICF International Classification of Functioning, Disability and 
Health 
ICIDH International Classification of Impairments, Disabilities and 
Handicaps 
KDIGO Kidney Disease: Improving Global Outcomes consortium 
KDQoL Kidney Disease Quality of Life Instrument 
NHP Nottingham Health Profile 
nMnP Non-Māori/Non-Pacific  
NZ New Zealand 
MCS Correlated mental health 
PCS Correlated physical health  
PHARMAC Pharmaceutical Management Agency 
x 
 
PD Peritoneal dialysis  
QWB Quality of Well-being Scale 
RR Relative risk  
RRT Renal Replacement Therapy  
SIP Sickness Impact Profile 
SF-36 Medical Outcomes Study 36 Item Short form (SF-36) 





1 Chapter One: Introduction and Background 
This chapter provides a brief introduction to the burden of chronic kidney disease 
(CKD) globally and in New Zealand (NZ), and focuses on those aged ≥65 years. 
Following this the Dialysis Outcomes in those aged ≥65 years Study (DOS65+) will be 
explained (1); the DOS65+ Study is the ‘parent’ study that led to the DOS65+ Health 
and Disability Outcomes Study (H&D Study) described in this thesis. The terms health-
related quality of life (HRQoL), disability and CKD will be introduced, before 
discussing the sub-cohort embedded in this thesis relating to older Māori with CKD and 
issues of health and disability associated with renal replacement therapy (RRT). Te 
Whare Tapa Whā (2), a Māori model of health and well-being, will also be outlined. 
The overall aims of this thesis will be discussed, and a summary of the research 
approach will be provided. This chapter will conclude by providing an overview of the 
subsequent chapters that are introduced in this thesis.  
1.1 Introduction to CKD Globally and in New Zealand 
In order to standardise the definitions of CKD, the Kidney Disease: Improving Global 
Outcomes consortium (KDIGO) have categorised kidney disease into five stages 
related to kidney function (3). Stage five is considered most severe and stage one is 
considered least severe. In most of the CKD outcomes literature, CKD is described as 
when the estimated glomerular filtration rate (eGFR) is <60ml/min/1.73m2 (stage 3 or 
below). From the DOS65+ Study and therefore the H&D Study, we focused 
specifically on chronic kidney disease stage five (CKD5) where individuals either had 
an eGFR < 15ml/min/1.73m2 and were pre-dialysis and/or individuals who were on 
dialysis. CKD5 is also known as end stage kidney disease (ESKD). For clarification, 
the abbreviation ‘CKD5’ will be used in this thesis when specifically focusing on those 
with chronic kidney disease stage five and the abbreviation ‘CKD’ will be used when 
discussing chronic kidney disease more generally.  
Globally, 10% of the population is affected by some form of CKD with the majority 
having CKD stage 3 (4). CKD is the 18th cause of global deaths, resulting in 16 per 
100,000 deaths as of 2013 (5). CKD is a worldwide problem and globally there has 
been a steep increase in the number of individuals with CKD in both absolute and 
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relative terms (6, 7). The rise of CKD has been attributed, in a large part, to the rise in 
diabetic kidney disease rates (8). In those aged ≥65 years, vascular disease has been a 
prominent cause of the rise in CKD (8). Related to the rapid rise of CKD in the past two 
decades, there has also been an increase in the proportions of older individuals (aged 
≥65 years for the purposes of this thesis) reaching CKD5 and commencing dialysis to 
manage this (9). Dialysis removes smaller molecular weight solutes that are normally 
excreted by the kidneys, as well as controlling salt and water homeostasis to maintain a 
stable but impaired internal environment in an individual. It does not replace normal 
kidney function (10). In England and France, researchers have estimated that among  
older individuals (aged ≥70 years) dialysis has the potential to extend life by an average 
of approximately 2 years (11, 12). Due to the nature of CKD5, as well as the 
interventions to manage CKD5 (dialysis), it has a large potential to have a negative 
effect on an individual’s HRQoL and can be quite overwhelming (1). This is because 
CKD5 (dialysis) often results in significant changes in lifestyles which is often difficult 
for patients to accept, and it is a painful and invasive treatment (13). Additionally, it is 
known that disability, related to comorbidities, is prevalent amongst many CKD5 
patients (14) and that those with CKD5 are often known to be encumbered by physical 
limitations, which often manifest as disabilities (15). However, it appears that limited 
research has investigated relationships between health-related quality of life (HRQoL) 
and disability among older individuals’ with CKD5, who are either pre-dialysis or on 
dialysis (8).  
In NZ, CKD is prevalent in approximately 12-14% of the population. Only a small 
proportion of these individuals will end up with CKD5 and require dialysis. From the 
latest Australian and New Zealand Dialysis and Transplantation registry (ANZDATA) 
(16), the incidence of new patients in 2017 commencing dialysis was 615 and the total 
number on RRT was 4658 (2768 on dialysis and 1890 with a transplant). Of those 
incident dialysis patients, 38% were aged ≥65 years (older) and 53% of the prevalent 
patients on dialysis were aged ≥65 years (16). By 2051 it is expected that there will be 
1.4 million older people in NZ (17), therefore the number of older individuals with 
CKD5 who may require dialysis will continue to rise (8). The increase of older patients 
on dialysis in NZ has significant implications for those affected and their families. This 




In NZ through taxation the NZ healthcare system is funded by the government to allow 
for universal access. Dialysis is expensive and therefore results in significant economic 
costs for the NZ government. Dialysis treatment is estimated to cost approximately 
$65,000-$80,000 per year, per individual (1). Annually over $56 million is spent on 
dialysis patients aged over ≥65 years in NZ. This does not include the costs related to 
hospitalisations and comorbidities (1). As a result of this, CKD5 poses a significant 
health burden that is not restricted to those with the disease but expands to NZ society.   
1.2 Introduction to the Dialysis Outcomes in those aged ≥65 
years Study (DOS65+) 
 
This thesis will use data from the DOS65+ Study. The DOS65+ Study is an 
“accelerated longitudinal” cohort which aimed to determine the HRQoL of older 
patients with CKD5, to compare and contrast survival between different treatment 
options and to develop evidence-based guidelines for management of older patients 
with CKD5 (1, 18).The study recruited ‘prevalent’ New Zealanders with CKD5 at the 
study’s commencement and additionally recruited ‘incident’ New Zealanders as the 
study data collection phrase proceeded in an accelerated fashion. The DOS65+ Study 
was designed to measure a range of outcomes such as HRQoL, measured by the EQ-
5D-3L (19, 20) and disability, measured by World Health Organisation Disability 
Assessment Schedule (WHODAS 2.0) (21). To be eligible for inclusion, participants in 
the DOS65+ Study had to have either commenced dialysis or been diagnosed with 
CKD5 and undergone pre-dialysis education (1). The protocol is further explained 
elsewhere (1) and is further explained in section 4.1 (Chapter 4). This thesis presents 
independent analyses of certain data collected from the DOS65+ Study. For clarity the 
DOS65+ Health and Disability Outcomes Study, which refers to the independent 
analyses and literature reviews presented in this thesis, will be referred to as the H&D 
Study.  The H&D Study is explained in the Methods (Chapter 4).  
1.3 Health-Related Quality of Life (HRQoL) and Disability  
As will be elaborated on in the literature review (Chapter 3), there is limited 
information describing the relationships between HRQoL and disability outcomes 
among older people with CKD5. As will be discussed in the aims (section 1.6), HRQoL 
and disability are the main predictor and outcome variables respectively in this thesis, 
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therefore it is important to understand what is meant by these terms. However, it is 
important to note that there is not a single, agreed upon definition or conceptualisation 
of HRQoL (22) and defining disability continues to be contested (23). The key 
frameworks, models and theories for HRQoL and disability have therefore been 
explored in a rapid review of the literature (presented in Chapter 2), to help inform the 
subsequent H&D Study analyses.  
1.4 Chronic Kidney Disease Stage Five (CKD5) 
Within NZ, individuals with CKD5 are managed as part of a multidisciplinary team. 
Unless very symptomatic, they are initially managed medically to reduce the impact of 
CKD5 and to control or reduce their associated symptoms. At the same time, 
individuals are educated with respect to on-going management for their CKD5. This 
includes an active conservative care pathway where symptoms continue to be actively 
managed medically but a decision not to undertake dialysis is made. Alternatively, RRT 
options include:  
Dialysis, either haemodialysis (HD) or peritoneal dialysis (PD), or renal transplantation 
is discussed and commenced when appropriate. The DOS65+ Study population only 
included individuals on dialysis (HD or PD), or those still on an active medical 
management pathway (1).  
Briefly, HD involves pumping blood through a semipermeable membrane while 
dialysis fluid is pumped past the other side in the opposite direction. This allows for the 
removal of unwanted solutes from the blood (24). A dialysis machine acts as the 
‘kidney’ and the blood stream is accessed through an intravenous (jugular) catheter or 
needling an arterio-venous fistula.  This treatment is completed three times a week on 
average (25). Within NZ, approximately 1 in 5 HD patients dialyse at home (26).  
PD is where an individual has a dialysate (a balanced salt solution) infused through a 
tunnelled catheter through the abdominal wall into the peritoneal cavity. Unwanted 
solutes and water diffuse down a concentration gradient from capillaries across the 
peritoneal membrane (a semipermeable membrane into the dialysate). The dialysate is 
regularly exchanged four times a day (24). PD has the distinct advantage of allowing 
home based dialysis and within NZ, 66% of individuals receiving dialysis (both PD and 
HD) were home based as of 2019 (27).  
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1.5 Importance of this Research for Māori  
In NZ, Māori (the indigenous people of NZ) continue to experience sustained inequities 
in health care access, treatments and outcomes compared to non-Māori (28). The Treaty 
of Waitangi, signed by the British Crown and Māori representatives in 1840, committed 
to ensuring Māori had at least the same rights and privileges as non-Māori, which 
encompasses health in a more contemporary context (29). Principles of the Treaty of 
Waitangi are included in health and disability legislation; however, Māori still 
experience lower rates of access to health services than non-Māori despite increased 
need (30). Additionally, Māori life expectancy is 7.1 years less than non-Māori (31).  
Māori have a 2-fold higher rate of CKD5 and often present at an earlier age than NZ 
Europeans (32, 33). Māori experience reduced life expectancy whilst dialysing even 
when socioeconomic, demographic and geographical factors are considered (34). 
Currently there is limited knowledge relating to Māori experiences with CKD5 
particularly related to HRQoL and disabilities (1, 35). Within the DOS65+ study, there 
was a decent Māori representation (36). As such, a sub-cohort of this H&D Study is 
focused on the health and disability of Māori participants.  
1.5.1 Te Whare Tapa Whā 
Given that this thesis explores Māori HRQoL and disability associated with CKD5, it is 
important to understand how Māori perceive and view health. A popular model is Te 
Whare Tapa Whā which represents a holistic approach to health and well-being (30, 37, 
38, 39). This model consists of four dimensions or pillars which represent four sides of 
a house, reflecting that if one dimension is weak or diminished then a person does not 
have optimal health and well-being (39, 40). The dimensions are:  
Taha Wairua: This means the spirituality of a person is essential to who they 
are. Spirituality allows for an important link to ancestors to be made and 
provides future direction (37, 39). 
Taha Hinengaro: This concept refers to mental health. It stresses that thoughts, 
feelings and ways of the mind cannot be separated from the body or the soul. 
The way an individual feels is important for their state of health (38, 39). 
6 
 
Taha Tinana: This represents the physical body. Physical health is important 
and considers the biomedical needs of the body (30), however it is noted that 
this is highly connected to the mind and soul. When the mind, body and soul 
interact positively, this allows for positive health outcomes (39).  
Taha Whānau: For full health to be realised, the relationship between 
individuals and their whānau (family or wider social networks) must be 
recognised. Whānau wellbeing is improved by individuals’ being well (37, 39).  
Acknowledgement and understanding of the Te Whare Tapa Whā will enable it to serve 
as a framework for the interpretation of the findings from the literature review, and in 
particular the findings that focus on Māori.  
1.6 Overall Aim 
The main aim of the H&D Study is to investigate the association between dimensions 
of HRQoL and disability, and to determine if HRQoL and/or other factors act as 
potential predictors of disability in people with CKD5 aged ≥65 years in NZ at 12 
months follow up. This will aid in developing knowledge to inform both nephrology 
professions and patients with respect to the impact of dialysis on their life.  
The specific objectives of this research are to:  
a) Describe characteristics of the H&D Study participants at baseline and to 
determine cross-sectional associations, if any, between health-related quality of 
life (HRQoL) and disability among a cohort of older New Zealanders with 
CKD5 at the time of recruitment (baseline);  
b) Determine, which, if any, factors at recruitment (baseline), and including 
HRQoL, predict disability outcomes 12 months later;  
c) Describe key characteristics (including HRQoL and disability) at recruitment 
(baseline) and again 12 months later for older Māori patients with CKD5.  
1.7 Research Approach  
As mentioned, the H&D Study analyses data from the DOS65+ Study. In the DOS65+ 
Study, all participants were interviewed first at time of recruitment to the study and 
again 12, 24 and 36 months later. Analyses undertaken as part of the H&D Study are 
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focused on data collected in the DOS65+ Study at baseline (interview 1) and again at 
12 months (interview 2).  
Quantitative analyses will be used to examine associations between HRQoL and 
disability. Other variables such as sex, ethnicity and age will also be analysed. Analyses 
will be completed to determine which factors at baseline, including HRQoL, predict 
disability in the H&D Study cohort of CKD5 patients aged ≥65 at 12 months. 
Descriptive analyses will be completed within the Māori cohort.  
Very little research has been completed investigating predictors of disability in CKD5 
patients, therefore this research will provide new evidence regarding the long-term 
disability outcomes in CKD5 patients within the NZ CKD5 context.  
1.8 Overview of the Thesis 
This thesis will detail a rapid review (Chapter 2) which aims to provide understanding 
of what is meant by HRQoL and disability, informed by the current literature to inform 
the subsequent H&D Study analyses. Following this, a scoping review of the literature 
will be presented (Chapter 3) to determine the relationship between HRQoL and 
disability respectively in people with CKD5, respectively, specifically in those ≥65 
years and to help identify potential predictors of outcomes and confounders to consider 
in the H&D Study. The study design and methods of the empirical work will be 
presented in the Methods (Chapter 4) before the Results are presented (Chapter 5). The 
thesis is concluded with the Discussion and Conclusions (Chapter 6).  
1.9 Summary 
This chapter has detailed the prevalence of CKD globally and within NZ It has 
introduced the reader to the DOS65+ Study and has described CKD5. It has also 
provided an introduction of the importance of this research for Māori. Additionally, the 




2 Chapter Two: Rapid Review 
This chapter aims to identify key frameworks, models and theories underpinning both 
health-related quality of life (HRQoL) and disability from sources identified through a 
rapid literature review (41). Firstly, the methods of the rapid review are presented, 
followed by a discussion of the main findings relevant to the HRQoL and disability 
research undertaken in this thesis.  
2.1 Review Methods  
Rapid reviews, with a narrative synthesis, allow for inclusion of a comprehensive range 
of literature (42, 43), in this case pertaining to HRQoL and disability. As mentioned, 
the aim of this rapid review is to identify key frameworks, models and theories 
underpinning health-related quality of life (HRQoL) and disability.  
Ovid, PubMed, Google Scholar and CINHAL databases were searched during this 
review. The search terms are presented in Tables 2.1 and 2.2 below. Additionally, to 
identify key Māori frameworks, models and theories relating to HRQoL and disability, 
each term in the following tables was searched with the Boolean “AND” Māori 
(variations of this term such as Maaori, Maori and Māori were also included). Several 
books focused on HRQoL and disability that were identified via journal bibliographies 
and recommended by supervisors were also included. 
Table 2.1 Search terms used to identify HRQoL literature  
Health Related Quality of 
Life 
Quality of Life Health status  
Health-Related Quality of 
Life 
QOL Generic health 
HRQOL Health EQ-5D  
HRQoL Perceived health  General health  
 
Table 2.2 Search terms used to identify disability literature 
Disability Disabilities Disability evaluation 
Disabled Handicapped Physically challenged  
Disab* Disabled persons Physically disabled  
Physically handicapped WHODAS 2.0 or WHODAS II 





In PubMed, when the terms “health related quality of life” and “disab*” were searched 
there were 328,361 and 208,202 results, respectively (as of 01/04/2018). As a result of 
the large number of results, the search was narrowed by adding the Boolean phrase 
“AND” followed by “define” or “definition” to the search. When this did not yield a 
manageable number of articles (the target being fewer than 300 results for each search), 
the “allintitle” restriction was added.  
2.2 Rapid Review Results and Source Selection  
In addition to identifying key frameworks, models and theories underpinning HRQoL 
and disability, sources had to be available in English. Initially sourced items were 
screened on the basis of their titles, then abstracts, and the full texts of remaining 
sources were then reviewed. 
Figure 2.1 Flow diagram of source selection 
 
* The numbers in the figure represent the number of items selected at each stage of the review process.  
As presented in Figure 2.1, after title and abstract screening a total of 67 full-text 
sources were assessed for eligibility and were all relevant for inclusion in the rapid 
review. Tables I (1-5) in Appendix I summarise the sources on HRQoL (n=17), 
HRQoL and Māori (n=2), disability (n=38), disability and Māori (n=7), and HRQoL 
and disability (n=3). These tables also summarise the main aims, findings and 
conclusions from each of these sources.  
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2.3 HRQoL History  
The term health-related quality of life (HRQoL) has developed over time and followed 
use of the term quality of life (QoL) (44). QoL is a term that appears to have increased 
in use from the 1940s (45-47) to depict the view that there is more to having a ‘good 
life’ than simply being financially secure (47). QoL can be perceived as the degree to 
which an individual’s needs are met (48) and involves elements aggregating together to 
form an overall perception of an individual’s QoL (49). QoL can be conceptualised in 
various ways which include:  
1) The philosophical perspective related to human existence.  
2) The ethical perspective related to the sanctity of life.  
3) The economic perspective which assesses QoL through evaluating economic 
growth.  
4) The sociological perspective which emphasises the relationship between the 
individual and their circumstances.  
5) The psychological perspective which defines QoL as an individual’s self-
appraisal of their life and goals (45).  
 
As the focus on patients’ wellbeing has increased over time, it has become clear that 
measures of mortality and morbidity are no longer sufficient to represent changes in 
population health (50). Research was first published on QoL in 1957 (45), and it 
became a key word in medical databases from 1975 (46). The term HRQoL became 
increasingly popular in the mid-1980s, and the number of HRQoL articles has 
continued to increase (46). For example, when HRQoL is searched as a key word in 
Ovid between 1902 and 1999 there are 1,395 results but searching between 2000 and 
2018 finds 29,293 results as of May 2018.  
2.3.1 Key Frameworks, Models and Theories of HRQoL  
The aim of this rapid review is to present key models, theories and definitions of 
HRQoL. As of yet, there is not a single agreed upon definition or conceptualisation of 
HRQoL (22). Wilson and Cleary are often regarded as the first to develop a model of 
HRQoL (22). They noted that most conceptualisations of HRQoL include the 
dimensions of physical functioning, social functioning, mental health and general 
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health perceptions. Concepts such as vitality, pain, and cognitive functioning were also 
identified as important in determining an individual’s HRQoL. Wilson and Cleary 
summarise their model of HRQoL with the idea that there are five causal factors which 
interact to influence HRQoL. These are biological/physiological factors, symptoms, 
functioning, general health perceptions and overall QoL (22). These factors are said to 
be on a continuum and each of the factors plays a different role in influencing the 
HRQoL of a person, depending on the circumstances of the individual.  
More recently, Karimi et al described four different models of HRQoL that they 
identified from the literature (50). Firstly, they noted that HRQoL can be defined 
according to how well a person functions and their perceptions of their physical, mental 
and social well-being (50). Secondly, HRQoL is often considered to be a subset of 
QoL, wherein QoL is seen as an all-inclusive concept incorporating all factors that 
impact upon people’s lives, whereas HRQoL only incorporates factors that are part of 
the individual’s health (50). Thirdly, HRQoL is self-perceived and well-being relates 
directly to the presence of disease or treatment. In this definition, it appears that an 
individual must be experiencing disease in order to have their HRQoL affected. Lastly, 
HRQoL can be seen as a means of valuing or ‘measuring’ health, whereby different 
values (i.e. utilities or preference weights) are assigned to different health states (50). 
This last model aids us in understanding how HRQoL may be measured.  
As a result of health professionals and researchers becoming more aware that patients’ 
needs extend beyond the physical body, HRQoL has also been defined as a measure of 
wellness (51). However, defining HRQoL as a measure of wellness is quite subjective, 
so instead HRQoL has been referred to as the psychological, social and physical factors 
that directly impact health (48). It is important that HRQoL is considered in a 
subjective, multidimensional and dynamic fashion (45), with personal priorities and 
experiences being considered (49). The ability of an individual to conclude what their 
HRQoL is, is important (52) which is why it is often seen as a subjective measure. 
Lastly, HRQoL can be seen as not only something that is important to the individual 
but as something that can be perceived by a group or influenced by the environment. 
The Centres for Disease Control and Prevention defines HRQoL as “an individual’s or 
group’s perceived physical and mental health over time” (53). It is important that the 
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determinants of the HRQoL of the population be understood in order to improve 
individuals’ and populations’ HRQoL (49). 
Table 2.3 provides a useful summary of the various ways HRQoL has been described. 
Table 2.3 Summary of the key definitions, frameworks, models and theories of 
HRQoL 














Components mentioned  
Cognitive 
Function 
✓   ✓    
Mobility ✓  ✓     
Self-care ✓  ✓     
Usual activities ✓  ✓  ✓    
Pain/Discomfort ✓   ✓    
Anxiety/ 
Depression  
✓     ✓  
Biological  ✓  ✓  ✓  ✓  ✓  
Physiological ✓  ✓  ✓  ✓  ✓  
Symptoms ✓  ✓  ✓    
Social/Support   ✓  ✓   ✓   
General health 
perceptions 
✓  ✓  ✓   ✓  
Patient 
Preferences 
✓     ✓  
Assigning values 
to health  
 ✓     
Holistic 
perspective 
   ✓   
Definition Not available One definition 






viewed as the 
way health 
affects quality 


































overall HRQoL.  
Not available  Not available Not available Not available  
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Theory  Biological and 
social sciences 












health. QoL is 
about all 
aspects of life.  




























2.3.2 Applications of HRQoL  
Various frameworks, models and theories of HRQoL need to be understood in order to 
apply the concepts of HRQoL. HRQoL is  increasingly being used to assess health 
outcomes globally (54, 55) and measures of HRQoL are often used in clinical trials 
(22). HRQoL is an important concept to consider when planning, implementing and 
evaluating both health care and social policies (44). HRQoL is an important outcome; 
medically an individual may be improving however if the treatment required is 
decreasing HRQoL significantly, there is a potential that the medical intervention needs 
to be re-evaluated. Therefore, HRQoL is a concept that is considered in a wide array of 
settings, nationally and globally.  
Within NZ, HRQoL is often used as a measure in research that focuses on patient care, 
as well as at a governmental level such as in policy and planning development (56). For 
example, the pharmaceutical management agency (PHARMAC) uses HRQoL as an 
important consideration when planning which pharmaceuticals and treatments it will 
fund (56). PHARMAC is the NZ Crown agency which decides which health-related 
products including medicines are subsidised within the publicly funded health system to 
those providing public health care (56). 
There is little merit in considering HRQoL as an outcome unless it can be measured 
(47, 52). Due to the large increase in interest about HRQoL, this has resulted in a 
number of valid and reliable measures of HRQoL being developed.  
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2.3.3 HRQoL Measures 
There are various measures of HRQoL available. However, when choosing which 
measure to use for a study it is vital that the measurement goals are clearly defined and 
that the measure is valid, reproducible and  easily interpreted (55). Additionally, the 
reliability, responsiveness (48) and breadth of the measure should be considered (57). 
There are also different ways to collect HRQoL data. This information can be collected 
from clinician assessments of individuals HRQoL, whānau assessment of HRQoL and 
an individuals’ assessment of HRQoL, however it is commonly regarded as important 
that personal priorities and views are considered (49) when contemplating HRQoL. 
This is due to only the individual truly being able to understand their own HRQoL.  
HRQoL can be measured through generic (non-disease specific) measures and non-
generic (disease specific) measures. Generic measures include the Medical Outcomes 
Study 36 Item Short form (SF-36) (58), Sickness Impact Profile (SIP) (59), Nottingham 
Health Profile (NHP) (60), Health Utilities Index (HUI)(61) , EQ-5D (62), Quality of 
Well-being Scale (QWB) (63) and the Health and Activities Limitations Index 
(HALex) (51, 64). Additionally, HRQoL questionnaires exist that are tailored for 
specific diseases, such as the kidney disease quality of life instrument (KDQoL)(65). 
Due to the large range of HRQoL measures, this rapid review will focus only on the 
main measures used. Currently, the EQ-5D and the SF-36 have been the most widely 
used measures of HRQoL (66).  
The EQ-5D was developed by the EuroQoL group as a short and user-friendly measure 
of HRQoL that can be self-reported by participants (20). The non-disease specific (i.e. 
'generic') nature of this measure allows it to be used alongside disease-specific 
measures, in healthy and unwell populations alike (20). The EQ-5D has five 
dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression 
(20). The main strengths of the EQ-5D are that it is quick to administer and complete, 
as well as easy to measure. 
There are two main versions of the EQ-5D available. The EQ-5D-3L has three response 
levels per dimension indicating whether the respondent has ‘no problems, moderate 
problems or extreme problems’, whereas the EQ-5D-5L has five response options – ‘no 
15 
 
problems, slight problems, moderate problems, severe problems or extreme 
problems’(62). The EQ-5D can be completed by the individual verbally by pen and 
paper or through online modes. Additionally, it can also be completed as proxy by 
others such as clinicians or loved ones. This measure also allows for an understanding 
of an individual’s overall rating of health according to social value sets ascribed to each 
of the possible health states; there are 243 possible health states with the EQ-5D-3L and 
3125 states with the EQ-5D-5L. In the EQ-5D-3L, a health state of ‘no problems’ with 
any of the five dimensions is equivalent to perfect health and is allocated to a 
preference (utility) weight index score of 1.0; a value of 0 is equivalent to dead, and 
individuals with ‘extreme’ problems across the five dimensions can have index scores 
of less than 0 (67). Index scores from groups of people can be used in economic 
analyses such as cost utility analysis and allows for focusing priorities for health care 
(67).  
Within NZ, index weights for different health states (68) of the EQ-5D-3L have been 
derived (56). Additionally, due to the EQ-5D being a non-disease specific measure this 
allows for comparisons of HRQoL in different disease groups and across different 
countries. There are over 170 countries that have used the EQ-5D (69). A limitation of 
the EQ-5D measure is that it was not originally developed to be a measure of HRQoL, 
but simply as a measure of health status (20) so it may not include all areas of health 
that impact HRQoL. 
The SF-36 is another common measure of HRQoL. This survey takes approximately 3-
5 minutes to complete and consists of 8 dimensions comprising physical functioning, 
role limitations-physical, bodily pain, general health, vitality, social functioning, role 
limitations-emotional and mental health. (57). The strengths of this measure are that it 
is quick and easy to complete and allows for comparisons between groups due to its 
standard questions. Additionally, it is multidimensional (57). The limitations of the SF-
36 measure include that it may not allow for the detection of small changes in specific 
disease states, (57) and like the EQ-5D it was not originally intended for a measure of 
HRQoL but to be used as a health status survey (46). Other limitations include the fact 
that there is no overall social preference weight. Correlated physical health (PCS) and 
correlated mental health (MCS) scores have been developed to summarise the 
information across the eight dimensions (70), however they can behave in a 
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contradictory manner making interpretation of the results difficult. A shorter version of 
the SF-36 is available, this is known as theSF-12. From the SF-36 and the SF-12 the 
SF-6D can be generated which allows for preference based scoring, however (71) it is 
important to note  that these measures were not developed with the idea of developing 
preference based scoring, unlike the EQ-5D (71).  
2.3.4 Māori Perspectives of HRQoL  
Despite there being a large amount of published literature on HRQoL, very little of this 
literature discusses Māori perspectives of HRQoL, or Māori HRQoL specifically. 
Māori views of the EQ-5D as a measure of HRQoL have begun to be investigated (72). 
Harwood has suggested that there is little evidence that commonly used European 
measures such as the EQ-5D are meaningful for Māori (73). A key issue in using the 
EQ-5D is that it may not capture health of indigenous populations such as Māori, due to 
Māori health being holistic and all-encompassing and including the range of 
characteristics captured in Te Whare Tapa Whā (see section 1.5.1, Chapter 1) (72).  
In a survey, 66 Māori were asked to evaluate the EQ-5D. Participants were recruited 
via snowball sampling in the year 2000 from Dunedin and Wellington. The average age 
of these participants was 41 years- over half were female and a large proportion of this 
sample were students. Three quarters of the participants considered the EQ-5D 
adequate which suggests the content was found to be valid (72). A ‘dead’ variable was 
added to this survey to determine how Māori would respond to having to rate this and 
the survey found that many participants did not value ‘dead’. This may have been due 
to an unwillingness to place a value on being dead, or due to being unaware of the need 
to do so. This suggests that there is potentially a lack of validity for Māori for placing a 
value on being ‘dead’. Five participants were interviewed after this survey and at the 
time did not believe that the way they viewed health was any different to non-Māori 
(72). Although this study is valuable, it had a small sample size of mostly students, 
limiting the generalisability of these findings. 
Very little research has been conducted about Māori perspectives of HRQoL, which 
demonstrates that further research is necessary not only to understand Māori HRQoL 
but to also understand what is important when measuring HRQoL for Māori. It is 
interesting to note, that as shown by a systematic review which analysed 41 studies that 
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examined HRQoL in indigenous populations, only three studies used indigenous-
specific measurements to measure HRQoL (74). Indigenous populations, including 
Māori, are likely to consider further dimensions of health that lie outside traditional 
measures (74). This indicates the need for further understanding of HRQoL 
perceptions, not just for Māori, but for indigenous populations globally.  
2.3.5 HRQoL in this Thesis 
As described, there are various frameworks, models and theories for HRQoL. This 
chapter does not aim to develop a new model or definition of HRQoL, but simply aims 
to determine which model, framework or theory will usefully inform the research 
questions addressed in this thesis. Firstly, the concept of HRQoL used in this research 
follows the widely agreed upon (various) frameworks, models and theories that HRQoL 
is influenced by physical function, ability to perform usual activity, mental health and 
general health perceptions (see Table 2.3). As concepts of pain/discomfort and 
cognitive function have also been identified as contributing to overall HRQoL, these 
have also been included in conceptualising HRQoL in this H&D Study (22). It is also 
important that an individual’s subjective view on their own HRQoL is considered when 
determining HRQoL, as it can be collected from clinicians or whanau’s assessment. 













Figure 2.2 HRQoL depicted for this thesis 
 
*Figure 2.2 displays how HRQoL will be viewed in this thesis. The individual’s perception is important 
in influencing how each element on the outside of the circle is represented.  
2.4 Disability  
Worldwide, over 1 billion people experience disability, with between 110-190 million 
experiencing extreme disability (defined by an individual’s level of difficulty in 
mobility, self-care, pain, cognition, interpersonal activities, vision, sleep and energy)  
(75). In NZ, 24% of adults report some form of disability and 59% of adult’s ≥ 65 
years’ experience disability (76). Despite significant levels of disability, how to best 
define disability continues to be contested (23). It is important that disability is clearly 
defined in this thesis as it is the key outcome variable in the analyses. 
2.4.1 Key Frameworks, Models and Theories of Disability  
There are a number of different frameworks, models and theories of disability. For 
example, models include the moral/religious, medical/individual, social/political, 
rehabilitation (77), experts, rights-based, economic and consumer models (78). This 
review will focus on three widely used models of disability, specifically, the medical 




















One prominent model of disability is the ‘medical model’, sometimes also referred to as 
the ‘individual’ model (77). This model views disability as impairments resulting from 
a ‘problem’ with a part of the body (80), meaning that disability results from the 
departure from normal anatomy or physiology (81). Nagi proposed an early draft of the 
medical model of disability (82). Disability was seen to result from disease, and this 
disease and its resulting pathology was what needed to be treated in order to reduce the 
disability and aid in ‘returning the patient to normal functioning” (82, 83). The medical 
model explains disability as something that is the result from functional deviations that 
are not considered ‘normal’ medically (84). One major criticism of the medical model, 
with its curative orientation, is that it necessarily positions disability as being viewed as 
a weakness and always as a negative health state (85). Disability is positioned as an 
issue solely to do with the individual with the ‘disability’, and there is no role of society 
in influencing this ‘disability’.  The medical model of disability often results in the 
individual and their family bearing all responsibility for this disability and being 
expected to adapt to meet the needs or expectations of society. 
Alternatively, the social model of disability positions disability as a social construct 
(86); this model is often understood to have developed as a reaction against the medical 
model (85). This model became particularly prominent in the 1970s and 1980s (80). In 
this model physical, mental, or learning impairments are viewed as the inability to 
function at what is considered ‘normal,’ and disability is the disadvantage or 
restrictions society then places on those who are ‘impaired’ resulting in their exclusion 
(80). In 1976, the British Union of Physically Impaired against Segregation declared 
disability as a phenomenon imposed on top of people’s impairments. They suggest that 
disability is a form of social oppression whereby those with impairments are excluded 
and isolated from participating in society (77). This has resulted in society devaluing 
and fearing disability (87). One way in which the social model can be understood is that 
no matter an individual’s level of physical, mental, or emotional functioning, 
disablement is the result of the societal environment failing to interact with individuals 
(88). One criticism of the model raised by both Palmer (2011) and Shakespeare (2006) 
is that it may not adequately address the medical needs related to the underlying 
impairments. This has the potential to lead to a lack of understanding of the proportion 
of disabled people who need access to health and social services (84, 89). The social 
model requires a socio-political approach in order to change environments, therefore 
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implying there needs to be a change in the way society views disability (77). A strength 
of the social model is that it challenges the discriminatory, and individually located, 
way in which disability can be portrayed under the medical model (90).  
The World Health Organization (WHO) has developed various models of disability. In 
the 1980s, WHO first published the International Classification of Impairments, 
Disabilities and Handicaps (ICIDH), which aimed to distinguish between impairments, 
disability and handicaps (91, 92). In this model impairment was defined as “any loss or 
abnormality of psychological, physiological or anatomical structure or function” (91). 
Disability was defined as “any restriction or lack (resulting from impairments) of 
ability to perform an activity in the manner or within the range considered normal for a 
human being” (91). Lastly, the ICIDH model defines handicap as “a disadvantage for a 
given individual, resulting from an impairment or a disability that prevents the 
fulfilment of a role that is normal (depending on age, sex, social and cultural factors) 
for that individual” (91). The ICIDH became popular in research and public health and 
was frequently used to conceptualise the health status of people in a wide variety of 
settings, such as in rehabilitation research, in the clinical setting and in the non-medical 
setting (93). However, the ICIDH model also has its challenges. One of these 
challenges is that the definitions of disability, impairment and handicapped are 
supposedly linked in a linear fashion, wherein the definitions were criticised due to 
their overlapping with each other (91). The idea of being ‘handicapped’ from this 
definition was also regarded as pejorative. In this definition, the cause of disability and 
handicap was an individual’s impairment, therefore problems encountered in daily 
living were attributed to personal flaws (77). The ICIDH model was regarded by some 
as overlooking the social aspects of disability, and it was not viewed as flexible or 
inclusive by disability scholars (92).  
As a result of criticism of the ICIDH, the model went through a series of 
redevelopments. In the early 2000s, the ICIDH was re-developed into the WHO 
International Classification of Functioning, Disability and Health (ICF) (91). This was a 
more inclusive approach, involving a number of disabled people in developing this new 
model (91). According to the ICF model, disability is related to impairments in 
functioning, activity limitations, and participation restrictions. It is also noted that 
environmental and personal factors influence all of these components (79). The ICF 
also describes participation restrictions in nine dimensions of: 1) learning and applying 
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knowledge, 2) general tasks and demands, 3) communication, 4) mobility, 5) self-care, 
6) domestic life, 7) interpersonal interactions and relationships, 8) major life areas, and, 
9) community, social and civic life (94). This ICF model of disability addresses both 
functions, and the social model of disability. This model has become popular and has 
been recognised in 191 countries, including NZ, and translated into many languages 
(91). The ICF model allows for a common language when describing disabilities across 
different countries (79), and across different time periods (95). However, despite the 
ICF being updated there are still criticisms of this model which include the fact that the 
model is still quite individually located, and there is little room within this model for 
developing an understanding as to how environments may in fact be the cause of 
disability (77). The ICF acts as a tool only to explore how the environment interacts 
with individual lives rather than allowing for investigating the direct impact of the 
environment (77).  
2.4.2 Disability is Important  
It is important to come to an understanding of the various frameworks, models and 
theories of disability, because disability is a major issue in society. In NZ, 
approximately 1.1 million people experience disability (76). People usually seek help 
not because of the health condition, but because of the impairments, limitations or 
restrictions (i.e. the disability) resulting from the health condition (96). Additionally, 
disability is costly at both personal and societal levels (23). Those with disabilities are 
often disadvantaged and experience large inequities (97). For example, in New 
Zealand, those who are considered ‘disabled’ are more likely to have lower incomes 
than those who are not disabled. Approximately 45% of adults considered disabled 
were employed in 2013, compared to 72% of non-disabled adults (76). At a societal 
level, $300 billion annually is spent on disabled individuals in the United States of 
America (98). In NZ, 24% of adults experience disability (76). As a result of the costs 
of disability, and more importantly the associated burden for the individuals and their 
families, it is vital that disability can be detected and measured. Through focusing on 
disability as an outcome it is then possible to identify opportunities to intervene to 
reduce disability wherever possible.  
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2.4.3 Disability Measures 
As with HRQoL, it is useful to consider approaches to measuring disability. The 
physical limitations can be assessed clinically, however this does not enable the 
individual to express how disability impacts them. Therefore, it is important to be able 
to measure disability from the perspective of the individual and how they perceive it to 
impact their lives. In response to the different models of disability, there are different 
ways to measure disability (86).  
For example, from the medical model perspective there has been measures such as the 
Karnofsky Performance Scale wherein an individual’s disability is assessed by a 
clinician. Through clinicians’ use of this scale, it allows them to have an improved 
understanding of a patient’s needs, abilities and ways of progression (99). However, in 
this measure the patient is not asked what their perspective of their functioning and 
ability is. Following this, in the social model of disability, Gale Whiteneck’s CHIEF 
(Craig Hospital Inventory of Environmental Factors) measure has been used. This 
measure looks at the ability of an individual to participate in society (100), and is done 
from the perspective of an individual rather than the clinician.  
One of the main measures of disability is the WHODAS, which has been further 
developed into WHODAS 2.0. This measure was developed in response to the ICF 
model of disability. It is a generic assessment useful for measuring health and disability 
across cultures in a standardised way (96, 101). WHODAS 2.0 measures six different 
dimensions which include cognition, mobility, self-care, getting along, life activities 
and participation (102). It is a useful measure as it provides an individual’s perspective 
on how their disability affects them and can be used with both disabled and non-
disabled people (103). 
2.4.4 Disability for Māori  
In this rapid review, I endeavoured to identify sources that focused on disability and 
models of disability specifically for Māori. As with HRQoL, few sources were 
identified. As per the Treaty of Waitangi, Māori have the same right to equal health 
outcomes as  non-Māori do (73, 104). One third of Māori experience disability (76, 
105)  and as a result of the large proportion of Māori experiencing disability, there is a 
need for services to provide Māori focused and appropriate care. Currently, there are 
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few models of disability specifically for Māori (105) or literature that explores what 
may be acceptable models of disability for Māori.  
2.4.5 Māori Models of Disability  
In NZ and internationally, the dominant models of disability include the 
medical/individual, social and ICF models. However, these models often do not 
consider the health needs of disabled Māori, or other indigenous populations. This is 
despite the fact that there is a larger proportion of disabled Māori and that disabled 
Māori have a higher proportion of unmet needs (105). When disability is viewed under 
the medical model, this leads to a focus on the medical needs of individuals and this is 
often from the perspective of the numerically dominant (non-Māori) culture of society. 
Despite Māori comprising 15% of the NZ population, often the medical model is used 
in care leading to the needs of the tangata whenua (people of the land, indigenous 
populations) not being met (106, 107). In contradiction to partnership and 
rangatiratanga (right to exercise authority) promised in the Treaty of Waitangi (104), 
NZ currently follows a strongly Anglo-European structure and therefore this often leads 
to the exclusion of Māori values (108).  
When developing a model of disability for Māori, it is crucial to understand that Māori 
have unique cultural needs and ways of viewing health. For example, Te Whare Tapa 
Whā (see section 1.5.1, Chapter one) is a Māori model of health developed from a 
Māori traditional world view (30, 37). As a result of the medical model of disability, 
dominating health care in NZ, and Māori viewing health through a traditional lens, 
barriers do exist when considering potential models of Māori disability. These barriers 
include poverty, access, environmental, legal, institutional and attitudinal barriers 
(109).  
A community based model has been proposed wherein the concepts of wairua, 
hinengaro, taha tinana and whānau of Te Whare Tapa Whā could underpin the 
development of a community based disability model (108). In this model, taha wairua 
links health to unseen and unspoken energies. Without this spiritual awareness, the 
mind and body can be open to illness. It aids in providing a link between whānau, the 
environment and a person’s health and wellbeing. Taha hinengaro reflects that 
thoughts, feelings and emotions are essential in determining health. Thought and 
expression are seen to arise not only from experience but are produced in response to an 
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experience. The third dimension of Te Whare Tapa Whā is taha tinana which 
acknowledges physical health. Physical health is also often considered central to non-
Māori models of health, however there is an important difference. Body parts such as 
the head are considered tapu (sacred or protected) and others are considered noa (non-
sacred, unprotected). Therefore, this can be important to consider when providing care 
to Māori to ensure tapu are respected. The final dimension is taha whānau and directly 
contributes to illness and wellness. Māori gain identity and a sense of purpose through 
their families. Often when an individual is severely disabled in NZ this leads to 
dependence on the health system for care, however this threatens whānau connection 
and can lead to the individual losing or diminishing their sense of identity and purpose 
that is key for well-being (108).   
A community-based model encompassing taha wairua, taha hinengaro, taha tinana and 
taha whānau would allow for further development of the idea that the person comes 
first, rather than impairment. This model would involve treating people as part of a 
community. Through developing a community-based model based on the concepts of 
Te Whare Tapa Whā this would allow for a holistic approach to be taken to ensure 
culturally appropriate services for all New Zealanders. It would be able to be adopted 
for all cultures and needs and would allow for equitable access for people with differing 
abilities and ethnicities (108), allowing for disability to be viewed more positively 
(110).  
More recently, Hickey and Wilson (2017) have developed Whānau Hauā as an 
alternative approach to conceptualising indigenous disability (105). This approach is 
informed by te ao Māori and provides a Māori view of disability. Whānau Hauā can be 
seen as an umbrella term that is suitable for disabled Māori. The term whānau includes 
those genealogically connected by common ancestors, those with a common or similar 
experience, and those who provide care and support that traditional whānau provides 
(105). The term ‘hau’ means mind or gale and the ‘ā’ refers to the motivation that 
drives the wind. The changing winds leads to a changing environment (105). Balance or 
peace is found in the whānau despite hauā consistently changing (105). This model is 
similar to the social model of disability wherein the barriers of daily life are not due to 
the disabled person but due to society. Whānau Hauā however involves a cultural 
dimension wherein whānau are needed to restore balance (105). It is positive to see the 
development of a Māori model of disability.  
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Currently in NZ, the He Korowai Oranga Māori Health Strategy is in place, which aims 
for Māori families to be able to achieve maximum health and well-being, and be 
provided with a supportive environment to allow for full participation and to gain 
maximum rehabilitation (111). The NZ Disability strategy is based on the social model 
of disability and in Objective 11, it aims to promote the participation of Māori (109). 
Additionally, Whāia Te Ao Mārama 2018 to 2022: The Māori Disability Action Plan is 
in place. This aims to reduce the barriers Māori face and is partnered with key Māori 
disability stakeholders (111). Despite progress towards developing disability care 
appropriate for Māori, there is still a lack of collaboration between ministries regarding 
Māori disability policy. Disabled Māori have found that often they have to be 
extremely proactive to access appropriate care due to the many barriers (109). Therein 
Māori models of disability require the need for incorporation of cultural care to be 
considered and have an emphasis placed on whānau support.  
In summary, although Māori models of disability have been developed, more work 
needs to be done to ensure Māori models of disability are developed and applied in 
practise and to ensure disabled Māori receive appropriate care. Māori are tangata 
whenua and were promised equal rights, and therefore equal health outcomes as non-
Māori (104). Yet one third of Māori are disabled and Māori frequently experience 
unequal access to services and there is a lack of culturally appropriate services (105). 
Therefore, further work needs to be done to acknowledge and use Māori models of 
disability.  
2.4.6 Disability in this Thesis 
The different models of disability are often accompanied by strong histories and 
perspectives (89, 112, 113). The medical model of disability tends to place all 
responsibility for the disability on the individual and their family. It is still important to 
address the medical needs often associated with disability (89). The social model of 
disability also provides an important perspective. The social model of disability views 
disability as the restrictions placed on individuals and their families due to the structure 
of societies (77). Lastly the ICF model considers disability according to impairments in 
functioning, activity limitations and participation restrictions but fails to address how to 
act to change the environment which would improve access for those with disability 
(77). Additionally, Māori models of disability discuss the need for the incorporation of 
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cultural care, as well as placing a large emphasis on whānau support (105, 108). 
Therefore, for the purposes of this thesis, disability will be conceptualised with both 
extrinsic and intrinsic factors (recognising the importance of the social model of 
disability, but also recognising the health condition that has led to the individual 
experiencing ‘disability’) and will follow the model depicted in the ICF with a focus on 
impairments, activity limitations and participation restrictions (79). As discussed, the 
Māori model of disability points to cultural care and whanau support and has therefore 
this has been included as a part of our model as these have the potential to influence an 
individual’s perception of disability within this cohort.  Figure 2.3 below shows a 
summary of the way disability will be viewed in this thesis.  




2.5 HRQoL and Disability  
Although the aim of the rapid review was to identify articles that discussed models or 
theories of HRQoL and disability separately, opportunistically three sources were found 
that discussed both HRQoL and disability. These sources discussed whether HRQoL 
and disability are seen as linked or as separate concepts. In some models, HRQoL has 
been viewed as an umbrella concept that encompasses impairments, disabilities and 
handicaps (115). Additionally, impairments have been seen to give rise to “handicaps”, 
which in turn results in disability which determines HRQoL (116). Others have argued, 
that HRQoL and disability should be viewed as separate concepts due to being 
developed separately for  a different purpose (23).  
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In the H&D Study, HRQoL will be considered as a possible predictor of disability. This 
is because health conditions such as CKD5 often result in functional limitations (which 
are included in most HRQoL measures, such as the EQ-5D) and these are explicitly 
considered aspects that make up the ICF model of disability (section 2.4.1).  
Disability, according to the social model of disability arises from society’s responses to 
health conditions/functional limitations. Therefore, it is important to understand that 
there are indeed relationships between HRQoL and subsequent disability at the 
individual level. The ICF model of disability, which we are predominantly focusing on 
in this thesis suggests there ought to be such relationships. If these relationships do 
exist, then being able to consider HRQoL (i.e. through the EQ-5D measure in this 
study) means that this will help provide an early opportunity in identifying groups of 
CKD5 patients who may be at risk of developing subsequent disability. From this it 
may mean that early initiatives can be taken to reduce the subsequent disability. This 
thesis will enable an understanding of whether HRQoL can act as a predictor of 
disability and if so, subsequent research could investigate initiatives to improve 
HRQoL and potentially prevent or reduce further disability.  
2.6 Conclusion  
As established in section 2.3.5 and displayed in Figure 2.2, an individual’s HRQoL is 
subjective and is formed by elements such as physical function, ability to perform usual 
activities, mental health, general health perceptions, pain/discomfort and cognitive 
function. It is plausible that if an individual’s perception of their HRQoL is negative 
this will likely impact the ICF. Therein it is feasible that HRQoL is examined as a 
possible predictor of disability.  
This chapter has summarised some of the key frameworks, models and theories 
underpinning both HRQoL and disability. This chapter has detailed the methods of the 
rapid review and provided a discussion on the importance of analysing HRQoL and 
disability. Information was provided which discussed various models, theories and 
definitions, as well as discussing how HRQoL and disability are measured. The 
available evidence surrounding Māori perspectives was analysed. This allowed 




3 Chapter Three: Scoping Review  
The H&D Study aims to describe associations between HRQoL and disability among a 
cohort of older New Zealanders with CKD5, and to determine which (if any) factors, 
including HRQoL, predict disability outcomes 12 months later. Additionally, the study 
aims to investigate disability outcomes specifically for older Māori with CKD5. This 
chapter presents findings from a scoping review of the literature that was undertaken to 
aid in informing the planning of statistical analyses for the H&D Study. Specifically, 
this chapter presents the methods and results of the scoping review focused on HRQoL 
and disability among people aged ≥65 years old diagnosed with CKD5.  
3.1 Methods 
Scoping reviews enable for the assessment of the breadth and quality of published 
research available on a topic, (41), as well as facilitating clarification of the key 
concepts (117). They are also useful for identifying knowledge gaps (117, 118). 
Scoping reviews also allow for clarifying of the quality and quantity of literature and 
often sorts sources by study design (41), which is how this scoping review is presented. 
In contrast rapid reviews do not allow for identification of knowledge gaps (118). This 
thesis aims to address some of those knowledge gaps.  
This scoping review has been conducted as suggested by Arkey et al (2005) and Levac 
et al (2010). Therein five steps of implementing a scoping review have been 
implemented. The five steps are as follows:  
Step 1: Identify the research question 
Step 2: Identify the relevant studies 
Step 3: Study selection  
Step 4: Charting data 
Step 5: Collating, summarising and reporting the results (118).  
This scoping review aimed to identify papers about ‘HRQoL and CKD’ and ‘disability 
and CKD’ in those aged ≥65 years.  
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To identify the relevant literature (step 2), database searching was conducted between 
February 2018 and May 2018. To ensure the scoping review was feasible within the 
timeframe for a Masters project, it was necessary to limit the literature search to four 
databases; (Ovid, PubMed, Google Scholar and CINHAL); to the time period of 
January 2000-May 2018, and to literature published in English. Additionally, the search 
was restricted to publications focused on human participants. Reference and 
bibliographic lists of the eligible papers were searched to determine if any further 
papers should be included; this helped to ensure relevant papers were not missed. The 
search terms are presented in Tables 3.1, 3.2 and 3.3. The HRQoL terms and disability 
terms were independently searched for alongside the CKD terms as shown in Figure 
3.1. Identification of papers discussing HRQoL or disability for Māori CKD patients 
was also completed when the search terms in Tables 3.1, 3.2 and 3.3 were combined 
with the Boolean “AND” Māori (this term includes terms such as Maaori, Maori and 
Māori). 









Table 3.1 Search terms used to identify HRQoL in literature 
Health Related Quality of 
Life 
Quality of Life Health status  
Health-Related Quality of 
Life 
QOL Generic health 
HRQOL Health EQ-5D 
HRQoL Perceived health  General health  
 
HRQoL and CKD 
HRQoL and 
Disability 
and CKD  
Disability and CKD  
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Table 3.2 Search terms used to identify disability in literature 
Disability Disabilities Disability evaluation 
Disabled Handicapped Physically challenged  
Disab* Disabled persons Physically disabled  
Physically handicapped WHODAS 2.0 or WHODAS II 
or just WHODAS 
Impairment 
 
Table 3.3 Search terms used to identify CKD in literature 
Chronic kidney disease ESRD Chronic renal failure 
CKD End stage kidney disease  Chronic renal dysfunction 
End stage renal disease ESKD Chronic renal insufficiency 
End stage renal failure  Renal insufficiency Kidney failure chronic 
Dialysis Renal conservative care Peritoneal dialysis 
Haemodialysis    
 
3.1.1 Results and Source Selection  
As shown in Figure 3.1 ‘HRQoL and CKD’ and ‘disability and CKD’ searches were 
completed separately. Through this search strategy, papers that discussed both HRQoL 
and disability in CKD patients were also sourced opportunistically. These sources were 
analysed separately. For step three of the scoping review (study selection) sources were 
screened based on their titles and then abstracts. The full texts of the remaining sources 
were then reviewed.  
Below are the inclusion and exclusion criteria for eligible sources. It is important to 
note that initially, the search was not limited to those ≥65 years of age in order to 
ensure minimal sources were missed. During screening of the abstracts, the following 
criteria were applied.  
Inclusion Criteria:  
• Discussed CKD with either a focus on HRQoL or disability (the source needed 
to include measures and/or theories; and not just discuss these in passing).  
• The participants in the study had to have CKD5. However, in cases where there 
was a clear sub-category reporting CKD5 patients, that source could be 
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included. Occasionally sources were included, such as reviews when the CKD 
status was unknown.  
• Additionally, the participants had to be ≥65 years of age. In cases where there 
was a clear category separating the results into different age groups, including 
the ≥65 years age group, the article could be included.  
Exclusion Criteria: Literature focused on the following topics was excluded:  
• Different drug therapies, for example literature that specifically focused on 
treatments aside from dialysis and non-dialysis.  
• Transplant patients, since there were no transplant patients in the H&D Study.  
• Surveillance, prevention or incidence of CKD. This scoping review focused on 
those with CKD.  
• Primarily on other diseases or health issues, like cardiovascular disease or falls 
prevention, since CKD was the population of interest. 
• Economic costs of dialysis therapy and disparities in access to care rather than 
the care itself.  
Figure 3.2 and 3.3 are flow diagrams that demonstrate the search results for ‘HRQoL 
and CKD’ and ‘disability and CKD’ respectively.  
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Figure 3.2 Flow diagram of scoping review for HRQoL and CKD in those aged 


























Records identified through 
database searching (n=500) 
Records after titles screened 
(n=433) 
Excluded (n= 67) based on applying 
criteria to the titles:  
• Pharmaceutical focus (13) 
• Transplant patients (2) 
• Epidemiology (4) 
• Economic Costs (3) 
• Other diseases focus (12) 
• Not CKD stage five (29) 
• Not about HRQoL (2) 
• Spouse/families/caregivers (2) 
 
Excluded (n=344) based on applying 
criteria to abstracts:  
• Alternative drug therapies (38) 
• Transplant patients(7) 
• Epidemiology (2) 
• Not CKD stage five (29) 
• Not about HRQoL (6) 
• Spouse/families/caregivers (2) 
• Not full paper (32)  
• Not aged ≥65 years (228)  
Records after abstract screened 
(n=89)  
Records after full text reviewed 
(n=22) 
Excluded (n=67) based on applying the 
criteria to the full texts:  
• Not CKD stage five (15) 
• Not aged ≥65 years (26) 
• Not about HRQoL (23) 
• Not full paper (3)  
Records identified after screening 
reference lists of included papers (n=2) 
























































Records identified through 
database searching (n=143) 
Records after titles screened 
(n=132) 
Excluded (n=11) based on applying 
criteria to the titles:  
• Transplant patients (6) 
• Economic Costs (1) 
• Other diseases focus (3) 
• Not CKD stage five (1) 
 
Records after abstract screened 
(n=52)  
Excluded (n=80) based on applying 
criteria to abstracts:  
• Alternative drug therapies (5) 
• Epidemiology (3) 
• Other diseases focus (23) 
• Not CKD stage five (7) 
• Not about disability (38) 
• Spouse/families/caregivers (2) 
• Not aged ≥65 years (2)  
 
Records after full text reviewed 
(n=13) 
Excluded (n=39) based on applying 
criteria to the full text:  
• Not CKD stage five (16) 
• Other diseases focus (1) 
• Not about disability (7) 
• Not aged ≥65 years (15) 
 
Records identified after screening 
reference lists of included papers (n=1) 





After applying the inclusion and exclusion criteria, 24 sources were identified which 
focused on HRQoL and CKD, and 14 articles on disability and CKD. Two articles 
discussing both HRQoL and disability were found; no additional papers were found 
after screening the reference lists of these two papers about HRQoL and disability. 
When the search was repeated for Māori, a total of 130 sources were found. After 
screening the titles, 50 remained. Abstract screening resulted in three papers remaining 
for full text assessment, which discussed either HRQoL or disability and CKD for 
Māori. No additional papers were found after screening the reference lists of the three 
included Māori papers.      
Following the identification of papers, as per steps 1-3 of completing a scoping review, 
charting the data (step 4) has been completed. In Appendix II the aim, study design, 
number of participants/number of papers reviewed, methods, inclusion/exclusion 
criteria, key findings and strengths and limitations of each paper is identified. This 
appendix shows the results of the 24 papers about ‘HRQoL and CKD’, the 14 papers 
about ‘disability and CKD’, the 2 papers about ‘HRQoL and disability in CKD’ and the 
3 papers about ‘HRQoL and disability in Māori with CKD’ presented in Tables II (1-4). 
Following this the papers were summarised, and the results are reported upon as 
follows in step 5. The papers were grouped by study design and the results that were 
focused upon, concentrated on how HRQoL and disability were defined and then 
analysed in the CKD population.  
Of note not all papers included in this scoping review focused on CKD5. Studies 
included in this scoping review, that did not focus on CKD5 specifically were still 
important in developing an understanding of ‘HRQoL and CKD’ and ‘disability and 
CKD’ and therefore were included. Tables 3.4 and 3.5 enable the reader to easily 
identify the CKD status included in each paper. It is important to distinguish between 
papers that focused on CKD5 and general CKD papers, as the H&D Study focused on 
CKD5. When comparing the results of the H&D Studies to the results of studies 






Table 3.4 CKD status of the 24 papers regarding ‘HRQoL and CKD’ 






Apostolou, T. (2007) ✓    
Balogun, S. A., et al. (2017) ✓    
Boateng, E. A. and L. East (2011) ✓    
Brown, E. A., et al. (2010) ✓    
de Jonge, P., et al. (2003) ✓    
Elliott, B. A., et al. (2014) ✓    
Finkelstein, F. O., et al. (2012) ✓    
Glover, C., et al. (2011) ✓    
Griva, K., et al. (2014) ✓    
Harris, S. A., et al. (2002) ✓    
Iyasere, O. U., et al. (2016) ✓    
Kanamori, H., et al. (2012) ✓    
Kutner, N. G. and S. V. Jassal (2002) ✓    
Lamping, D. L., et al. (2000) ✓    
Loos, C., et al. (2003) ✓    
Naik, N., et al. (2012) ✓    
Phillips, L., et al. (2001) ✓    
Ronsberg, F., et al. (2005) ✓    
Tyrrell, J., et al. (2005) ✓    
Unruh, M. L., et al. (2008) ✓    
Finkelstein, F. O., et al. (2009).  ✓   
Ghiasi, B., et al. (2018)   ✓  
Unruh, M. L. and R. Hess (2007)   ✓  
Unruh, M. L., et al. (2005)   ✓  
*CKD stage five; represents sources that describe those with CKD5 
**CKD status known; represents sources wherein CKD is known and discussed, however CKD is not 
solely CKD5. Often various stages of CKD are compared and contrasted, however in doing so CKD 
status is always clearly identified.  
***CKD status unknown; represents sources that have not clearly identified the CKD status discussed.  
 
Table 3.5 CKD status of the 14 papers about ‘disability and CKD’  






Bossola, M., et al. (2018) ✓    
Cook, W. L. and S. V. Jassal (2008) ✓    
Farragher, J. and S. V. Jassal (2012) ✓    
Farrokhi, F. and S. V. Jassal (2013) ✓    
Jassal, S. V., et al. (2008) ✓    
Kutner, N. G., et al. (2000) ✓    
Tappe, K., et al. (2001) ✓    
Tawney, K. W., et al. (2003) ✓    
Fried, L. F., et al. (2006)  ✓   
Cook, W. L. (2009)   ✓  
Greco, A., et al. (2014)   ✓  
Intiso, D. (2014)   ✓  
Lam, M. and S. V. Jassal (2015)   ✓  
Shlipak, M. G., et al. (2004)   ✓  
*CKD stage five; represents sources that describe those with CKD5 
**CKD status known; represents sources wherein CKD is known and discussed, however CKD is not 
solely CKD5. Often various stages of CKD are compared and contrasted, however in doing so CKD 
status is always clearly identified.  




3.2 HRQoL and CKD Scoping Review 
A total of 24 sources focused on HRQoL and CKD. Of these sources, 12 were reviews. 
The following paragraphs describe the way these papers defined HRQoL, and how 
HRQoL was related to CKD. Due to several papers focusing on the differences between 
HD and PD patients this will be also discussed, as well as considering findings specific 
for those ≥65 years or over. Finally, the strengths and limitations of the papers will be 
discussed, before identifying possible knowledge gaps that this thesis can help address.  
3.3 HRQoL Defined 
In Chapter 2, the rapid review resulted in HRQoL being defined as comprising of 
physical function, ability to perform usual activities, mental health and general health 
perceptions. It is important that HRQoL is measured from the individual’s perspective 
and that it is based on an individual’s experience of HRQoL (see Figure 2.2). Of the 24 
papers identified in the scoping review, 13 provided an in-depth description of the 
definition they used for HRQoL.  
Papers included in the HRQoL scoping review identified physical health, symptoms, 
functional status, activities of daily life, mental well-being and social health (119, 120), 
as important elements of HRQoL. Some sources specified that HRQoL was related 
specifically to a medical condition and/or its treatment (121-125), supporting the idea 
that HRQoL is specifically about health, as identified in the rapid review (48). 
Additionally, as described in the rapid review, a large majority of the sources included 
in this scoping review, identified the need for HRQoL to be reported from the view of 
the individual, whose health was being affected (126-128).  
Eleven papers did not explicitly define HRQoL, although they often discussed the 
measurements used, or how the measurements used had to act to engage a person’s 
values (129). These papers did note that HRQoL was an important outcome measure, 
particularly in CKD treatment decisions (130-140).  
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3.4 HRQoL and CKD 
Of the 24 papers about HRQoL and CKD, six were cross-sectional, six were 
longitudinal cohorts, eight were narrative or rapid reviews, and four were systematic 
reviews.  
3.4.1 HRQoL and CKD in Cross-Sectional Studies  
The main limitation of cross-sectional studies is that they do not allow for an 
understanding of how HRQoL may develop and change as the disease progresses (141). 
However, they still provide useful insights into how those with CKD perceived their 
HRQoL, and the factors that may be associated with HRQoL. In a cross-sectional study 
completed in French Lorraine, 169 participants aged ≥65 years who were just initiating 
dialysis were investigated to determine the effect of  pre-dialysis education on HRQoL 
outcomes (138). They found that those who were not warned of their need for dialysis 
and therefore had very little pre-dialysis education, were likely to have poorer HRQoL 
(138). The SF-36 was used to assess  HRQoL and it was found that there was a 
difference across all dimensions of the SF-36 (138). Patients with planned dialysis had 
improved scores for all eight dimensions of the SF-36 and this was statistically 
significant for the components of physical function and vitality. The variables that were 
adjusted for in their analysis included age, sex, and comorbid conditions. Importantly, 
the researchers noted that it was possible that these associations were only observed due 
to those with unplanned dialysis having more clinical complications than those with a 
planned start to dialysis (138), which may confound the results.  
A Singaporean study included 201 patients with 74 being aged ≥65 years and 127 being 
younger than 65 years. This study compared younger patients to those aged ≥65 and 
found that those aged ≥65 reported better HRQoL, despite often having worse clinical 
findings (142). The SF-12 (an abbreviated form of the SF-36) was used in this study. 
After controlling for education, employment, dependence on a carer, comorbidities and 
phosphate levels, older patients were found to have improved HRQoL on the two 
physical and mental (including anxiety and depression) dimensions of HRQoL 
compared to the younger cohort (142).  
In a qualitative study of 31 individuals from Minnesota, it was noted that HRQoL was 
largely dependent on how individuals viewed their health (129). Qualitative interviews 
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enabled for perspectives from individuals at different stages of dialysis therapy. Those 
who had just initiated dialysis reported to be thriving. This is because they were still 
able to maintain positive social connections. One participant stated that “I am enjoying 
life as I live it, it’s still a good life” (129). However, as an individual’s disease and 
dialysis progressed, individuals instead reported to be merely surviving, mostly for the 
benefit of loved ones. As time spent on dialysis therapy began lengthening, participants 
began questioning if continuing dialysis therapy was what was best for them. One 
participant noted that  “I’m just tired all the time, I don’t ever feel good” (129). It is 
helpful to gain insight about how individuals’ perspectives may change depending on 
their stage of the disease (129).  
Lastly it has been noted that non-dialysis factors such as frailty, morbidity, falls, 
hospitalisations (135), underlying kidney disease, other pathologies such as 
cardiovascular diseases and the process of aging may also affect the HRQoL of CKD5 
patients (128). Tyrrell et al completed a study of 51 French dialysis patients over the 
age of 70. They concluded that cognitive impairment and depressive mood are frequent 
within their cohort of dialysis patients (128). Additionally, the type of dialysis may be 
important in influencing HRQoL. In a study completed in England and Northern 
Ireland, 251 dialysis patients (129 PD and 122 HD) were included and the SF-12 was 
used to measure HRQoL. This study found no difference in HRQoL between HD and 
PD patients according to the SF-12. The researchers also measured treatment 
satisfaction and found that PD patients had higher levels of satisfaction than HD 
patients (135).  
3.4.2 HRQoL and CKD in Longitudinal Cohort Studies 
There were six papers that reported the HRQoL of CKD patients in longitudinal cohort 
studies. The main advantage of longitudinal cohort studies is that they allow for an 
assessment of the development or change of disease or condition, and therefore they 
allow for understanding of how HRQoL progresses in those with CKD over time (141).  
These cohort studies, focused mainly on comparing groups. One paper compared those 
on HD and PD (134), two simply examined older people with CKD5 (120, 137), and 
three compared older to younger patients (136, 139, 140).  
In a study completed in the UK, by Harris, comparisons were made between  HRQoL 
in 96 HD and 78 PD patients (134).The SF-36 was used to assess HRQoL. After 
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adjusting for time on dialysis, age, sex social class, comorbidity and baseline SF-36 
scores this study found that PD patients were more likely to meet the criteria for 
adequate HRQoL within the first three months (134). However, at 6 and 12 months 
there was no difference between the HRQoL in HD and PD participants. A limitation of 
this study is that there was potentially selection bias, as there were both medical and 
social factors and individual preferences which may affect the dialysis chosen and 
therefore the outcomes. Additionally, there was a 30% non-participation rate, and those 
who did not participate were more likely to have more comorbidities than those who 
did participate, resulting in a potential selection bias (134). 
Following this, again in the UK, a 12-month prospective cohort study was completed 
that analysed the outcomes of 221 patients with CKD5 aged over 70 years (137). At 12 
months, there were 125 CKD5 patients and their HRQoL was assessed with the SF-36. 
The study found that the MCS scores of older CKD5 patients were not significantly 
different to the general UK older population, both at the initial stage of dialysis, and at 
3 months of follow-up and after being on dialysis for some years (137). A limitation of 
this paper is that the focus was on mental HRQoL, and this study did not go into detail 
about any other elements of HRQoL.  
Additionally, in the Netherlands, a study was undertaken with 80 dialysis patients who 
were followed up to determine what factors predicted their HRQoL. A total of 60 
patients were followed to 12 months (120). This study focused on determining if 
INTERMED predicted HRQoL at 12 months. INTERMED is an observer-rated 
instrument that classifies information from a structured medical history. This considers 
biological, psychological, social and health care needs which lead to a score that 
indicates a patient care needs (120). There are 20 variables with a score of 0-3 each. 
INTERMED scores of less than 21 were classed as low and a score of 21 or more as a 
high INTERMED score. A high INTERMED score, age and diabetes were found to 
predict poorer HRQoL in dialysis patients at 12 months. HRQoL was measured by the 
SF-36, and patients with high INTERMED scores, were likely to have poorer physical 
and mental health according to the MCS and PCS scores among surviving patients. 
However, this paper was somewhat limited due to its small sample size and, there was 
no assessment of HRQoL using the SF-36 at baseline. Since baseline HRQoL is likely a 
predictor of HRQoL at 12 months, this is a potential confounder of the relationship seen 
in this study (120). 
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Three papers compared the HRQoL over time of older adults with those who were not 
older. A retrospective cohort was completed in Scotland between 1 January 1994 and 
31 December 2003 (139). Within this study, a small sub-analysis was completed for 45 
HD patients, where they compared the SF-36 scores of the 6 patients who were over 80 
years of age and the SF-36 scores of 39 participants under 80 years of age. They found 
that the six older patients had a tendency towards similar social functioning and mental 
health, but poorer physical health than their younger counterparts. However, a 
limitation of this sub-analysis is the small sample size (139). The small sample size 
may have contributed to the results not being statistically significant making it 
impossible to draw reliable conclusions from the findings.  
In a study completed in the USA for HD patients, those aged ≥70 years were compared 
to patients younger than 70 years of age. At baseline, 1813 (98%) completed a KDQoL 
survey (140). It is one of the few studies that had a comprehensive follow-up and 
analysis of HRQoL for a longer period of time. This study found that younger patients 
had a similar decline in KDQoL HRQoL scores compared to those patients aged ≥70 
years’ (140).  
Lastly, a cohort study was undertaken in Japan with 211 HD patients (72 were aged 
≥65 years and 139 were under the age of 65) (136). This was also a three-year 
prospective study where HRQoL was assessed through 10 items, in a measure unique to 
the study. The participants were asked to assess each item on a VAS scale of 0-100 
(136). The 10 items were health conditions, appetite, sleep, mood, memory, family 
relationships, friendship, economic status, life satisfaction in daily life and happiness 
(136). Similarly, to Unruh et al (2008), as this study found no difference between 
HRQoL in those aged ≥65 years and those under 65 years. This was demonstrated by 
the VAS scores of any of the 10 items not being statistically different in those aged ≥65 
years when compared to those under 65 years. This study also found that there was no 
significant change in the HRQoL score in older patients over the period of three years 
(136). A limitation of this study was once again a smaller sample size. In addition, 
despite the measure of HRQoL being comprehensive, due to the score being unique and 
not standardised, this limits comparability with other HRQoL studies in CKD5 patients.  
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3.4.3 HRQoL and CKD in Review Studies  
Amongst the studies included in this scoping review there were a number of review 
studies. Of these, eight were of a narrative or rapid nature, where detailed methods and 
article inclusion criteria were not well described. This is a limitation as it is difficult to 
replicate the searches. It is also difficult to determine if these reviews meet the 
inclusion and exclusion criteria for this scoping review. However, despite these 
possible limitations, these reviews were included in the scoping review to search for 
relevant information about HRQoL in CKD that is potentially useful to informing the 
H&D Study. 
All reviews concluded that HRQoL is important to routinely measure among CKD 
patients (119, 122, 124-127, 143, 144). It has been discussed that it is vital for patient 
reported outcomes such as HRQoL, be incorporated into the care of CKD patients (122) 
as this may allow for the dialysis team to identify target areas in order to improve 
HRQoL outcomes (125, 126).  
Additionally, the reviews identified important variables that may be crucial in 
influencing HRQoL in CKD patients. HRQoL has often been found to be dependent 
upon the severity of comorbid conditions as well as physical decline over time (119). 
Other factors that may influence CKD patients’ HRQoL outcomes include physical 
symptoms, depression, anxiety, sleep disturbances, energy and vitality, sexual 
functioning, marital and family discord, social functioning, spirituality, burden of 
illness and care, satisfaction of care and time of recovery after each dialysis session 
(122, 143, 144). It is also thought that the types of dialysis may impact HRQoL, with 
HD patients reporting worse health status compared with other dialysis modalities 
(127). It may also be that the HRQoL of patients can influence the timing of the 
initiation of dialysis (125).  
It has been found that  older adults have similar HRQoL in CKD5 compared to their 
younger cohort (119), however it is possible that there is a different reference point 
between older and younger patients in terms of HRQoL (124). This means there is a 
potential that the reasons for older adults experiencing the same, or improved HRQoL, 
compared to younger patients, could be due to their different perceptions about 
HRQoL. Therefore, it is important to note that, when measuring HRQoL in patients, it 
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is important to ensure the measure is valid, reliable and sensitive to change due to 
change in a patient’s outlook (125).  
3.4.4 HRQoL and CKD in Systematic Reviews 
Four of the reviews were done in a systematic fashion, where the reviews included an 
in-depth description of how they were completed and their inclusion and exclusion 
criteria was discussed (123, 131, 132, 145).  
One review noted that few studies have focused on HRQoL in older patients (131). This 
study re-confirmed findings of other studies wherein the mental component of HRQoL 
in older patients was similar to, or higher than, age-matched controls of younger 
individuals (131). Additionally, this study concluded that more research is necessary to 
fully understand older adults HRQoL, and it was noted that there is little understanding 
of HRQoL in the cognitively impaired or those with a functional impairment, as often 
these individuals are not included in studies (131).  
In one systematic review, a total of 17,200 individuals with CKD participated in 45 
studies in which they had their average HRQoL estimated through meta-analysis (145). 
The researchers concluded that HRQoL in CKD patients was lower than the general 
population, suggesting that more work is necessary to improve HRQoL in CKD 
patients (145). Despite the systematic nature of this review, it does have its limitations 
as it is unclear whether all the patients included in the meta-analysis were CKD5 or 
were aged ≥65 years. This study did note that HRQoL did not decrease over time (145).  
Two of the systematic reviews focused on characteristics of appropriate measures of 
HRQoL in CKD5 patients. Both papers discuss generic and specific HRQoL measures 
(123, 132). These studies suggested that there was no simple answer to determine the 
best way to measure HRQoL in CKD5 patients. However, they did note that 
measurement needed to address all of the health issues a CKD5 patient had if possible 
(123). Due to the diverse array of patients’ needs this may not be possible which is why 
standardised measures of HRQoL may be more important.  
3.4.5 Summary of HRQoL and CKD 
To summarise, of the 24 papers that discussed HRQoL in CKD patients it was positive 
to see that, of the papers that defined HRQoL, definitions aligned with the conceptual 
findings of the rapid review. An important finding was that the HRQoL of individuals 
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changes over time depending on how their disease progresses. Comorbidity and 
physical decline were associated with poorer HRQoL. Those who had less dialysis 
education were more likely to have a poorer HRQoL. There was no difference in the 
HRQoL in HD and PD patients.  
The scoping review also indicates that no studies published before May 2018 have 
investigated HRQoL as a predictor of disability outcomes for CKD patients. In one 
study (120) the researchers focused on determining what factors predicted HRQoL in 
CKD patients. This thesis will help address this knowledge gap by determining if 
HRQoL predicts disability in CKD patients at 12 months. HRQoL has the potential to 
be easily measured at baseline, and if it is found to be associated with disability this 
would aid in informing patients, and their family’s choices regarding CKD treatment. It 
was also positive to see that of the 24 papers regarding HRQoL and CKD only four 
were not strictly focused on CKD5.  
3.5 Disability and CKD Scoping Review  
As presented in Figure 3.3, there were 14 papers identified that discussed disability and 
CKD in those aged ≥65 years. The following sections aim to describe how disability 
was defined and how disability has been related to CKD. The papers will be described 
and examined according to the study design the paper followed. The strengths and 
limitations of the studies will be discussed before considering the knowledge gaps 
which the H&D study may help to address.  
3.6 Disability Defined 
The rapid review established the position that when defining disability, it is important 
that disability will be conceptualised with both intrinsic and extrinsic factors 
(recognising the importance of the social model of disability, but also recognising the 
health condition that has led to the individual experiencing ‘disability’). Additionally, it 
will follow the model depicted in the ICF with a focus on impairments, activity 
limitations and participation restrictions. The rapid review also acknowledged 
environmental and cultural factors that influence an individual’s disability (see Figure 
2.3). It is therefore important to identify how disability is defined in the CKD literature 
included in this scoping review.  
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Of the 14 papers identified, six did not clearly define disability. However, they all 
acknowledged that disability is an important concept, and described various measures 
that could be used (146-150). Additionally, Farragher (2012) discussed how one of the 
main aims of measuring disability and taking it into consideration was to allow for the 
development of rehabilitation methods to prevent further disability (151).  
Of the eight papers that did define disability, the majority focused on the individual 
model of disability, with disability being defined as an individual’s ability or lack of 
ability to perform necessary tasks without assistance (14, 152, 153). Daily necessary 
tasks can refer to eating, transferring from a bed to a chair, dressing and undressing and 
personal hygiene (154). Disability was often viewed as the inability to maintain 
homeostasis (153) as the result of the cumulative decline in physiological systems 
during a lifetime (155). Despite it being well-known that disability is caused by 
numerous events and pathologies at many different stages of life, the articles in this 
review tended to attribute disability to age-related deterioration and comorbidity (156). 
This is possibly due to the specific focus on those aged ≥65 years. Additionally, as well 
as disability resulting in the absence of normal function (15, 157), in some cases, an 
individual is only thought to be disabled if the impairment results in death, or if the 
disability lasts more than 12 months (157). As identified in the rapid review, disability 
can take different forms, in all different phases of an individual’s life. Only one of the 
14 papers discussed the social model of disability, saying that disability can lead to the 
inability to perform social roles (15). 
Therefore, it can be concluded that these papers provided a good overview of the 
medical model of disability but were lacking information regarding the social model of 
disability. Of the 14 sources, none of the sources explained the ICF model of disability 
or used WHODAS 2.0 to measure disability. 
3.7 Disability and CKD  
Of the 14 papers about disability and CKD, two were cross-sectional, four were 
longitudinal cohort studies, seven were reviews and one was a systematic review.  
3.7.1 Disability and CKD in Cross-Sectional Studies 
Of the 14 papers, two were cross-sectional studies. As mentioned previously, a 
limitation of cross-sectional studies is they do not allow for follow-up, so long term 
45 
 
outcomes cannot be understood (141), which is a limitation of the following two 
studies. In the first cross-sectional study (completed in Canada) (146), the mean age of 
the participants was 75 years and there were 162 participants, most of whom were 
male. These participants were assessed for disability and difficulty in performing self-
care tasks with the Barthel and Lawton scales (146). All of the participants were 
completing HD and the results showed that; eight had no disability, 69 required help at 
times but did not consider themselves disabled and 85 had a disability (146). This 
cross-sectional study therefore demonstrated that disability is prevalent in the older 
adults on HD and this makes self-care difficult (146). The study advised that strategies 
needed to be implemented to identify older CKD5 patients that were at risk of 
disability, to help limit their disability and allow for interventions to be put in place to 
make daily living easier (146).  
The second cross-sectional study was completed in the USA and the participants who 
had a GFR of above 30ml/min/1.73ms2, (which indicates that they did not have CKD5) 
were compared to those with no CKD at all. The study was included despite the 
participants not having CKD5 due to the large sample size of 5,888 adults aged ≥65 
years and it provided valuable insight into disability in the CKD population (154). In 
the unadjusted analysis both fragility and limitations in daily living activities, which 
was how disability was measured in this study, were found to be associated with CKD 
severity. After adjusting for demographic characteristics (age, sex, ethnicity and 
education) and comorbidity it was found that older adults with CKD were three times 
more likely to be frail than those with a renal function of above 60 ml/min/1.73ms2 
(154). As a result of the cross-sectional nature of this study and, despite the strong link 
between fragility and disability in those with CKD, it is difficult to know the causal 
direction of this relationship and to understand the biological mechanisms contributing 
to this association (154). However, it can be concluded that preventing fragility which 
is often associated with disability in those with CKD is likely to lead to improved 
outcomes. It is important to note that disability was discussed in more of an individual 
sense than as defined in the ICF paper.  
3.7.2 Disability and CKD in Cohort Studies 
Prospective cohort studies provide an opportunity to determine how disability develops 
and changes amongst people with CKD. Of the four cohort studies, one focused on how 
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disability in CKD5 patients impacts on survival (152). The remaining three papers 
focused more on illustrating how disability developed in CKD patients (147, 150, 158).  
In a prospective cohort study by Bossola et al (2018) the researchers aimed to evaluate 
if functional impairment was a significant risk factor in reducing survival in patients 
with CKD5, specifically patients on HD (152). All patients in the dialysis and 
transplant registry from 2008-2013 in Italy were eligible (the population was not 
strictly aged ≥65 years) provided they had been dialysing for at least 90 days. In five 
years of follow up, 122 patients died in the cohort of 3356 patients. The strength of this 
study was the large sample size; however it is important to note that the follow-up 
period varied between participants. In these patients, functional impairment (which was 
determined by the physician) was a risk factor for reduced survival (152). Additionally, 
through measuring with the Karnofsky performance scale index, it found that functional 
impairment had the potential to be prevented or reversed through rehabilitation (152). 
Therefore, this study concluded that functional impairment, and therefore disability in 
CKD5 patients reduced survival; however, rehabilitation has the potential to reduce the 
functional impairment (152). Therefore, they advised that early identification of 
patients who could benefit from rehabilitation to reduce their functional impairment is 
important (152).  
Cohort studies have also been conducted to determine if CKD is independently 
associated with disability. Fried et al (2006) aimed to assess if CKD was associated 
with disability. A prospective cohort in Pennsylvania and Tennessee recruited 2,135 
men and women aged between 70-79 years with CKD. Those with a CKD function of 
above 60ml/min/1.73ms2 were compared to those with a function of below 
60ml/min/1.73ms2 (158). In this comparison, more advanced CKD was found to be 
associated with disability (functional impairment) independently of comorbidity, body 
composition and tests of strength and physical performance. This may be due to the 
heightened inflammatory state of CKD patients (158). Fried et al concluded that CKD 
severity was associated with impaired physical function, which is a risk factor for 
disability. It was suggested that further work needs to be completed to determine how 
to reduce the development of disability in those with CKD (158). It is possible that 
rehabilitation as recommended by Bossola et al could provide a solution. Similarly, in a 
prospective cohort study completed in urban Georgia, 112 prevalent renal failure 
patients on HD were compared with 286 age matched controls (150). This study found 
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that CKD5 patients had a higher level of impairment at three years (after adjusting for 
baseline impairment) than non-CKD5 patients (150). Again, this study advised that care 
for those with CKD5 needs to focus on preventing functional impairment and therefore 
disability (150). Once again, disability was seen in a more individual sense than the 
way it is viewed through the ICF lens.  
In the final prospective cohort study of 167 patients from Toronto Canada (57% male, 
all ≥65 years of age), 83% of the patients depended on others for help (147). This study 
aimed to determine if a quick four item scale was useful for measuring disability. This 
four-item scale asked about walking, transferring, bathing and dressing (147). It was 
found that this measure was useful for predicting severe disability and increased 
mortality (147). However, the researchers did note that this measure did not take into 
account, difficulties in stair climbing, which may be an important indicator of physical 
disability. This paper demonstrates that the four-item scale may be useful for measuring 
disability in CKD5 patients and that the majority of patients in this study had some 
form of disability (147). Once again emphasising the need for intervention, to not only 
reduce disability, but to determine effective ways to measure disability.  
3.7.3 Disability and CKD in Review Studies 
As explained when HRQoL was discussed above, the limitations of the following 
review studies are their methods are not clearly described, and therefore their 
inclusion/exclusion criteria are not clearly outlined. This makes it difficult to determine 
if the papers included in these reviews and therefore the reviews met the inclusion 
criteria for this thesis. Since these reviews still provide a useful insight into disability in 
CKD patients they have been included.  
There were seven reviews and the majority of these focused on how older adults with 
CKD develop and experience disability. Initially the cause and embodiment of 
disability will be discussed before proceeding to describe the proposed methods to 
prevent disablement in CKD patients. 
It is known that disability is very prevalent in CKD5 patients (14) and that it can lead to 
accelerated aging, hospitalisations and reduced survival (156). Disability in older 
CKD5 patients can be thought of as being caused by a combination of factors, including 
issues directly related to their clinical condition, including weakness, low energy and 
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low activity often associated with CKD5. This combined with common geriatric 
syndromes like falls, cognitive impairment, incontinence and the use of many 
medications often leads to poor outcomes, including disability and hospitalisation in 
older CKD5 patients (153). Therefore, it can be understood that disability and fragility 
is often associated with poor physical performance in CKD patients (155), independent 
of age, gender and comorbidities (149). Additionally, CKD5 patients are often on 
dialysis and this often results in low energy, limited spare time (due to the time spent 
dialysing), psychological adjustment to their new situation and enforced immobilisation 
which contributes to disability and functional decline (151). Therefore, from these 
reviews, disability is very prevalent in CKD patients.  
The reviews were valuable as they included many suggestions and methods aimed at 
reducing disability among CKD patients. A common suggestion was physical activity. 
It is well-known that physical activity decreases among dialysis patients and decreases 
with age (155). Greco et al (2014)  concluded that physical exercise training 
programmes have been found to be effective in reducing and preventing disability in 
CKD patients (155).   
Rehabilitation was also suggested as an important method in reducing disability in 
CKD patients. Rehabilitation often provides a holistic approach to an individual and 
aims to allow for independent living and autonomy (149). Methods of rehabilitation can 
include regular exercise, such as walking, and nutritional changes. Other methods 
include cognitive rehabilitation, education, psychosocial intervention and 
environmental modifications (151). Additionally, more individual focused 
rehabilitation strategies can include occupational therapy, gait training and joint 
mobilisation (149).  It has been concluded that rehabilitation is a possibility in older 
patients and that it has the potential to decrease disability and improve outcomes (14). It 
can also be noted that dialysis education, oral supplements, antidepressant therapy and 
pain medication can also aid in improving dialysis outcomes in geriatric patients (14).  
Lam et al (2015) takes a different view, proposing that in order to allow for the best 
outcomes, comprehensive assessments of  geriatric CKD patients ought to be taken 
before initiating dialysis (156). This could allow more individualised, patient centred 
interventions to prevent disability and improve health in geriatric CKD patients. 
Additionally, Tawney et al discussed that preventing disability altogether in CKD5 
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patients would be the best solution (15). It is important to further understand how 
disability and fragility can occur in CKD5 patients in order to know where it is best to 
intervene to optimise physical performance and independence in geriatric CKD5 
patients (153). In order to prevent disability, it is important to understand what factors 
may act to cause, or act as predictors of disability in CKD patients. This is an area that 
this H&D Study aims to address, therefore helping to address an important knowledge 
gap.  
3.7.4 Disability and CKD in Systematic Reviews 
One of the 14 papers was a systematic review (157). This review was undertaken 
because in the USA all individuals with CKD5 are eligible for disability benefits, and 
there have been questions about whether this alone is enough to diagnose disability. 
Therefore, this systematic review was completed to determine which factors were 
valuable predictors of disability and working status in CKD5 patients (157). A total of 
27 databases were searched for records up to the year 1998 and only 14 had any 
indication of predictors of employment for CKD5 patients. After adding the authors’ 
exclusion criteria (including having to be under 65 years, due to employment), 10 
studies remained in their review (157). The studies were all cross-sectional and were all 
very different from each other and therefore it was concluded that finding factors that 
predicted disability in CKD5 patients was too difficult so no conclusions were made. 
However, as a part of this study the United States Renal Data Systems (USRDS) were 
analysed which did note a decrease in those with CKD5 working, suggesting CKD5 
does result in disability severe enough for individuals to stop work (157). Despite the 
systematic nature of this review, the research question of this review sought to 
determine predictors of working status in CKD5 patients, rather than predictors of 
disability in CKD5 patients. This suggests that this thesis will be important in 
developing an understanding of what factors predict disability in CKD5 patients.  
3.7.5 Summary of Disability and CKD 
It can be concluded that it is well-known that disability is prevalent among CKD 
patients and that this can contribute to poorer outcomes. Many papers suggest the use of 
physical activity and other rehabilitative strategies to reduce disability in this 
population. A limitation of the papers included in this scoping review was they did not 
have a broad view of what disability is and were largely focused on the individual 
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model of disability, rather than encompassing the ICF model. Of the 14 papers 
included, 6 did not strictly discuss CKD5, and although they aided in developing our 
understanding of disability in CKD patients, it is important to note this difference, as 
the H&D Study focuses on the CKD5 population. No sources included in this scoping 
review focused on factors that acted to predict disability in CKD patients. This thesis 
aims to address this knowledge gap by establishing potential predictors of disability in 
this population. By determining which factors may predict disability, this may aid in 
developing rehabilitation strategies, which could potentially target predictors of 
disability (once identified) rather than disability.  
3.8 HRQoL and Disability in CKD 
Opportunistically, two papers have been identified that discussed both HRQoL and 
disability in CKD5 patients. Fidan et al (2016) aimed in their study to assess HRQoL in 
patients on HD using the KDQoL in order to determine its relationship with 
musculoskeletal problems, hand disability and depression (159). A total of 50 patients 
from Turkey were included in the study and those under the age of 65 years were 
compared to those aged ≥65 years. This study found that all patients had some form of 
musculoskeletal problems, with older patients having poorer physical functioning than 
younger patients and that all of these patients experienced low HRQoL scores (159). 
This implies that disability and poor physical functioning are linked with poor HRQoL. 
As a result of the cross-sectional nature of this study it is difficult to determine which 
direction this association is. Additionally, the sample size of 50 is small.  
The second study that analysed both HRQoL and disability was completed in Korea 
and involved a sample of 1,616 patients from 27 hospitals in 2012 (160). This study 
aimed to evaluate the differences in HRQoL, fragility and disability according to 
dialysis modality (160). It found that disability was more common in PD patients than 
HD patients. In terms of HRQoL, sleep, social interaction and social support were 
better in HD patients, but patient satisfaction and staff support was improved in PD 
patients (160). This study was completed in a retrospective nature, was not restricted to 
the ≥65 year’s population and once again did not allow for a direct link to be made 
between whether HRQoL impacts on disability in CKD5 patients.  
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3.9 Sources that Discussed Either HRQoL or Disability in Māori 
CKD Patients 
 
It is also important to identify and understand the evidence that discusses either HRQoL 
or disability for Māori. Two of the three studies identified were qualitative and asked 
about Māori patients’ experiences with CKD5 (161, 162). Shih interviewed seven 
rurally based Māori patients and their whānau (family) about CKD5 experiences. This 
research revealed four main themes of Māori experience with HD and CKD5. These 
were learning to face fear, coping with stress from regular dialysis, having to learn, 
adjust and change attitudes towards their illness and finally that family support was 
very important (161). Walker et al echoed some of these themes in the qualitative study 
where 13 Māori CKD5 patients were  interviewed (162). This study found that Māori 
with CKD5 can experience a sense of whakamā (disempowerment and embarrassment). 
Embarrassment was often felt by Māori as there was a stigma that kidney disease was 
self-induced, and sickness was associated with weakness. Disempowerment was felt 
due to delayed diagnosis. Additionally, a sense of loss of whakamana (sense of self-
esteem and self-determination) was felt in Māori participants. Whakamana was felt 
when Māori had the opportunity to involve whānau and peers in their treatment and 
were able to build relationships and trust with the medical professionals (162). These 
ideas align well with the holistic view that Māori people have of health which includes 
the importance of wairua (spirit), hinengaro (mind), tinana (body) and whānau (30, 37). 
As a result of the stress and fear Māori may face with dialysis, there is the potential for 
decreased HRQoL and disability among the Māori population on CKD5.  
The third study that presented findings relating to CKD5 for Māori analysed the effects 
of intense blood pressure measurements in a community based model of care compared 
to usual clinical care (163). This study was a randomised control trial (RCT) of Māori 
and Pacific patients and followed patients up at 12 months and then at four years after 
the intervention. It was found that short term (12 month follow-up) intense blood 
pressure control, followed by usual care did not translate into a reduction in long term 
mortality but was associated with reduced hospitalisations (163). This was an important 
finding as it was noted that as a result of the intervention, initially it was seen that there 
was less end organ damage. However, it was found that after four years of follow-up 
there was no difference between the intervention and control groups. This demonstrated 
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that the intervention did not aid in improving long term HRQoL and disability for 
Māori and Pacific peoples with CKD5. The study did note, however, that if the 
intervention could have been commenced earlier in the disease progression and 
maintained longer term it may be effective in achieving improved outcomes and 
therefore less disability. However, the costs and benefits of this intervention for the 
health system, health professionals and patients would need to be explored before this 
could be a plausible intervention (163).  
Therefore, it can be concluded from the limited information that Māori with CKD5 
experience adverse health outcomes. The three studies did not explicitly describe or 
define HRQoL and disability.  There is a need for more research investigating the 
outcome for Māori with CKD5 and this H&D Study will contribute to this.  
3.10 Conclusion 
This scoping review has allowed for an understanding of how the literature has 
presented ‘HRQoL and CKD’ and ‘disability and CKD’. The main findings were that 
HRQoL may change with an individual’s stage of CKD and that it has not previously 
been considered as a predictor of disability. Additionally, disability is highly prevalent 
in CKD patients and it is recommended that these patients be provided treatment for 
rehabilitation however no work has been done to understand what predicts disability in 
these patients. Very little research has been done investigating HRQoL or disability in 
Māori with CKD.  
The H&D Study presented in this thesis is therefore novel, as previously there has been 
no research that has prospectively analysed if HRQoL and other factors have the 
potential of being predictors of disability at 12 months. Despite disability frequently 
being used as a predictor, in the H&D Study we have used HRQoL as a predictor, as 
the ICF model of disability suggests that there ought to be relationships between 
HRQoL and disability. Examining HRQoL as a predictor of disability, may enable 
early identification of CKD5 patients who may be susceptible to disability, through 
analysing their HRQoL and therein, adjusting their care accordingly.  Additionally, we 
will provide information concerning Māori experience with CKD5 in terms of HRQoL 
and disability.    
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4 Chapter Four: Methods 
This chapter will begin with an overview of the methods of the DOS65+ Study, 
including a brief explanation of the design, recruitment and inclusion/exclusion criteria 
used. This chapter then describes the methods used in the H&D Study, focusing on the 
explanatory, predictor and outcome variables and the statistical analyses.  
4.1 The Dialysis Outcomes in those aged ≥65 Study (DOS65+) 
The DOS65+ Study provided the participants and the data for the H&D Study. The data 
collection for the DOS65+ was completed between 2010 and 2016 (see Figure 4.1) and 
the DOS65+ Study protocol has been published previously(1, 18).Therefore, this 
section provides a brief overview of DOS65+ relevant to the H&D Study.  
The aims of the DOS65+ Study (1) were to:  
1) “determine the impact of age, sex, ethnicity duration of dialysis, satisfaction 
with health services and comorbidity on the HRQoL in older (≥65 years) 
patients with chronic kidney disease” 
2) “compare and contrast survival, health service utilisation, costs and HRQoL 
outcomes of older patients with CKD according to the type of renal replacement 
therapy including modality (haemodialysis versus peritoneal dialysis) and 
location (home versus facility) or maximal conservative therapy (no dialysis)” 
3) “develop evidence-based guidelines for optimal management of older patients 
with severe CKD” (p 2) (1).  
Figure 4.1 Diagram of the DOS65+ illustrating the clinical mortality and interview 






















Death or Lost to follow-up 
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4.1.1 Ethical Approval 
DOS65+ received ethical approval from the New Zealand Multi-Regional Ethics 
Committee. The approval number is MEC/10/084, and the trial was registered under the 
Australian and New Zealand clinical trials registry at ACTRN12611000024943. I (the 
MPH researcher) signed a confidentiality agreement before accessing de-identified data 
for H&D Study analyses.  
4.1.2 DOS65+ Methods in Brief  
The DOS65+ Study was an “accelerated longitudinal design” comprising of both cross-
sectional and longitudinal components. Baseline interviews were conducted with 
patients who met the inclusion criteria, and clinical information was sourced from 
medical records and collected by professionals with approval for such access. Follow-
up interviews were completed at 12, 24 and 36 months after the initial interview with 
participants who were still alive.  
4.1.3 Inclusion/Exclusion Criteria 
Eligible DOS65+ patients were approached by their nephrology team. Participants were 
eligible if they had CKD5, were aged ≥65 years, and were being treated at either 
Middlemore, Hawkes Bay or Dunedin Hospitals for CKD5. Eligible participants had to 
be; on dialysis for over 90 days prior to the first interview; have commenced renal 
replacement education- including an active conservative pathway; or presenting acutely 
and requiring immediate dialysis indefinitely (1). All consenting patients were 
contacted by telephone to arrange an interview, and all interviews were completed 
either by telephone or face to face by the DOS65+ research interviewer team (1).  
Patients were excluded if they were unable to give informed consent or were unable to 
participate in a telephone or face-to-face interview. Additionally, they were excluded if 
they had an inter-current illness requiring hospitalisation within two weeks of the 
survey date and if this affected the patient’s ability to take part, as judged by the 
opinion of the physicians (e.g. for a terminal diagnosis or a serious cognitive 
impairment making an interview impossible) (1, 18). 
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4.2 H&D Study  
The H&D Study is focused on exploring associations between HRQoL and disability, 
and to determine which factors at baseline (interview one) predict disability outcomes 
12 months later (interview 2) (see Figure 4.1). Importantly, the H&D Study includes a 
specific focus on analysing HRQoL and disability outcomes for Māori participants. 
Overall, this H&D Study aims to investigate the association between the dimensions of 
the HRQoL and disability and to determine if HRQoL and/or other factors predict 
disability in people with CKD5 aged ≥65 years in NZ. This will aid in developing 
knowledge to inform both nephrology professionals and patients with respect to the 
impact of dialysis on their life.  
4.2.1 H&D Study Participants  
A total of 227 participants were recruited into the main DOS65+ Study, of whom 50 
were Māori. H&D participants included all DOS65+ unless they had received a kidney 
transplant. Transplant patients often experience an improved HRQoL compared to non-
transplant patients (164), and it would have been inappropriate to include the patients 
who received a transplant in the H&D analysis where the goal was to understand 
longer-term HRQoL and disability outcomes for people with CKD5. Participants were 
also excluded from the H&D Study analyses if they did not have complete data 
available for the potential predictor of interest (the EQ-5D-3L; see section 4.3.1) or the 
outcome of interest (the WHODAS 2.0; see section 4.3.2). Figure 4.2 illustrates the 




Figure 4.2 Diagram of the H&D Study in relation to the DOS65+ Study, indicating 
the numbers of participants at each data collection points 
 
4.3 Predictor, Outcome and Explanatory Variables 
The H&D Study aimed to determine if associations exist at baseline (Interview 1) 
between HRQoL and disability, and to determine which if any factors including 
HRQoL predicts disability outcomes 12 months later (Interview 2); and to describe 
associations specifically for Māori participants. HRQoL acts as the main predictor, 
disability as the main outcome variable and explanatory variables have the potential to 
be both potential predictors and confounders.  
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4.3.1 Predictor Variables 
The main objective of this thesis was to determine if HRQoL predicted disability 
outcomes 12 months later. For the purposes of this thesis HRQoL was measured using 
the EuroQoL’s EQ-5D-3L (69). The EQ-5D-3L is brief, and easy to administer and the 
various dimensions of the EQ-5D-3L can be considered as predictors of disability and 
easily interpreted unlike the SF-36. Additionally the EQ-5D-3L is useful as it is 
applicable to a range of health conditions and treatments including dialysis and CKD 
(1, 62, 69). The EQ-5D has been tested for applicability in the Māori population and 
has been found to be acceptable (72).  
In the EQ-5D-3L, participants were asked if they have no problems, moderate problems 
or extreme problems with the five dimensions of mobility, self-care, usual activities, 
pain/discomfort and anxiety/depression. The participants were asked to report their 
HRQoL based on how they were feeling that day. They were also asked to rate their 
own health state on a visual analogue scale, with 0 representing the worst imaginable 
health state and 100 being the best imaginable health state (19, 67).  
Cognitive function has been identified as an important factor influencing HRQoL, as it 
was identified as a key factor in HRQoL by Wilson and Cleary (1995) and Kaplan and 
Kies (2007) (see Chapter 2) (22, 51). Therefore, an additional question in the same 
format as the EQ-5D-3L questions, asked participants to report their cognitive 
functioning. The question asked participants if they had no problems, moderate 
problems or were unable to perform intellectual activities. Cognitive activities included 
remembering, concentrating, thinking and solving day-to-day problems (36, 165, 166).  
Initially for the analysis of the EQ-5D-3L and the cognitive functioning question, the 
categories of no, moderate and extreme problems were presented separately in our first 
table of descriptive analysis. For the remainder of the analysis the categories of 
moderate and extreme problems were combined, creating a new category of ‘moderate-
severe problems’. This was due to sample size restrictions. Analysis was completed 
with each domain of the EQ-5D-3L separately, to allow for the development of an 
understanding of which components, if any, are important in predicting subsequent 
disability. The overall EQ-5D-3L health rating was not included in the H&D Study 
analyses, because the overall aim was to specifically investigate dimensions of HRQoL 
that act to predict disability. Additionally, it was not possible to ascertain what 
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respondents actually consider when responding to the VAS scale and it can often be 
misunderstood and misinterpreted (67).It is not possible to ascertain what an individual 
is considering when providing an overall score. Additionally, practically it is not useful 
to health services who may wish to implement strategies to reduce subsequent 
disability, as the EQ-5D-3L overall health rating does not allow for an understanding of 
what HRQoL dimensions may be acting to impact on disability.   
4.3.2 Outcome Variable 
The main outcome of interest for this H&D Study is disability. This was measured 
using the WHODAS 2.0. As described in the rapid review (Chapter 2), this is a brief 12 
item questionnaire, and it is one of the few measures specifically designed to measure 
disability according to the WHO ICF model of disability (1, 167, 168). It provides a 
generic (overall) standardised assessment of self-reported disability (96, 101). This 
measure has been translated into 47 languages (including Te Reo Māori; the Māori 
language) and is used in 27 areas of research (169). Being a self-reported measure the 
WHODAS 2.0 provides individuals’ perspectives on how their disability affects them, 
and the measure can be used in both disabled and non-disabled people (169).  
The WHODAS 2.0 measures six different dimensions which include cognition, 
mobility, self-care, getting along, life activities and participation (170). Participants 
were asked about how much difficulty (while using any aids or appliances they have 
access to) they have across the six different dimensions over the past 30 days. In each 
question participants were asked to rate their response with a 0,1,2,3 or 4 which 
correspond to no issues, moderate issues, severe issues or extreme issues or cannot do 
respectively. The WHODAS 2.0 allows for the responses to be scored numerically, 
allowing participants to have a maximum sum of 48 (maximum disability) and a 
minimum sum of 0 (no disability). For those missing a response to one question the 
average of the remaining 11 responses was imputed in place of the missing response 
when calculating the overall WHODAS 2.0 score (171, 172). Scores were not 
calculated for participants with two or more missing responses. Participants who had a 
WHODAS 2.0 score of 0-9 were classified as experiencing ‘lesser/no disability’, and 




4.3.3 Explanatory Variables 
The scoping review aided in identifying key potential explanatory variables. The 
explanatory variables identified that were important in the scoping review and that were 
included in this H&D Study are: sex, age, comorbidities (138, 159, 160), ethnicity, 
dialysis vintage (140), living arrangements (134), and type of dialysis/dialysis location 
(133, 135, 160).  
Often the studies in the scoping review did not focus on HRQoL and disability 
specifically or considered aspects that were not relevant to the aims of the H&D Study 
largely due to their biomedical nature. For example, variables found in the scoping 
review, but not included in the analyses include; haemoglobin, serum albumin, urea, 
creatinine (160), phosphate levels (130), dose of dialysis, dialysis flux and diabetic 
status (140).  
A list of the explanatory variables used in the H&D Study is given below, including the 
justification when necessary, as to why they were used, how they were measured and 
what was asked. The majority of these variables were asked using questions from the 
NZ Census (173).  
1) Sex: Participants were grouped as male or female (173).  
2) Age group: All participants were aged ≥65 years and were grouped into 65-74 
years and 75+ years as determined by participants date of birth (173).  
3) Ethnicity: Data was collected using the NZ census question, which allows 
multiple ethnic groups to be specified. Ethnic groups that could be selected were 
New Zealand European, Māori, Samoan, Cook Island Māori, Tongan, Niuean, 
Chinese, Indian or ‘other’, wherein they had a free text option if their ethnicity 
was not included in the list. In this thesis, participants were grouped into three 
groups: Māori, Pacific and Non-Māori/Non-Pacific (nMnP). If a participant 
selected more than one ethnic group, they were prioritised into one of these 
three groups using NZ statistics ethnic prioritisation guidelines. For example, if 
an individual identifies as both Māori and NZ European, they would be 
classified as Māori (173, 174).  
4) Living arrangements: Individuals were asked about whether they lived in the 
same household as others, and if so what their relationship with them was. For 
example, spouse or civil union partner, mother and or father, son(s) and or 
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daughter(s), flatmates(s). In this thesis, those who lived alone were grouped 
together and those who lived with others were grouped together (173).  
5) Dialysis vintage: Duration of dialysis was provided from the clinical data 
collected for all participants. This was categorised into non-dialysing at the start 
of the study, less than 2 years on dialysis and ≥2 years or more on dialysis (1) 
6) Number of comorbidities: Information about comorbidities was collected from 
the clinical data. In this study participants were grouped into those with 0-2 
comorbidities and those with 3+ comorbidities (36). Comorbidities included 
cardiovascular disease, cerebrovascular disease, peripheral vascular disease, 
diabetes, lung disease, cancer (excluding skin cancer), musculoskeletal disease 
and other (which included cognitive impairment, peripheral neuropathy, 
Parkinson’s disease, depression, bipolar disorder, substance abuse, 
gastrointestinal disease, diabetic retinopathy, legally blind and hearing 
disability).  
7) Dialysis location: This was categorised into home, in-centre or non-dialysing 
(1).  
The explanatory variables are important to take into consideration, as some may act as 
confounders when determining if HRQoL variables do in fact predict disability. 
Additionally, these variables have the potential to act as independent predictors of 
disability, so these variables were controlled in the multivariable analysis. However, in 
addition to the explanatory variables, in order to gain an improved understanding of 
who the study sample represented, additional variables have been used in the basic 
descriptive statistics and univariate analysis. They were not considered explanatory 
variables due to the reasons discussed below and due to the small sample size. If all 
these variables were included this would have resulted in limited statistical power. 
These are described below;  
1) Treatment Type: Participants were asked what type of dialysis they used; either 
HD or PD (1). A sub-analysis was completed comparing the outcomes for those 
on dialysis, so this variable was included in these sub-analysis models. 
However, in our main analyses this variable was excluded, as type of dialysis is 
often determined by dialysis location. Therefore, only dialysis location was 
included in our models of the entire cohort.  
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2) District Health Board (DHB): Depending on the location of the treating 
hospital, participants were assigned a DHB of either Counties Manukau, 
Hawkes Bay or Southern. This was not considered to be an explanatory variable 
as the sample size of the H&D Study restricted the number of variables that 
could be used in the analyses (1).  
3) Adequate Income: Participants were asked if their income adequately met their 
everyday needs for accommodation, food, clothing and other necessities. They 
were asked if they had not enough income, just enough income, enough income 
or more than enough income. This was further categorised into two groups of 
just or not enough and enough or more than enough (175). The cohort is all ≥65 
years and therefore all receive a universal superannuation, so to a degree are all 
in a similar financial situation, therefore it is not considered as an explanatory 
variable.  
4) Body mass index (BMI): BMI information was calculated from participants’ 
medical records of weight and height information. Those with a BMI <30 were 
grouped together and those with a BMI ≥30 were grouped together. This is 
well-linked to the ethnicity (176) and is not known to be a significant factor in 
dialysis outcomes (177).  
5) Highest educational qualification: Participants were asked about their highest 
qualification, including not having completed one. In this thesis, participants 
were grouped into those with school education and those with a tertiary 
education (173). This was not considered an explanatory variable as the sample 
size of the H&D Study restricted the number of variables that could be 
accommodated.   
4.4 Statistical Analyses 
Initially, descriptive analyses (n, %) were completed to gain an understanding of the 
study cohort. Further baseline (see Figure 4.1) descriptive analyses (n, %) were then 
completed to compare the characteristics of those with ‘lesser/no disability’ (WHODAS 
2.0 <10) and ‘considerable disability’ (WHODAS 2.0 ≥10). Chi-square tests were used 
to examine the differences in the respondent characteristics (explanatory variables) by 
the disability status (outcome variable). Following the baseline descriptive analyses, 
analyses were undertaken to determine which baseline variables predicted the disability 
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at 12 months (using WHODAS 2.0). The relative risks (RR) of disability at 12 months 
was estimated using modified Poisson regression with robust standard errors (178). 
This method was used because it allows direct estimation of relative risks for 
disability(178).   
Initially, a univariate analysis was done to assess the association of each explanatory 
variable with experiencing ‘considerable disability’ compared to ‘lesser/no disability’. 
Following this, a multivariable model was built to identify a subset of explanatory 
variables associated with the outcome, while considering collinearity and accounting 
for the possible confounding effects between them. Table 4.1 shows all the variables 
that were initially included. The backward selection procedure was used to eliminate 
variables using a p-value threshold of less than or equal to 0.1 to retain variables. This 
procedure does not allow for assessment of the appropriateness of the included 
variables and did not fix any of the explanatory variables because we did not have a 
priori hypothesis to do so. Therefore, in the results chapter the model presented has no 
variables fixed. Then another two models were built using the same procedure except 
that in the first model age, sex, ethnicity and the five EQ-5D-3L dimensions were fixed, 
and then the second model built only fixed EQ-5D-3L dimensions were fixed. The 
purpose of the subsequent models was to determine if fixing the variables had any 
impact upon the models.  These analyses are only presented in the Appendix III.  
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Direct comparison of disability outcomes between HD and PD patients which excluded 
non-dialysing patients was undertaken, as the literature revealed this comparison to be 
important and provides clinically valuable information that can be more comparable to 
those in the literature (134). First basic descriptive statistics was completed (n, %), then 
a univariate analysis using chi-square tests was conducted to compare the 
characteristics between HD and PD patients Additionally the Poisson regression 
explained above was completed with this sub-cohort of patients to determine if any 
variables that predicted disability were different in this sub-cohort compared to the 
entire sample that included non-dialysing patients.  
Following this, analyses were completed to compare participants who were followed up 
to 12 months to those who were lost to follow-up. Reasons for loss to follow-up 
included refusal to participate, being too unwell for a follow-up interview, or due to 
dying between the baseline interview and follow-up. Chi-square tests were used to 
compare the characteristics of those who were followed up to those who were not.  
4.5 Analysis of the Māori Cohort  
As described in objective c, an aim of this thesis was to conduct specific analyses of the 
Māori data. Due to the smaller number of Māori participants (DOS65+ recruited 50 
Māori), initially basic descriptive (n, %) statistics were completed. Analysis was also 
completed comparing Māori who were classified as having ‘lesser/no disability’ to 
those who were experiencing ‘considerable disability’ at baseline. This analysis was 
completed again at 12 months and the chi-square test was used. Following this, the 
results were discussed in as much detail as possible.  
All analysis was completed using Stata 15.1 ® software (StataCorp 2017) (180).  
4.6 Summary 
This chapter explained the methods used in this thesis. First an overview of the ‘parent’ 
DOS65+ Study was provided, before describing the predictors, outcome of interest, and 
other explanatory variables that were focused on in the H&D Study. The chapter 
concluded with an explanation of the statistical analyses for the entire cohort, and for 




5 Chapter Five: Results 
This chapter presents the results and describes associations or otherwise between 
HRQoL and disability, among a cohort of older New Zealanders with CKD5 pre-
dialysis or on dialysis. The results also identify the factors which predict disability 
outcomes 12 months later. A separate analysis focused on these outcomes for older 
Māori patients with CKD5 is also presented. 
5.1 Study Participants 
At baseline there were 227 participants included in the DOS65+ Study. Two 
participants were excluded because they were transplant patients and two participants 
were excluded due to not having a complete WHODAS 2.0 score, leaving 223 
participants at baseline. At 12 months, 157 participants remained in the study; 66 
participants were lost to follow up or had died. A missing data point meant that only 
156 participants were included in the final multivariable model.  
Separate analysis of the Māori cohort was completed. Māori were over-sampled, 
resulting in 50 Māori participants in the H&D Study. One participant did not have 
complete EQ-5D-3L or WHODAS 2.0 scores; 49 Māori remained at baseline. At 12 
months, 37 Māori participants were followed up, with 12 Māori participants either lost 
to follow-up or having died by 12 months.  Figures 5.1 and 5.2 illustrate the 
participants included in the H&D Study.  





*Participants who were not followed up included those who were lost to follow-up, due to no longer 
wanting to participate, due to being unable to be contacted, missing data or due to death. 
 
DOS65+ Study Participants at Baseline (n=227) 
Excluded (n=2) transplant patients (n=225) 
Excluded (n=2) who did not have a complete WHODAS 2.0 score at baseline (n=223) 




Figure 5.2 H&D Study Māori participants 




*Participants who were not followed up included those who were lost to follow-up, due to no longer 
wanting to participate, due to being unable to be contacted or due to death. 
 
5.2 Participant’s Characteristics at Baseline 
Descriptive information was collected prior to the outcome data for the 223 participants 
who had completed WHODAS 2.0 and EQ-5D-3L measures at baseline (time of 
recruitment into the study). Table 5.1 details the basic demographics, HRQoL and 
disability variables for these participants. The mean of the WHODAS score was 11.72 
(95% CI 10.67-12.78). The median was 11 (minimum value 0 and a maximum value 
38), with an inter-quartile range of 5 to 17. The standard error was 0.54 and there was 











Māori DOS65+ Participants at Baseline (n=50) 
Excluded (n=1) who did not have a complete WHODAS 2.0 score at baseline (n=49) 




Table 5.1 Baseline descriptive characteristics of the 223 participants 
Variable n % 
Sex 
  
  Male 143 64 
  Female 80 36 
Age group 
  
  <75 years 150 67 
  75+ years 73 33 
Ethnicity  
  
  Non-Māori, Non-Pacific 122 55 
  Māori 49 22 
  Pacific 52 23 
DHB 
  
  Counties Manukau  150 67 
  Hawkes Bay 29 13 
  Otago 44 20 
Dialysis location 
  
  Home (HD+PD) 68 31 
  In-centre 92 41 
  Non-dialysis or training* 63 28 
Dialysis vintage 
  
  Non-dialysis 55 25 
  <2 years 87 39 
  ≥2 years 81 36 
Treatment type 
  
  Haemodialysis 108 48 
  Peritoneal dialysis 60 27 
  Non-dialysis 55 25 
Number of comorbidities 
  
  0-2 104 47 
  3+ 119 53 
Adequate income** 
  
  Just or not enough 120 54 
  Enough or more than enough 102 46 
BMI 
  
  <30 121 54 
  30+ 102 46 
Highest educational qualification  
  
  School 110 49 
  Tertiary  113 51 
Living arrangements 
  
  With others 191 86 
  Alone 32 14 
Disability at baseline (WHODAS 2.0) 
  
  WHODAS <10 101 45 
  WHODAS ≥10 122 55 
EQ-5D-3L mobility 
  
  No problems 





  Severe problems 10 5 
EQ-5D-3L self-care 
  
  No problems 





  Severe problems 15 7 
EQ-5D-3L usual activities 
  
  No problems 





  Severe problems 19 8 
EQ-5D-3L anxiety/depression 
  
  No problems 





  Severe problems 2 1 
EQ-5D-3L pain/discomfort 
  
  No problems 







  Severe problems 6 3 
Cognitive function  
  
  No problems 





  Severe problems 5 2 
*The non-dialysis group contained 8 participants who were in the process of training for dialysis (less than 90 days); 
hereafter, this group is simply called ‘non-dialysis’. To clarify, this is only the case in the dialysis location group. 
The dialysis vintage and treatment type group include these 8 participants in the dialysing variable.  
** Adequate income has one individual missing; therefore, the total number of participants presented in this group is 
222.  
 
A higher proportion of H&D Study participants were male, and in the under 75 years 
age group (Table 5.1). A larger proportion of participants were on HD (48%) compared 
to PD (27%). The majority of participants lived with others (86%). Additionally, a large 
proportion of the participants came from the Counties Manukau DHB (the largest renal 
unit in NZ).  
At baseline, 45% of the H&D Study participants reported WHODAS 2.0 Scores <10 
indicating ‘lesser/no disability’, and 55% of participants had WHODAS 2.0 ≥10, 
indicating ‘considerable disability’. The majority of participants reported no problems 
with self-care, anxiety/depression according to the EQ-5D-3L, or problems with 
cognitive functioning. However, 51% reported moderate problems with usual activities, 
and 43% of participants had moderate problems with pain/discomfort. For the 
remainder of the analysis the moderate and severe categories were combined due to 
sample size restrictions.  
5.2.1 Disability at Baseline  
Table 5.2 compares the characteristics of participants with ‘lesser/no disability’ 
(WHODAS 2.0 <10) to those with ‘considerable disability’ (WHODAS 2.0 ≥10) at 
baseline. The number and percentages are shown, as well as the chi-square p-values.
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Table 5.2 Disability described at baseline (n=223) 
Characteristic  WHODAS 2.0 
<10 
WHODAS 2.0≥10 P-value  





  0.729 
  Male 66 46 77 54   





  0.554 
  <75 years 70 46 80 53   





  0.566 
  Non-Māori, non-Pacific 50 41 72 59   
  Māori 25 51 24 49   
  Pacific  26 50 26 50   




  0.467 
  School 66 44 84 56   





  0.122 
  Counties Manukau 74 49 76 51   
  Hawkes Bay  13 45 16 55   





  0.942 
  Non-dialysis 26 47 29 53   
  Haemodialysis 48 44 60 56   
  Peritoneal dialysis  27 45 33 55   




  0.681 
  Non-dialysis 27 49 28 51   
  <2 Years 37 43 50 57   
  ≥2 Years 37 46 44 54   




  <0.000 
  0-2 61 59 43 41   





  0.958 
  <30 55 46 65 54   
  30+ 46 45 56 55   




  0.765 
  Home (HD+PD) 32 47 36 53   
  In centre 39 42 53 58   
  Non-dialysis 30 48 33 52  




  0.704 
  Just or not enough 56 47 64 53   





  0.035 
  Live others 92 48 99 52   





  <0.000 
  No problems 65 72 25 28   





  <0.000 
  No problems 89 55 74 45   
  Moderate-severe problems 12 20 48 80   




  <0.000 
  No problems 66 73 25 27   





  0.013 
  No problems 64 53 57 47   





  0.001 
  No problems 92 51 89 49   





  <0.000 
  No problems 83 55 69 45   
  Moderate-severe problems 18 25 53 75   
*There were 4 individuals missing in the highest education qualification characteristic variable and one individual 
missing data in the BMI and adequate income variable.  
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**Row percentages are presented.  
 
Two-thirds of those with 3 or more comorbidities were experiencing ‘considerable 
disability’.  Those who had moderate-severe problems with EQ-5D-3L mobility were 
more likely to have higher WHODAS 2.0 scores, as were those with problems with 
EQ-5D-3L self-care, EQ-5D-3L usual activities, and EQ-5D-3L anxiety/depression.  
5.3 Predictors of Disability at 12 Months 
Of the 223 H&D Study participants at baseline, 157 participants completed follow-up 
interviews at 12 months. Sixty-six participants were either lost to follow-up or had died 
prior to the 12 month interview.  
5.3.1 Univariate Analyses 
Table 5.3 presents the relative risks of WHODAS 2.0 ≥10 (considerable disability) at 
12 months according to baseline characteristics. The relative risks were estimated using 
modified Poisson regression. Of the 157 participants followed to 12 months after 
baseline, one did not have information about dialysis vintage available in their clinical 
record and is therefore not included in the analyses for that variable. As described in the 
methods, only 156 participants were included in the final multivariable model (as 
displayed in Figure 4.2 (Chapter 4) and Figure 5.1) However, 157 participants were 
able to be included in the univariate analyses. Additionally, two participants did not 
provide information about their level of education and therefore these individuals are 
not included in the analyses for that variable in Table 5.3 below. The mean WHODAS 
2.0 score for the 157 remaining at 12 months was 11.76 (95% CI 10.50-13.02). The 
median was 11 (minimum 0 and maximum value 33), with an interquartile range of 5-
17. The standard error was 0.64 and the standard deviation was 8.05.  
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Table 5.3 Univariate analysis of risk of WHODAS 2.0 ≥10 representing 
‘considerable disability’ after 12 months follow-up according to characteristics of 
the participants (n=157) 
Variable Relative 
Risk  
95% CI  P-Value  Overall 
P-
Value* 
Sex     
  Male Ref    
  Female 1.31 1.00-1.70 0.047  
Age group      
  <75 years Ref    
  75+ years 1.16 0.88-1.52 0.295  
Ethnicity      
  Non-Māori, Non-Pacific Ref   0.870 
  Māori  0.91 0.65-1.29 0.613  
  Pacific 0.95 0.67-1.35 0.784  
Highest educational qualification (n=155)     
  Tertiary Ref    
  School 1.27 0.90-1.78 0.172  
Treatment type      
  Non-dialysis Ref   0.255 
  Peritoneal Dialysis 1.04 0.75-1.45 0.817  
  Haemodialysis 0.81 0.58-1.12 0.208  
Dialysis vintage (n=156)     
  Non-dialysis Ref   0.151 
  <2 years 1.06 0.78-1.45 0.693  
  ≥2 years 0.77 0.53-1.11 0.195  
Number of comorbidities     
  0-2 Ref    
  3+ 1.21 0.92-1.59 0.171  
BMI     
  <30 Ref    
  30+ 1.22 0.93-1.60 0.155  
Dialysis location      
  Non-dialysis  Ref   0.958 
  Home (HD+PD) 1.00 0.70-1.44 0.979  
  In centre  1.04 0.75-1.45 0.795  
Adequate income     
  Enough or more than enough Ref    
  Just or not enough 1.08 0.82-1.42 0.585  
Living arrangements      
  With others Ref    
  Alone 1.19 0.85-1.67 0.307  
EQ-5D-3L mobility      
  No problems Ref    
  Moderate-severe problems 1.98 1.42-2.76 <0.000  
EQ-5D-3L self-care     
  No problems Ref    
  Moderate-severe problems 1.67 1.32-2.11 <0.000  
EQ-5D-3L usual activities      
  No problems Ref    
  Moderate-severe problems 1.89 1.35-2.64 <0.000  
EQ-5D-3L pain/discomfort      
  No problems Ref    
  Moderate-severe problems 1.25 0.96-1.64 0.100  
EQ-5D-3L anxiety/depression     
  No problems Ref    
  Moderate-severe problems 1.21 0.90-1.63 0.212  
Cognitive function      
  No problems Ref    
  Moderate-severe problems 1.35 1.04-1.76 0.022  
Disability at baseline (WHODAS 2.0)     
  WHODAS <10 Ref    
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  WHODAS ≥10  2.24 1.64-3.07 <0.000  
*Overall p-value refers to the p-value which was calculated when there was more than one p-value 
presented for an explanatory variable. 
The univariate analyses indicate that sex (although this was borderline as the 95% CI 
included 1.00), EQ-5D-3L mobility, EQ-5D-3L self-care, EQ-5D-3L usual activities, 
cognitive function and ‘considerable disability’ at baseline may predict disability 12 
months later. Univariate analyses did not demonstrate a difference in risk of disability 
for dialysis type (HD and PD), dialysis vintage or those dialysing at home or in centre 
compared to non-dialysing patients. Multivariable analyses were then undertaken to 
provide understanding of factors that may independently predict disability outcomes at 
12 months.  
5.3.2 Multivariable Analyses 
Three models were completed in the multivariable analyses. Table 5.4 shows the results 
of the multivariable model with no variables being fixed. Additionally, but not 
presented here, the models were rerun with age, sex, ethnicity and all EQ-5D-3L 
dimensions fixed, and again with only the EQ-5D-3L dimensions fixed (Appendix III; 
Tables III) (1-2). These sub-analyses produced results similar to those in Table 5.4 and 
are not discussed again, as the focus is on Table 5.4. The final multivariable model 
portrays the results of only 156 participants, as one participant was missing a value for 













Table 5.4 Multivariable analysis of variables predicting WHODAS 2.0 ≥10 
representing ‘considerable disability’ at 12 months (n=156) 
Variable  Relative Risk  95% CI  P-value Overall P-
value 
Sex 
    
  Male Ref 
   
  Female   1.31 1.03-1.67 0.014 
 
Dialysis vintage  
    
  Non-dialysis Ref 
   
  <2 years 0.54 0.24-1.21 0.023 0.091 
  ≥2 years 0.39 0.17-0.88 0.048 
 
Dialysis location 
    
  Non-dialysis Ref 
   
  Home (HD+PD) 2.29 1.00-5.21 0.048 0.014 
  In centre 1.75 0.80-3.85 0.160 
 
EQ-5D-3L mobility  
    
  No problems Ref 
   
  Moderate-severe 
problems 
1.38 1.00-1.89 0.048 
 
EQ-5D-3L self-care 
    
  No problems Ref 
   
  Moderate-severe 
problems 
1.31 1.04-1.67 0.025 
 
Disability at baseline 
(WHODAS 2.0) 
    
  WHODAS <10 Ref 
   
  WHODAS ≥10 1.86 1.36-2.53 <0.001 
 
Variables included but not retained; age, ethnicity, number of comorbidities, living arrangements, EQ-5D-3L usual 
activities, EQ-5D-3L pain/discomfort, EQ-5D-3L anxiety/depression and cognitive function. 
The key findings of this multivariable model are that, provided other variables in the 
model remained unchanged, those who were disabled at baseline have an 86% 
increased risk of disability 12 months later (RR=1.86, 95% CI=1.36-2.63; p<0.001), 
when compared to those with ‘lesser/no disability’ at baseline. Those with EQ-5D-3L 
self-care problems have a 31% higher risk (RR=1.31, 95% CI =1.04-1.67; p=0.025) of 
disability and those with EQ-5D-3L mobility problems have a 38% higher risk 
(RR=1.38, 95%CI =1.00-1.89; p=0.048) of disability compared to those with no 
problems at baseline. Females were at a 31% higher risk of ‘considerable disability’ at 
the 12 month follow-up (RR=1.31, 95%CI=1.03-1.67; p=0.0137) compared to men.  
When considering dialysis vintage, patients dialysing for a shorter period of time (0-2 
years) had no statistically significant difference in risk of disability compared to the 
non-dialysis group (RR=0.54, 95%CI =0.24-1.21). However, those dialysing for 2 or 
more years had a 61% (RR=0.39. 95%CI 0.17-0.88) lower risk of ‘considerable 
disability’ 12 months later compared to the non-dialysis group. Additionally, those 
dialysing at home were 2.29 (RR=2.29, 95%CI 1.00-5.21) times as likely to experience 
‘considerable disability’ at 12 months compared to those not dialysing, although this 
was not statistically significant.  
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5.4 Outcomes for Older people on Dialysis 
Clinically, it is important to make comparisons between outcomes between HD and PD 
patients. As demonstrated in Chapter 3, much of the literature had focused on such 
comparisons. In the H&D Study, 168 patients were on dialysis (HD =108, PD =60) at 
baseline (interview one), 52 had died, were too un-well or were lost to follow-up at 12 
months, leaving 116 dialysing patients with data available at 12 months.  
5.4.1 Descriptive Analyses 
Initially, descriptive analyses and chi-square tests were undertaken to compare the 
characteristics of these groups. Understanding the difference in outcomes between HD 
and PD may help individuals, clinicians and whānau decide which treatment is best. 
Location has been removed from analysis, as location of dialysis therapy in NZ is often 
determined by the type of dialysis, with those on HD being more likely to dialyses in-
centre and those on PD often dialysing at home (9).
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%* P Value 
Sex 
  
  0.053 
  Male 63 59 44 41 
 
  Female 45 74 16 26 
 
Age group  
  
  0.595 
  <75 years 78 66 41 34 
 




  0.004 
  Non-Māori, Non- Pacific  43 52 40 48 
 
  Māori  30 77 9 23 
 




  0.108 
  <2 years 49 57 37 43 
 
  ≥2 years 58 72 23 28 
 
Number of comorbidities  
  
  0.854 
  0-2 52 65 28 35 
 
  3+  56 64 32 36 
 
Living arrangements  
  
  0.620 
  With others 98 65 53 35 
 




  0.373 
  No problems 41 60 27 40 
 
  Moderate-severe 
problems 
67 67 33 33 
 
EQ-5D-3L self-care  
  
  0.584 
  No problems 73 63 43 37 
 
  Moderate-severe 
problems 
35 67 17 33 
 
EQ-5D-3L usual activities 
  
  0.088 
  No problems 36 56 28 44 
 
  Moderate-severe 
problems 





  0.285 
  No problems 65 68 31 32 
 
  Moderate-severe 
problems 





  0.931 
  No problems 87 64 48 36 
 
  Moderate-severe 
problems 
21 64 12 36 
 
Cognitive function  
  
  0.538 
  No problems 65 63 39 38 
 
  Moderate-severe 
problems 
43 67 21 33 
 
Disability at baseline 
(WHODAS 2.0) 
  
  0.945 
  WHODAS <10 48 64 27 36 
 
   WHODAS ≥10 60 65 33 35 
 
Disability at 12 months 
(WHODAS 2.0)  
  
  0.280 
  WHODAS <10  38 73 14 27 
 
  WHODAS ≥10 39 60 26 40 
 
  Participants not followed        
for 12 months 
31 61 20 39  
*Row percentages are presented 
A higher proportion of people on PD were Māori or Pacific. There was a tendency for 
more females on HD, however this was not statistically significant. With these 
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exceptions, and with this relatively small sample, HD and PD patients had similar 
characteristics. There is no statistically significant difference in disability between HD 
and PD patients at baseline or 12 months.  
5.4.2 Multivariable Analysis of Disability Outcomes among Dialysis 
Patients (HD or PD) only 
 
Multivariable analyses were undertaken to consider which, if any, variables predicted 
disability 12 months later among the dialysis (HD or PD participants) only. Cognitive 
function had to be removed from these analyses in favour of other variables due to the 
smaller sample size. Table 5.6 shows the multivariable analyses with no variables being 
fixed.  
Table 5.6 Multivariable analyses of variables predicting WHODAS 2.0 ≥10 
representing ‘considerable disability’ at 12 months, among older dialysis patients 
(HD and PD) only (n=116) 
Variable  Relative Risk  95% CI  P-value 
Dialysis vintage 
   
  < 2 years Ref 
  
  ≥2 years 0.73 0.55-0.98 0.036 
EQ-5D-3L self-care 
   
  No problems Ref 
  
  Moderate-severe problems 1.38 1.03-1.85 0.030 
EQ-5D-3L usual activities 
   
  No problems Ref 
  
  Moderate-severe problems 1.54 0.99-2.40 0.058 
Disability at baseline 
(WHODAS 2.0) 
   
  WHODAS <10 Ref 
  
  WHODAS ≥10  1.62 1.10-2.38 0.015 
Variables included but not retained in the model; sex, age group, ethnicity, number of comorbidities, living 
arrangements, EQ-5D-3L mobility, EQ-5D-3L pain/discomfort, and EQ-5D-3L anxiety/depression.  
From these analyses it can be seen that among current dialysing patients those who 
were disabled at baseline are at a 62% (RR=1.62, 95%CI 1.10-2.38, p=0.015) higher 
risk of being disabled compared to those with ‘lesser/no disability’. Additionally, those 
dialysing for 2 or more years had a 27% (RR=0.73, 95%CI 0.55-0.98, p=0.036) 
decreased risk of experiencing disability compared to those dialysing for <2 years. 
Those with problems with EQ-5D-3L self-care at baseline were at a 38% (RR=1.38, 
95%CI 1.03-1.85, p=0.030) higher risk of being disabled at 12 months compared to 
those with no problems. The EQ-5D-3L domain of usual activities shows that those 
with moderate-severe problems with usual activities at baseline were at a 54% 
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(RR=1.54, 95% CI 0.99-2.40, p=0.058) higher risk of disability, however this result did 
not quite reach statistical significance.  
5.5 Analyses Māori Cohort 
5.5.1 Māori Descriptive Analyses 
One of the aims was to conduct a separate analysis of outcomes for Māori participants. 
The descriptive characteristics of the Māori participants of the H&D Study is shown are 




Table 5.7 Baseline characteristics of the Māori cohort (n=49) 
Variable  n % 
Sex 
  
  Male 28 57 
  Female 21 43 
Age group 
  
  <75 years 40 82 
  75+ years 9 18 
Highest education qualification  
  
  Tertiary 15 31 
  School 33 69 
Adequate income  
  
  Just or not enough 34 69 
  Enough or more than enough 15 31 
Living arrangements 
  
  With others 36 73 
  Alone 13 27 
Treatment type 
  
  Haemodialysis 30 61 
  Peritoneal Dialysis 9 18 
  Non-dialysis 10 21 
Dialysis vintage 
  
  <2 years 19 39 
  ≥2 years 20 41 
  Non-dialysis 10 20 
Number of comorbidities 
  
  0-2 20 41 
  3+ 29 59 
BMI 
  
  <30 19 39 
  30+ 30 61 
Dialysis location 
  
  Home (HD+PD) 10 20 
  In-centre 27 55 
  Non-dialysis 12 25 
EQ-5D-3L mobility 
  
  No problems 19 39 
  Moderate-severe problems 30 61 
EQ-5D-3L self-care 
  
  No problems 37 76 
  Moderate-severe problems 12 24 
EQ-5D-3L usual activities 
  
  No problems 23 47 
  Moderate-severe problems 26 53 
EQ-5D-3L pain/discomfort 
  
  No problems 24 49 
  Moderate-severe problems 25 51 
EQ-5D-3L anxiety/depression 
  
  No problems 44 90 
  Moderate-severe problems 5 10 
Cognitive function  
  
  No problems 32 65 
  Moderate-severe problems 17 35 
Disability at baseline (WHODAS 
2.0) 
  
  WHODAS <10  25 51 
  WHODAS ≥10  24 49 
 
There was a higher proportion of Māori males than females, and the majority of Māori 
were under the age of 75 years.  Additionally, a large proportion (69%) of Māori had 
just or not enough income. The majority of Māori were on HD and had 3 or more 
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comorbidities. Very few Māori had problems with EQ-5D-3L self-care, EQ-5D-3L 
anxiety/depression; or cognitive function at baseline. However, a larger proportion of 
Māori had problems with EQ-5D-3L mobility and EQ-5D-3L usual activities. There 
was a similar proportion of individuals with ‘lesser/no disability’ and those with 
‘considerable disability’.  
5.5.2 Univariate Analyses 
Due to the small sample size it was not possible to conduct multivariable analyses. 
Instead univariate analyses was undertaken to investigate associations between Māori 
who had ‘lesser/no disability’ at baseline and those had ‘considerable disability’ at 
baseline (interview 1). The results are shown in Table 5.8.
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Table 5.8 Disability described at baseline in the Māori participants (n=49) 
Characteristic  WHODAS 2.0 <10 WHODAS 
2.0  ≥10  
 
P-value 
 n % n %  
Sex 
    
0.680 
  Male 15 54 13 46 
 
  Female 10 48 11 52 
 
Age group 
    
0.299 
  <75 years 19 48 21 52 
 
  75+ years 6 67 3 33 
 
Highest educational qualification 
   
0.613 
  Tertiary 7 47 8 53 
 
  School  18 55 15 45 
 
DHB 
    
0.561 
  Counties Manukau 20 56 16 44 
 
  Hawkes Bay 4 40 6 60 
 
  Otago 1 33 2 67 
 
Treatment type  
    
0.573 
  Non-dialysis 5 50 5 50 
 
  Peritoneal Dialysis 6 67 3 33 
 
  Haemodialysis 14 47 16 53 
 
Dialysis vintage  
    
0.037 
  <2 years  6 32 13 68 
 
  ≥2 years 13 65 7 35 
 
  Non-dialysis 6 60 4 40 
 
Number of comorbidities 
    
0.027 
  0-2 14 70 6 30 
 
  3+ 11 38 18 62 
 
BMI 
    
0.684 
  <30 9 47 10 53 
 
  30+ 16 53 14 47 
 
Dialysis location 
    
0.812 
  Home (HD+PD) 6 60 4 40 
 
  In-centre 13 48 14 52 
 
  Non-dialysis and Training  6 50 6 50 
 
Adequate income 
    
0.305 
  Enough or more than enough 6 40 9 60 
 
  Just or not enough 19 56 15 44 
 
Living arrangements 
    
0.682 
  With others 19 53 17 47 
 
  Alone 6 46 7 54 
 
EQ-5D-3L mobility  
    
0.002 
  No problems 15 79 4 21 
 
  Moderate-severe problems 10 33 20 67 
 
EQ-5D-3L self-care 
    
0.038 
  No problems 22 59 15 41 
 
  Moderate-severe problems 3 25 9 75 
 
EQ-5D-3L usual activities 
    
0.015 
  No problems 16 70 7 30 
 
  Moderate-severe problems 9 35 17 65 
 
EQ-5D-3L pain/discomfort 
    
0.032 
  No problems 16 67 8 33 
 
  Moderate-severe problems 9 36 16 64 
 
EQ-5D-3L anxiety/depression 
    
0.603 
  No problems 23 52 21 48 
 
  Moderate-severe problems 2 40 3 60 
 
Cognitive function  
    
0.315 
  No problems 18 56 14 44 
 
  Moderate-severe problems 7 41 10 59 
 
*Row percentages presented 
These univariate analyses presented in Table 5.8 suggests that problems related to EQ-
5D-3L mobility, EQ-5D-3L self-care, EQ-5D-3L usual activities and EQ-5D-3L 
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pain/discomfort are all associated with disability at baseline compared to those with no 
problems. Similarly, those with 3 or more comorbidities are associated with being more 
disabled than those with 0-2 comorbidities (p=0.027). Additionally, those who had been 
dialysing for more than 2 years were associated with lower disability at baseline 
(p=0.037).  
At 12 months there were 37 Māori participants, and again univariate analysis was 
undertaken to compare those who had ‘lesser/no disability’ at 12 months compared to 
those experiencing ‘considerable disability’ at 12 months.  
Table 5.9 Baseline characteristics of Māori participants who had ‘lesser/no 
disability’ compared to those who were disabled at 12 months (n=37) 
Baseline Characteristics  WHODAS 2.0 <10 WHODAS 
2.0 ≤10   
 
P-value 
 n % n %  
Sex 
    
0.014 
  Male 12 67 6 33 
 
  Female 5 26 14 74 
 
Age group 
    
0.509 
  <75 years 13 43 17 57 
 
  75+ years 4 57 3 43 
 
Highest educational qualification 
   
0.836 
  Tertiary 5 50 5 50 
 
  School  12 46 14 54 
 
DHB 
    
0.534 
  Counties Manukau 14 45 17 55 
 
  Hawkes Bay 2 40 3 60 
 
  Otago 1 1 0 0 
 
Treatment type  
    
0.351 
  Non-dialysis 2 25 6 75 
 
  Peritoneal Dialysis 3 43 4 57 
 
  Haemodialysis 12 55 10 45 
 
Dialysis vintage  
    
0.001 
  <2 years  2 15 11 85 
 
  ≥2 years 12 75 4 25 
 
Number of comorbidities 
    
0.900 
  0-2 8 47 9 53 
 
  3+ 9 45 11 55 
 
BMI 
    
0.286 
  <30 8 57 6 43 
 
  30+ 9 39 14 61 
 
Dialysis location 
    
0.860 
  Home (HD + PD) 3 43 4 57 
 
  In-centre 10 50 10 50 
 
  Non-dialysis  4 40 6 60 
 
Adequate income 
    
0.447 
  Enough or more than enough 4 36 7 64 
 
  Just or not enough 13 50 13 50 
 
Living arrangements 
    
0.659 
  With others 13 48 14 52 
 
  Alone 4 40 6 60 
 
EQ-5D-3L mobility  
    
0.006 




Baseline Characteristics  WHODAS 2.0 <10 WHODAS 
2.0 ≤10   
 
P-value 
 n % n %  
  Moderate-severe problems 6 27 16 73 
 
EQ-5D-3L self-care 
    
0.383 
  No problems 14 50 14 50 
 
  Moderate-severe problems 3 33 6 67 
 
EQ-5D-3L usual activities 
    
0.035 
  No problems 11 65 6 35 
 
  Moderate-severe problems 6 30 14 70 
 
EQ-5D-3L pain/discomfort 
    
0.147 
  No problems 10 59 7 41 
 
  Moderate-severe problems 7 35 13 65 
 
EQ-5D-3L anxiety/depression 
    
0.774 
  No problems 15 47 17 53 
 
  Moderate-severe problems 2 40 3 60 
 
Cognitive function  
    
0.501 
  No problems 12 50 12 50 
 
  Moderate-severe problems 5 38 8 62 
 
Disability at baseline (WHODAS 
2.0) 
    
<0.001 
  WHODAS <10  14 70 6 30 
 
  WHODAS ≥10 3 18 14 82 
 
*Row percentages were presented  
The H&D Study shows that a greater proportion of Māori who were disabled at 
baseline also experienced ‘considerable disability’ at 12 months. A higher proportion of 
Māori females were disabled at 12 months compared to Māori males.  In Table 5.9, 
those who dialysed for ≥2 years experienced decreased disability compared to those 
who had been dialysing for <2 years. Additionally, those with moderate-severe 
problems with EQ-5D-3L mobility and EQ-5D-3L usual activities problems had a 
greater likelihood of being disabled compared to those with no problems.  
As with the overall cohort, aspects of HRQoL appear to be associated with disability 
among the Māori cohort. However, as a result of the small sample size, further research 
is needed to determine if HRQoL does predict disability for Māori or whether this 
association is confounded by other factors.  
5.6 Comparison of Participants Remaining in the Study at 12 
months to Baseline only Participants 
 
Due to a large proportion (42%) of H&D Study participants lost to the 12 month 
follow-up, the characteristics of those followed to 12 months were compared with those 
only interviewed at baseline. Pearson’s chi-square test was used compare the 
characteristics of the 67 participants who were not followed to 12 months with the 156 
participants interviewed with complete data.  
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Table 5.10 Characteristics of participants followed-up at 12 months (n=156) 
compared to baseline only participants (n=67) 
Baseline characteristics Baseline 
(n=67) 






     
  Male 45 67 98 63 0.535 
  Female  22 33 58 37 
 
Age group 
     
  <75 years 43 64 107 69 0.520 
  75+ years 24 36 49 31 
 
Ethnicity  
     
  Non-Maori, Non-Pacific  34 51 88 56 0.314 
  Maori  13 19 36 23 
 
  Pacific  20 30 32 21 
 
Dialysis vintage  
     
  Non-dialysis  15 22 39 25 0.358 
  <2 years 29 43 58 37 
 
  ≥2 Years 22 32 59 38 
 
  Missing  2 3 0.0 0.0 
 
Dialysis location  
     
  Non-dialysis 15 22 48 31 0.444 
  Home (HD+PD) 22 33 46 29 
 
  In centre 30 45 62 40 
 
Number of comorbidities  
     
  0-2 25 37 79 51 0.067 
  3+  42 63 77 49 
 
Living arrangements  
     
  With others 56 84 135 87 0.564 
  Alone  11 16 21 13 
 
EQ-5D-3L mobility 
     
  No problems 21 31 69 44 0.072 
  Moderate-severe problems 46 69 87 56 
 
EQ-5D-3L self-care  
     
  No problems 46 69 117 75 0.327 
  Moderate-severe problems 21 31 39 25 
 
EQ-5D-3L usual activities  
     
  No problems 26 39 65 42 0.690 
  Moderate-severe problems 41 61 91 58 
 
EQ-5D-3L pain/discomfort  
     
  No problems 32 48 89 57 0.202 
  Moderate-severe problems 35 52 67 43 
 
EQ-5D-3L anxiety/depression  
     
  No problems 55 82 126 81 0.817 
  Moderate-severe problems 12 18 30 19 
 
Disability at baseline 
(WHODAS 2.0) 
     
  WHODAS <10  21 31 80 51 0.006 
  WHODAS ≥10  46 69 76 49 
 
Treatment type  
     
  Non-dialysis 15 22 40 26 0.772 
  Haemodialysis 20 30 40 26 
 
  Peritoneal Dialysis  32 48 76 49 
 
Cognitive function   
     
  No problems 43 64 109 70 0.403 




*Column percentages have been presented 
The only statistically significant difference between those followed up for 12 months 
and those who only had a baseline interview was in baseline disability. It appears that a 
higher proportion of those disabled at baseline were lost to follow-up. Additionally, it 
appears that there was a tendency towards a higher proportion of individuals with 
higher comorbidities and impaired EQ-5D-3L mobility to not be followed up for 12 
months (interview 2), however neither of these differences were statistically significant.  
Analysis was also completed to compare Māori who were followed-up to 12 months to 
those who were not. A total of 12 Māori participants were not followed up to 12 
months. A greater proportion of Māori females were followed up at 12 months, and 
there were no other differences between the two groups (see Table III (3) in Appendix 
III).  
5.7 Conclusion   
Within the entire H&D Study cohort, it is apparent that ‘considerable disability’, EQ-
5D-3L self-care and EQ-5D-3L mobility problems at baseline predict disability at 12 
months. Dialysing for greater than 2 years was associated with a lower risk of 
disability. In the univariate sub-analysis of dialysing patients, it was apparent that there 
was no significant difference in disability at 12 months between HD and PD patients. 
However, in the multivariate analysis home dialysis (which is predominantly PD) was 
associated with a greater degree of disability. For the smaller sample of Māori 
participants, HRQoL and baseline disability also appear to be important in predicting 
disability at 12 months.  
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6 Chapter Six: Discussion 
This chapter discusses the key findings and conclusions of the H&D Study. Firstly, the 
results of the H&D Study are summarised according to the three main objectives 
identified in Chapter One and discussed in relation to other studies. Following this, the 
strengths and the limitations of the H&D Study are considered, and then the 
implications and recommendations for further research are presented. This chapter 
closes with the final conclusions.  
6.1 Results 
The key findings from this H&D Study are summarised in relation to each of the H&D 
Study objectives below.  
6.1.1 Objective One 
Describe characteristics of the H&D study participants at baseline and determine 
cross-sectional associations, if any, between health-related quality of life (HRQoL) and 
disability among a cohort of older New Zealanders with CKD5 at the time of 
recruitment (baseline);  
At the time of recruitment, the majority of participants reported no problems with self-
care (73%), anxiety/depression (81%) according to the EQ-5D-3L, and also to a 
question about cognitive functioning (68%). A total of 59% of participants reported 
moderate-severe problems with usual activities and 46% of participants had moderate-
severe problems with pain/discomfort according to the EQ-5D-3L (Table 5.1, Chapter 
Five). Apostolou et al (2007) identified that physical decline (119), which could be 
associated with reduced ability to perform usual activities and lead to pain/discomfort, 
is important in influencing HRQoL. The cross-sectional results from the H&D Study 
suggest that consideration of patient’s issues with usual activities and perceptions of 
pain/discomfort may be important when attempting to enable individuals to maximise 
their HRQoL. Additionally, at baseline, 45% of participants had ‘lesser/no disability’ 
and 55% of participants had ‘considerable disability’ (Table 5.1), which suggests that 
disability is prevalent among those with CKD5.  
To further consider associations between HRQoL and disability at baseline participants 
with ‘lesser/no disability’ were compared to those with ‘considerable disability’ by the 
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predictor and explanatory variables in terms of unadjusted associations (Table 5.2). 
Analysis at baseline demonstrated that those who had moderate-severe problems with 
EQ-5D-3L mobility, EQ-5D-3L self-care, EQ-5D-3L usual activities, EQ-5D-3L 
pain/discomfort, EQ-5D-3L anxiety/depression, and cognitive function  also 
experienced ‘considerable disability’ at baseline. This was also found in those with 
three or more comorbidities. This observation did not control for confounders. 
However, it demonstrates that those with moderate-severe problems with HRQoL at 
baseline appeared to also experience disability. As identified in section 3.7.1 (Chapter 
3), Cook et al (2008) in a cross-sectional analysis found that disability was prevalent in 
older adults on HD and this makes self-care difficult (146). Fidan et al (2016) found 
that disability and poor physical function appeared to be linked to poor HRQoL, 
however this study had a very small sample size of 50 people and focused on hand 
disability. Additionally, the participants average age was 56 therefore these results may 
not be directly applicable to those aged ≥65 years (159). Little is currently known about 
the relationship of HRQoL and disability in CKD5 patients, but the H&D Study 
findings align with findings from research conducted previously, that HRQoL is cross-
sectionally associated with disability among people with CKD5(146, 159).  
6.1.2 Objective Two 
Determine, which, if any, factors at recruitment (baseline), including HRQoL, predict 
disability outcomes 12 months later;  
After establishing that disability is an important issue at baseline in the H&D Study 
cohort, the H&D Study aimed to determine baseline predictors of disability at 12 
months. A univariate analysis (Table 5.3) was completed to assess the risk of baseline 
‘considerable disability’ at 12 months of follow-up according to the explanatory and 
predictor baseline characteristics of the participants. The unadjusted univariate analysis 
indicated that sex, EQ-5D-3L mobility, EQ-5D-3L self-care, EQ-5D-3L usual 
activities, cognitive function and ‘considerable disability’ at baseline predicted 
‘considerable disability’ 12 months later.  
Multivariable analyses determined the factors that independently predicted disability at 
12 months in the CKD5 patients of the H&D Study. Females had a 31% higher risk of 
‘considerable disability’ at 12 months compared to males (Table 5.4). In contrast, to the 
studies identified in the scoping review (section 3.7.2 and 3.7.3), it appears that the 
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majority of the papers did not note a difference between males and females (146, 158). 
Females traditionally were the homemakers among older New Zealanders, and 
therefore they may do more around the home than males, meaning that their perception 
of being disabled could be greater than males. However, this a hypothesis and further 
research needs to be undertaken to try and understand what underpins the risk of 
disability for females with CKD5.  
There was a trend for those who dialysed at home (Table 5.4) to be more likely to 
experience ‘considerable disability’ than those who were not dialysing which may 
initially seem counter-intuitive. In NZ, PD is often available to people who are more 
unwell which may act to explain this finding. Within the H&D Study cohort, most 
home dialysis patients were on PD, which is a simpler dialysis modality and allows for 
independence at home, despite often having significant comorbidities and disabilities. 
Individual preferences with clinical guidance largely dictate the treatment chosen and 
therefore the outcomes (134).  
In terms of HRQoL, participants who had moderate-severe problems with mobility and 
self-care as measured by the EQ-5D-3L (Table 5.4) were more likely to experience 
‘considerable disability’ at 12 months compared to those with no problems with these 
dimensions at baseline. Therefore, it appears the EQ-5D-3L mobility and EQ-5D-3L 
self-care can be useful in predicting subsequent disability for CKD5 patients. This is a 
novel finding since no previous studies identified in the literature search used HRQoL 
as a predictor of disability. Previously de Jonge et al (2003) investigated if INTERMED 
could be used as a predictor of HRQoL (120), however no studies have investigated if 
HRQoL could be used as a predictor in CKD5 patients. The H&D Study findings 
suggest that future research could investigate the use of the explicit assessment of 
mobility and self-care in the clinical review and pre-dialysis education of individuals 
with CKD5 as they approach the need for renal replacement therapy. This could allow 
patients and nephrologists to use the experiences of others to aid the decision making of 
those who are investigating RRT.  
Individuals with ‘considerable disability’ at baseline had a significantly (86%) higher 
risk of experiencing ‘considerable disability’ at 12 months compared to those with 
‘lesser/no disability’ at baseline (Table 5.4). Although the scoping review found 
literature reporting that patients with CKD5 often experience disability (150, 158), 
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previous studies have not clearly identified disability as a predictor of later disability in 
CKD5 patients. Therefore, this H&D Study contributes a significant finding through 
demonstration of disability as a predictor of later disability in CKD5 patients. These 
results are important for future patient and family education, when discussing the 
potential impact of dialysis on the individual, to reduce any possible misunderstanding 
as to the ‘benefits’ of dialysis with respect to existing disabilities.  
Additionally, in this H&D Study, those who dialysed for ≥2 years had a 61% 
(RR=0.39, 95% CI=0.17-0.88) (Table 5.4) lower risk of having ‘considerable 
disability’ compared to those who were not dialysing. A plausible explanation for this 
is related to this being a self-selected group with improved survival (increased dialysis 
vintage) due to likely having little or no comorbidities upon commencing dialysis. To 
expand, those who were healthier when they commenced dialysis appeared more likely 
to have improved outcomes in the longer term, in terms of disability. However, this 
study did not have access to those individuals’ health data at the time they commenced 
dialysis. This study used an ‘accelerated longitudinal’ design with both prevalent 
dialysis participants who had been on dialysis for variable time periods as well as 
incident patients newly presenting with CKD5 at time of recruitment(18). In NZ, 
survival after commencing dialysis in the 65-74 year old age group is 87% at 12 
months, 73% at 2 years and 37% at 5 years (181). For those aged 75-84, survival is 
81% at 12 months, 64% at 2 years and 19% at 5 years (181). The result from the H&D 
Study demonstrates another important finding for informing patients and their families 
about the impact of dialysis. For those individuals, who are healthier, with “lesser/no 
disability” at the initiation of dialysis can expect advantageous outcomes  
Additionally, a small sub-study was completed (section 5.4) that only analysed the 
dialysis population (HD and PD) as clinically it is important to make comparisons 
between the dialysis modalities. Basic descriptive analysis found that HD and PD 
participants had similar HRQoL and disability results (Table 5.5). This echoes the 
results of papers identified during the scoping review which found no substantive 
differences in outcomes between HD and PD patients (134, 135). Upon completing the 
multivariable analysis of the HD and PD patients (Table 5.6), similar results were seen 
as for the entire H&D Study sample (i.e. HD, PD and non-dialysing CKD5 participants) 
(Table 5.4). Specifically, for the dialysing participants, dialysis vintage of 2 or more 
years lowered the likelihood of ‘considerable disability’ at 12 months and moderate-
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severe problems with EQ-5D-3L self-care and ‘considerable disability’ at baseline 
predicted ‘considerable disability’ at 12 months in the dialysing patients (Table 5.6). 
6.1.3 Objective Three 
Describe key characteristics (including HRQoL and disability) at recruitment 
(baseline) and again 12 months later for older Māori patients with CKD5;  
Due to the limited sample size, it was not possible to undertake multivariable analysis 
for the Māori cohort. However, the univariate analysis demonstrated that Māori who 
had moderate-severe problems with EQ-5D-3L mobility, EQ-5D-3L self-care, EQ-5D-
3L usual activities and EQ-5D-3L pain/discomfort had a higher likelihood of 
experiencing ‘considerable disability’ compared to Māori with no problems at baseline. 
Also, a greater proportion of Māori with three or more comorbidities were 
‘considerably disabled’ 12 months later compared to those with 0-2 comorbidities 
(Table 5.8). The same analysis was completed for the 37 Māori who were followed up 
at 12 months. Māori females had more disability at 12 months than Māori males. Once 
again, dialysing for 2 or more years at baseline was associated with less disability at 12 
months, and participants with moderate-severe problems with EQ-5D-3L mobility and 
EQ-5D-3L usual activities at baseline were more likely to experience ‘considerable 
disability’ at 12 months. Those who experienced ‘considerable disability’ at baseline 
were also associated with ‘considerable disability’ at 12 months in the Māori cohort 
(Table 5.9). There has been very little previous research identifying HRQoL and 
disability in Māori. Walker et al (2016) and Shih et al (2010) have previously 
demonstrated that Māori may experience stress and fear when dialysing (161, 162). 
This stress and fear was found to be minimised when Māori experienced whakamana, 
which is a sense of self-esteem and self-determination. This often occurs when whānau, 
are involved and when relationships can be built with medical professionals (162). 
Therefore, the H&D Study shows that Māori with CKD5 experienced ‘considerable 
disability’. The H&D Study has added to the limited literature about Māori CKD5 
experiences; it would be beneficial to have more research focused on Māori outcomes 
with larger sample sizes. Additionally, it would have been useful if this research 
investigated methods in which the Māori model of health, Te Whare Tapa Whā could 
have been incorporated into the care of Māori with CKD5.  
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Briefly the results have been assessed to compare the results of the Māori cohort to the 
entire H&D Study cohort. In the multivariable analysis of the 156 participants who 
were followed to 12 months, it was encouraging to see that ethnicity was not retained in 
the multivariable analyses (Table 5.4). This indicates that Māori had no observed 
difference in terms of experiencing ‘considerable disability’ at 12 months compared to 
Pacific and non-Māori/non-Pacific groups after adjusting for other confounders. This 
result has limited generalisability due to the small sample size of the Māori cohort 
included in the H&D Study. As discussed above, further research regarding Māori 
CKD5 experiences and outcomes is important and could aid in improving outcomes for 
Māori.  
6.2 H&D Study Strengths and Limitations 
6.2.1 Strengths 
One key strength of the H&D Study is the use of two literature reviews; the rapid 
review enabled definitions of HRQoL and disability to be summarised and understood 
for the purposes of this thesis. This ensures the definition of HRQoL and disability 
were appropriate to use as measures in this study.  
The scoping review provided an understanding of the broad range of literature related 
to ‘HRQoL and CKD’ and ‘disability and CKD’. It clearly demonstrates the gap in the 
literature that the H&D Study aimed to fulfil in that no previous studies identified what 
factors including HRQoL predicted disability in CKD5 participants.   
The EQ-5D-3L was used as a valid measure of HRQoL (20). The five dimensions are 
mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Cognitive 
function was added to the H&D Studies HRQoL measure due to being identified by 
Wilson and Cleary (1995) and Kaplan and Ries (2007) as an important domain of 
HRQoL (22, 51). The EQ-5D-3L has previously been used and recognised in NZ (56) 
and has been tested for appropriateness in the Māori population (72). Additionally, the 
EQ-5D-3L allows for individuals to provide their perspective on their HRQoL. 
Therefore, it was a quick and easy measure to administer to CKD5 patients.  
Disability in this thesis was conceptualised primarily around the ICF model and 
therefore the brief 12-item WHODAS 2.0 was an appropriate measure to use. It is also 
useful as it is a generic assessment of measuring disability across cultures and is used in 
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a standardised way (96, 101) and again is gathered from the perspective of the 
individual. It includes the concept of cognition, mobility, self-care, getting along, life 
activities and participation (114) and has the potential to be easily administered to the 
CKD5 population.  
A strength of this study was that prior to the DOS65+ Study a smaller pilot study was 
completed to test the questionnaire and the measures used in the DOS65+ Study (1). 
This ensured that the measures used in the DOS65+ Study and therefore the H&D 
Study was satisfactory to older New Zealanders including Māori.  
Another strength of the H&D Study is that I had the privilege of having access to a 
large robust dataset that was gathered in the DOS65+ Study. This allowed for a wide 
range of explanatory variables to be considered and included being able to access (de-
identified) DOS65+ Study clinical and mortality data about H&D participants. 
Finally, we have confirmed statistically some findings that may have been known by 
clinicians intuitively; that disability in CKD5 patients predicts future disability and that 
self-care and mobility problems are also important in predicting disability. No previous 
studies have demonstrated these findings. We also focused on the relationships between 
HRQoL and disability for Māori. The sample size of Māori was small however these 
results add to the small body of research completed in the past and act to suggest that 
further research is necessary.   
6.2.2 Limitations 
Bias 
Selection bias is likely to have been an issue in this study, as participants selected for 
the DOS65+ Study were excluded if they had an inter-current illness requiring 
hospitalisation within two weeks of the survey data and if this affected the patient’s 
ability to take part of judged by the opinion of the physician (1, 18).This suggests that 
the CKD5 population in the H&D Study is potentially healthier than the total 
population of older New Zealanders with CKD5. Therefore, the H&D cohort are likely 
to experience better HRQoL and less disability than the total population. This means 
the findings of the H&D Study are likely to be underestimating the true strength of the 
associations and relationships due to the participants included being heathier 
participants at baseline.  
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It is possible that misclassification bias may have occurred in terms of dialysis location; 
eight individuals who were ‘in training’ were included in the non-dialysis group. ‘In-
training’ means that they had not been dialysing for more than 90 days. Some of these 
eight participants may have dialysed very little and some may be near the end of the 90 
days. Therefore, some of these participants may have been better included within the 
dialysing group. However, given the small number of participants in the ‘in training 
group’, this is unlikely to have significant effects on the overall results of the study.  
Loss to follow-up, including death, would contribute to bias in this study. Of the 223 
individuals who provided baseline data, 67 were loss to follow up or had died. They 
were more likely to experience disability, three or more comorbidities, and impaired 
EQ-5D-3L mobility at baseline, compared to those (156 individuals) who were able to 
be followed up at 12 months (Table 5.10). These were the characteristics associated 
with disability at 12 months (Table 5.4). Therefore, it is possible that the results 
presented in this thesis are underestimating the effects of disability, comorbidity or 
moderate-severe problems with EQ-5D-3L mobility in predicting disability at 12 
months. To further explain this, as demonstrated in Table 5.10, 79% of those not 
disabled at baseline were followed to 12 months, whereas 62% of those who were 
disabled were followed to 12 months. Table 5.4 demonstrates that those disabled at 
baseline were more likely to be disabled at 12 months. Therefore, this means that if we 
had retained more participants who were disabled at baseline in our analysis, we would 
have observed an even larger RR in table 5.4. This loss-to-follow-up has therefore 
likely resulted in the underestimation of the relationship between baseline disability and 
disability at 12 months. Within the Māori population, there was no observed difference 
between Māori followed to 12 months and those who were not, apart from more Māori 
females being followed for 12 months.  
Confounding  
The H&D Study had a small sample size. A total of 156 participants were followed up 
for 12 months, and due to the size of the sample, there were a limited number of 
explanatory/confounding variables that could be controlled for in the multivariable 
model. The scoping review provided many potential explanatory variables, and 
although a larger number of them were clinical issues so were not relevant to the aims 
and objectives of the H&D Study (160), a few additional variables may have been 
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useful to include such as education, had the sample size been larger. Additionally, some 
categories were broad groups (e.g. age was categorised into those aged 65-75 years and 
those aged ≥75 years). It may be that such groupings are too large. However, due to the 
sample size and the scope of this thesis it was not possible to undertake the modelling 
with narrower age groups. Increasing the number of categories may have reduced the 
statistical power, as would have adding more explanatory variables. There may be a 
risk of other unknown residual confounders relevant to the objectives influencing the 
results of the H&D Study.  
Additionally, although Māori were oversampled relative to the NZ CKD5 population in 
general, due to their only being 49 Māori participants at baseline in this study. 
Therefore, this small number of participants precluded any multivariable analysis to 
control for potential confounders that have the potential to modify the observed 
associations. Having identified this limitation, the H&D Study has highlighted 
associations for Māori, and signals potential ways forward for future research.  
6.3 Implications 
In the scoping review it was suggested that further effort is necessary to integrate 
HRQoL measures into standardised clinical care with the purpose of improving patient 
outcomes (122, 144). HRQoL is complex and spans many dimensions. The H&D Study 
investigated the HRQoL dimensions of the EQ-5D-3L which include mobility, self-
care, usual activities, pain/discomfort, and anxiety/depression and also investigated 
cognitive functioning. Individuals may have problems with all dimensions or just some 
dimensions of HRQoL. By investigating which areas of HRQoL individuals have 
problems with, and then intervening in the particular area or areas of concern, 
(126)could be a useful way in improving HRQoL in CKD5 patients and preventing 
disability. Through managing clinical knowledge, effective coordination of patient care 
and through improving HRQoL in areas of a patients need, (125) this may result in 
improved outcomes in CKD5 patients.  
The H&D Study findings, if supported by research elsewhere, indicates that assessment 
of mobility and self-care should be included in the clinical review and pre-dialysis 
education of individuals with CKD5 as they approach the need for renal replacement 
therapy. A potential method of assessing mobility and self-care (as well as other 
dimensions of HRQoL) could be to provide patients with the EQ-5D-3L questionnaire 
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or other HRQoL measures in routine clinical assessments of older patients with CKD5 
in NZ and potentially in other countries (20, 62). This would allow for patients to 
express their perspective on their HRQoL and could aid in informing health 
professionals about what areas a particular patient may require more assistance in. 
Additionally, it is important to inform patients and their families about the impact of 
comorbidities and how this may affect their HRQoL on dialysis. Pre-existing disability 
will more likely progress with time on dialysis. Conversely, for those individuals, who 
are healthier, with little or no disabilities at the initiation of dialysis, should expect little 
significant deterioration in their clinical status. Additionally, in the scoping review it 
was identified that disability in CKD patients could be reduced through rehabilitation 
(152). Therefore, it is possible that rehabilitation strategies could be advised for those 
with earlier stages of CKD to reduce their disability before they reach CKD5. These 
rehabilitation strategies could be aimed at enabling patients to maintain their self-care 
and mobility as these were the main two HRQoL dimensions that appeared to predict 
disability in this study. Additionally, disability predicted disability, so investigating 
strategies to reduce disability would also be valuable. However further research would 
be needed to determine whether intervening to promote self-care, mobility and to 
reduce disability could be areas for interventions to reduce adverse disability outcomes. 
It would have also been beneficial to follow-up the participants for longer, such as for 
24 and 36 months as the DOS65+ study intended. This would allow for determining if 
the results observed are long lasting. However, this was not possible within the scope of 
this thesis. The H&D Study suggests that further research investigating rehabilitation 
strategies and having increased follow-up is likely to be a valuable direction for future 
research.  
The H&D Study also enabled me to build upon the small body of research regarding 
Māori experience with CKD5 and demonstrated that baseline disability and the EQ-5D-
3L dimensions of mobility, self-care, usual activities and pain/discomfort predicted 
disability in the Māori population. However, due to the sample size, it was not possible 
to determine how confounders may have influenced these associations. It was 
encouraging to see that in our multivariable model it appeared that Māori did not 
experience greater disability than non-Māori/non-Pacific and Pacific within those aged 
≥65 years.  
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6.4 Future Research  
The H&D Study has provided novel research in investigating predictors of disability in 
the CKD5 population and in particular investigated if HRQoL dimensions could be 
predictors of disability. The scoping review identified many various rehabilitation 
strategies including regular exercise, such as walking, education, environmental 
modifications (151), occupational therapy, gait training and joint mobilisation (149) to 
prevent disability in those with CKD. However, it is difficult to determine which 
rehabilitation strategies may actually work in NZ.  It has been suggested that whānau 
support (162) could potentially be important, particularly in the Māori population. From 
the results of this research, it is possible that rehabilitation could be targeted at 
mobility, self-care and baseline disability.  Further research could investigate if this 
would be effective. It would be beneficial if future longitudinal cohort studies of a 
larger sample size that evaluate the effectiveness of rehabilitation targeting mobility, 
self-care and disability. Additionally, it would be advantageous to see cohort studies 
that investigated these predictors of disability to help confirm the findings from the 
H&D Study. 
The research questions that remain unanswered particularly when considering the 
Māori population are which factors predict disability in the Māori CKD5 cohort and 
upon identifying predictors, which interventions would be effective in improving health 
outcomes for this group. To answer these unanswered questions, it would be useful to 
further investigate Māori experiences both in a quantitative and qualitative fashion with 
HRQoL and disability in CKD5 patients. This thesis identified an association that 
HRQoL and baseline disability were associated with subsequent disability for Māori. 
Further research could be based upon these findings to evaluate if this association is 
replicable. A larger sample of Māori CKD5 patients would be useful to explore this. 
Additionally, the Māori health model Te Whare Tapa Whā could be valuable when 
designing future research for Māori with CKD5. Te Whare Tapa Whā represents a 
holistic approach to health and well-being and considers Taha Wairua (spiritual), Taha 
Hinengaro (mental), Taha Tinana (physical) and Taha Whānau (family). This model of 
Māori health could be used to aid in informing the selection of potential predictors of 
outcomes that are specifically important for the Māori population for example. Once 
specific predictors for Māori have been replicated/confirmed and in conjunction with 
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qualitative research then interventions can start to be designed and implemented to 
improve outcomes specifically for Māori. 
6.5 Final Conclusions 
In summary the main aim of the H&D Study was to investigate the association between 
HRQoL and disability and to determine if HRQoL and/or other factors predict 
disability in people with CKD5 aged ≥65 years in NZ at 12 months. 
This study clearly demonstrates that the EQ-5D-3L mobility, EQ-5D-3L self-care and 
‘considerable disability’ at baseline were associated with higher rates of ‘considerable 
disability’ at 12 months. Additionally, baseline disability was the strongest predictor of 
disability at 12 months. Intuitively this may seem obvious to clinicians, however this is 
the first known time that it has been confirmed prospectively in a clinical study. The 
findings of the H&D Study do aid in developing knowledge that may inform 
nephrology professionals and patients with respect to the impact RRT may have on 
their life.  
Additionally, this study focused on the EQ-5D-3L and the WHODAS 2.0 measures 
which assess HRQoL and disability respectively from the perspective of the patient 
rather than the health professionals. Although nephrologists and the nephrology team 
are experts and very attuned to the needs of their patients, the literature reviews enabled 
for an understanding that an individual’s rating of their HRQoL and disability is very 
important (49, 77). Therefore using the EQ-5D-3L and WHODAS 2.0 which are both 
robust, easy to understand and easy to administer measures (62, 182) allows for an 
assessment of patients perspectives which may improve the clinical experience and 
recommendations for the patients.  
Also, of interest is that individual’s aged ≥65 years with increased dialysis vintage were 
associated with decreased disability risk. This suggests that the individuals in this older 
age group, who are healthier, with ‘lesser/no disabilities’ at the initiation of dialysis, 
should not expect any significant deterioration in their clinical status.  
Within the Māori analyses, baseline problems with EQ-5D-3L mobility, EQ-5D-3L 
self-care, EQ-5D-3L usual activities, EQ-5D-3L pain/discomfort and ‘considerable 
disability’ were associated with ‘considerable disability’ at 12 months. Of importance, 
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it was very positive to see that in a multivariable model Māori with CKD5 did not 
experience greater disability than non-Māori/non-Pacific and Pacific. 
The H&D Study has significantly demonstrated in a group of older people with CKD5 
both on dialysis or pre-dialysis, that self-reported EQ-5D-3L measures of mobility, self-
care and ‘considerable disability’ impact upon subsequent disabilities at 12 months. 
Patient and family participation in assessing these HRQoL components and baseline 
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Appendix I: Tables to Support the Rapid Review 
 
Table I (1): Overview of the Rapid Review of literature discussing HRQoL  
 No.  Bibliography Details Aim  HRQoL areas discussed Overall HRQoL Conclusions  HRQoL 
Measure
ment  
1.  Title: Research Methods in 
Health. Investigating Health and 
Health Services. Chpt 2 pp 36-
37 
 
Author: Bowling A  
 
Buckingham: Open University 
Press; 1997. 
This book aimed to 
establish social research 
on health and 
sociological and 
psychological concepts 
and approaches.  
The importance of 
measuring HRQoL when 
assessing health outcomes 
and dimensions that shape 
HRQoL.  
Emotional, psychological, physical and social well-being 
are all important dimensions in determining HRQoL.  
 
A large range of measurements have been developed to 




2.  Title: EuroQol: the current state 
of play.  
 
Author: Brooks R 
Health Policy. 1996;37. 
This book aims to 
describe the results of 
EuroQol’s 1987 
discussion about creating 
a non-disease specific 
instrument for measuring 
HRQoL.   
This source describes 
EuroQoL in detail, the 
strengths of the 
measurement and the 
reasons it was developed.  
The EuroQoL group designed the EQ-5D as an 
instrument that could be self-completed by the 
participants.  
 
Five dimensions that are important in determining HRQoL 
include mobility, self-care, usual activities, 
pain/discomfort and anxiety and depression.  
 
This measurement is short and user friendly.  
EQ-5D 
3.  Title: EQ-5D concepts and 
methods: a developmental 
history. 
 





The aim of this book is to 
describe the 
development of the 
EuroQoL instrument, as 
well as assessing this 
instrument and the 
effective methods of 
using this instrument.  
Very comprehensive 
coverage of the uses and 
development of the EQ-5D.  
The EuroQoL instrument has two distinct tasks in terms 
of measuring HRQoL. Firstly it allows for information to 
be gained on how an individual rates their current health 
state and secondly it applies a tariff to the social value of 
health states which can be used alongside cost data in 
the planning context when determining priorities for 




 No.  Bibliography Details Aim  HRQoL areas discussed Overall HRQoL Conclusions  HRQoL 
Measure
ment  
4.  Title: Definition of Health-
Related Quality of Life 
Centers for Disease Control and 
Prevention 
2017. 
This source defines 
HRQoL.  
NA “Health-related quality of life (HRQOL) is an individual’s 
or group’s perceived physical and mental health over 
time.”  
NA 
5.  Title: Selecting a measure of 
health related quality of life.  
 
Authors: Dempster M, Donnelly 
M 
 
Soc work in health 
care.2000;32(1):45-56. 
 
This paper aimed to 
assist social workers to 
make informed choices 
about the appropriate 
measure of HRQoL. 
Quality of life was defined. 
The purpose of measuring 
HRQoL as well as generic 
and condition-specific 
measures was discussed.  
This source also discusses 
issues to evaluate when 
choosing a HRQoL 




Quality of life (QoL) is often perceived as the degree to 
which human needs are met. This includes physical, 
social, economic, and psychological needs. HRQoL 
refers to these needs in relation to health.  
 
Most attempts of defining QoL and HRQoL are based on 
WHO’s definition of health.  
 
What matters is what the patient feels rather than what 











6.  Title: Health-related quality of 
life: A primer for 
gastroenterologists. 
 
Authors: Eisen G, Richard G 
 
Ame J Gastroenterol. 
1999;94(8):2017-21. 
This article provides a 
definition for HRQoL and 
the techniques for its 
measurement and the 
tools available for this 
task.  
Described HRQoL and 
reasons to measure 
HRQoL.  
This source describes the 
strengths of psychometric 
instruments for measuring 
HRQoL and the information 
that is important for this 
including validity, reliability, 
responsiveness, and 
coverage.  
Additionally, generic and 
specific HRQoL measures 
for different diseases 
where discussed.  
QoL is not a new concept and it has always been 
attempted to be incorporated by health care professionals 
in order to achieve the patient’s wellbeing.  
 
HRQoL includes physical function, somatic sensation, 
psychological state and social interactions that affect 
one’s health status.  
 







7.  Title: Quality of life as an 
outcome measure in nursing 
research: 'may you have a long 
and healthy life'. 
The aim is to provide an 
understanding of the 
difference between the 
definition of QoL and 
It discusses how QoL is a 
term that has emerged 
from WW2 when it became 
apparent that longevity of 
QoL is “a person’s perception of their health status and 
aspects of their life that are considered important in 










Authors: Harrison M, Juniper E, 
Mitchell-DiCenso A. 
 
Can J Nurs Res. 1996;28(3):49-
68. 
what contributes to QoL, 
which is aimed to assist 
with nursing evaluations 
on patient’s outcomes.   
life was important along 
with QoL.  
Nurse’s roles in ensuring 
QoL are discussed.  
This source also discusses 
various HRQoL 
instruments and the quality 
of these instruments and 
the fact that there are both 
generic and specific 
measures.  
This source notes that QoL has already became 
important in planning, implementing and evaluating both 
health care and social policies.  
8.  Title: Health-Related Quality of 
Life in Old Age: How to Define it, 
How to Study?  Preparation for 
Aging. 
 




The aim was to discuss 
the background of 
HRQoL in gerontological 
research, to analysis 
theoretical and 
methodological principles 
in HRQoL and analysis 
the struggles of looking at 
empirical research.  
This source describes past 
QoL research generally 
and specifically in the older 
population, it describes 
different concepts and 
measures as well as 
outlining the need for 
careful analysis of QoL.  
This paper questions the validity of talking about HRQoL 
if we cannot measure it.  
 
HRQoL was able to emerge as medicalisation was no 
longer enough to paint a picture of an individual’s health.  
 
A great deal of emphasise of having a ‘good functioning’ 
level predicts QoL.  
 
This paper concludes that many authors emphasis that 
QoL is multidimensional and of a subjective 
phenomenon.  
 
9.  Title: Quality of life: concept and 
definition. 
 
Authors: Kaplan R, Ries ACopd. 
2007;4(3):263-71. 
Four Objectives:  
1) Definition of HRQoL 
2) Measurement of 
HRQoL 
3)Relationship between 
exercise and HRQoL in 
general 
4) Relationship between 
exercise and HRQoL in 
COPD patients.  
This paper defines HRQoL, 
how QoL is measured and 
the differences between 
these measures. 
Additionally, estimation of 
HRQoL and physical 
activity in the population 
and in COPD patients is 
discussed.   
Over the past years new methods to measure wellness 
have been developed and these are often quantitative. 
Since these measures are generally used to evaluate 
health status in general the term HRQoL is used.  
 








10.  Title: Health, Health-Related 
Quality of Life, and Quality of 
Life: What is the Difference? 
This paper aims to 
determine the history and 
The history of the various 
terms is discussed as are 
the definitions and 
 

















definitions of the terms 
HRQoL, QoL and health.  
differences between the 
three terms and measures.  
 
WHO definition of health was important for the 
development of the EQ-5D.  
There are at least four definitions of HRQoL which 
include:  
1) How well a person functions in their life and his or her 
perceived wellbeing in the physical mental and social 
dimensions of health.  
2) QoL is an all-inclusive concept incorporating all factors 
that impact upon an individual’s life whereas HRQoL only 
include factors that are part of health.  
3) HRQoL are aspects that are self-perceived and are 
related to or affected by the presence of disease or 
treatment.  
4) HRQoL refers to the values assigned to different health 
states.  
11.  Title: Quality of life: a concept 
analysis. 
 
Author: Meeberg G 
 
J Adv Nurs1993;18:32-8. 
 
To stimulate further 
thought on what was 
meant by QoL in the 
health care context.  
How QoL is referred to in 
the literature is discussed 
as is dictionary definitions 
of this terms and cases are 
discussed.  
QoL cannot be used as an outcome unless it is clearly 
defined.  
 
QoL was first used after WW2.  
QoL has subjective components which include a personal 
satisfaction, however there are objective components that 
are necessary in shaping ones QoL which include outside 
forces such as socioeconomic status.  
 
12.  Title: Definitions of Quality of 
Life: What Has Happened and 
How to Move On. 
 
Author: Post M 
 
TopSpinal Cord Inj 
Rehabil2012;20(3):167-80. 
To show how the 
concepts of HRQoL and 
QoL have evolved over 
time and various ways 
these terms have been 
defined and measured 
and to provide 
recommendations on 
how to be consistent 
when completing QoL 
research.  
This paper described QoL 
in medicine and discusses 
the many different 
variations and models of 
QoL. Additionally, QoL in 
spinal cord injury research 
is discussed.  
QoL is a term that was introduced in medical literature in 
the 1960s and is a term that has become increasingly 
popular in recent decades.  
 
QoL is a term that evolved from the WHO definition of 
health in 1947.  
 
In QoL more than just a medical issue needed to be 
considered but the patients subjective experiences also 






 No.  Bibliography Details Aim  HRQoL areas discussed Overall HRQoL Conclusions  HRQoL 
Measure
ment  
Researchers need to be clear about the concept and 
operationalisation of QoL in their studies.  
13.  Title: Environmental and health-
related quality of life: conceptual 
and methodological similarities. 
 
Author: Rogerson R 
 
Soc Sci Med 1995;41(10):1373-
82. 
This source aimed to 
develop a conceptual 
framework of QoL in both 
environmental and health 
studies.  
The background of QoL is 
discussed in relation to 
health and the 
environment.  
Environmental QoL is 
discussed as is what 
HRQoL is.   
Conceptualising QoL is difficult.  
 
QoL should be viewed holistically, which may involve 
components aggregated together to form a whole.  
 
When defining QoL, two major components are at play 
which include those which relate to the internal 
psychological-physiological mechanism which produces a 
sense of satisfaction and gratification at the individual and 
or community level and communities or social groups 
which are external but result in internal satisfaction.  
 
Environmental QoL considers the priorities and 
preferences of population groups.  
 
14.  Title: Statistical issues 
encountered in the comparison 
of health-related quality of life in 
diseased patients to published 
general population norms: 
problems and solutions. 
 
Authors: Rose M, Koshman M, 
Spreng S, Sheldon R 
 
J Cli. Epidemiol.. 
1999;52(5):405-12. 
To investigate statistical 
issues when comparing 
HRQoL measured using 
SF-36 in a diseased 
group to the population 
norms and to facilitate 
comparisons with the 
general population.  
This study primarily 
discusses the strengths 
and limitations of the SF-36 
health survey.  
HRQoL is important in clinical epidemiology, clinical trials 
and general health care research.  
 
SF-36 and EuroQoL have now widely been accepted to 
measure HRQoL.  
 
Overall SF-36 can be used to compare HRQoL of the 
“diseased” population to the “normal” population but care 
must be taken to not misuse statistics and make 
erroneous assumptions about the data.  
SF-36  
15.  Title: A concept analysis of 
health-related quality of life in 
young people with chronic 
illness. 
 
Authors: Taylor R, Gibson F, 
Franck L 
 
This paper aimed to 
critique existing analysis 
of QoL and discuss why 
a definition is specifically 
needed for young people 
with chronic illness.  
This paper discussed what 
QoL was as well as 
critiques to the concepts of 
QoL.  
 
Additionally, HRQoL in 
young people with chronic 
illnesses was discussed, 
QoL is a term that became very popular after WW2.  
 
A persons QoL can be influenced by many factors and 
often the terms QoL and HRQoL are used 
interchangeable.  
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Measure
ment  
J Clin. Nurs. 2008;17(14):1823-
33. 
although this section was 
not relevant to this thesis.  
1) The philosophical perspective related to the nature of 
human existence; this provides a definition of a good life.  
2) The ethical perspective focuses on the sanctity of life.  
3) The economic perspective equates QoL to the 
assessment of economic growth.  
4) The sociological perspective emphasises the social 
aspects of QoL and the relationship between individuals 
and their circumstances.  
5) The psychological perspective relates QoL to an 
individual’s appraisal of life and fulfilling life goals.  
16.  Title: On assessing 
responsiveness of health-related 
quality of life instruments: 
guidelines for instrument 
evaluation. 
 
Authors: Terwee C, Dekker F, 
Wiersinga W, Prummel M, 
Bossuyt P 
 
Qual Life Res. 2003;12(4):349-
62. 
This study aimed to 
evaluate responsiveness 
and to evaluate the 
issues with 
responsiveness in 
relation to the HRQoL 
instruments.  
HRQoL and its importance 
of an outcome 
measurement.  
A literature review about 
responsiveness was 
completed and a 
methodology of assessing 
responsiveness was 
developed.  
HRQoL is now considered to be one of the most 
important outcomes in clinical studies.  
 
 
Four important steps for developing a useful HRQoL 
include 1) defining the measurement goals of the 
instrument 2) testing longitudinal validity 3) testing 
longitudinal reproducibility 4) Assessing interpretability of 
score changes on the instrument.  
 
17.  Title: Linking clinical variables 
with health-related quality of life. 
A conceptual model of patient 
outcomes. 
 
Authors: Wilson I, Cleary P 
 
Jama. 1995;273(1):59-65. 
A conceptual model and 
an understanding of 
patient’s health outcomes 
is discussed in this 
paper.  
This discusses how it is 
necessary to develop a 
conceptual model of 
HRQoL so that health 
professionals can intervene 
to improve HRQoL, it 
describes a conceptual 
model and describes the 
various factors contributing 
to this model.  
HRQoL is increasingly used as an outcome measure for 
clinical trials.  
 
Increased usage of HRQoL is due to increased valid and 
reliable measures.  
 
How can physicians and health professionals intervene to 
improve HRQoL.  
 
Biomedical models focus on the biological agents 
contributing to QoL.  
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HRQoL includes dimensions of physical, social, role 
functioning and mental and general health perceptions. 
Another important concepts include vitality, pain and 
cognitive functioning.  
 
 
Table II (2): Overview of the Rapid Review of literature discussing HRQoL focused on Māori  





1.  Title: Rehabilitation and 
indigenous peoples: the Māori 
experience.  
 




The main aim of this 
article was to present a 
perspective for Māori to 
improve rehabilitation 
services to improve their 
health and wellbeing.  
Discusses how EQ-5D may 
not be applicable to 
indigenous populations.  
It is noted that tools to measure outcomes are necessary 
to not only plan service but also to gauge the 
effectiveness of treatment and care.  
There is limited evidence or literature about measures of 
indigenous health outcomes.  
Further work is required to overcome tension in using 
outcome measures with indigenous peoples that have 
been developed and validated in European nations like 
EQ-5D-3L or are clinical in nature. These measures may 
not allow for meaningful information about Māori HRQoL 
to be collected.  
EQ-5D 
2.  Title: The validity and reliability 
of EQ-5D health state valuations 
in a survey of Māori. 
 
Authors: Perkins M, Devlin N, 
Hansen P. 
 
Qual Life Res. 2004;13(1):271-
4. 
The aim of this source 
was to determine if EQ-
5D was adequate in 
capturing the health state 
of the Māori population.   
This discusses the EQ-5D, 
the validity of the EQ-5D in 
different populations and 
discusses the strengths 
and weakness of using the 
EQ-5D in the Māori 
population by portraying 
the results of a small study.    
EQ-5D is an internationally recognised health state 
measurement, a key issue is to determine if this is a valid 
instrument for other QoL instruments. Three quarters of 
the 66 participants considered the EQ-5D model 
adequate. However, there may be underlying differences 






Table I (3): Overview of the Rapid Review of literature discussing disability 
No.  Bibliography Details Aim  Disability areas discussed Overall Disability Conclusions  Disability 
Measuremen
t Discussed 
1.  Title: Definitions, concepts, 
and measures of disability. 
 
Author: Altman B 
 
Annals of Epid 2014;24(1):2-7. 
The aim of this paper is 
to analyse concepts and 
definitions surrounding 
disability.  
This paper discusses the 
variety of disability definitions 
and ways that these 
definitions can be translated 
into measurement.  
It is generally agreed that no matter an individual’s 
level of physical, mental or emotional functioning 
disablement is the result of the persons interaction 
with his or her environment.  
 
Disability is contributed to impairment it is also a 
social construct.  
 
It is necessary to examine the complete process 
associated with the development of disability.  
 
The term disability has become a shorthand 
expression to represent a variety of different aspects 
of the disability process, including the disease 
progression and the limitations caused by the 
environment.  
 
There are many different definitions of disability and it 
is important to translate these into the correct 
measurement. 
 
2.  Title: Relevance of disability 
models from the perspective of 
a developing country: An 
analysis. 
 





This article examines 
various models of 
disability and explains the 
diverse perspective 
surrounding how 
disability is understood. 
Additionally, it focuses on 
disability in developing 
countries, specifically 
Ghana.  
Initially a literature review is 
described, which entails the 
models of disabilities and the 
practical implications of 
these models.  
The models of disability are numerous and include: 
the medical, charity, social, expert, right-based, 
religious/moral, economic, customer, and 
rehabilitation models.  
 
The models are based on two fundamental 
philosophies which the first sees disabled individuals 
dependent on society and the second views disabled 
people as customers to what society has to offer.  
 
3.  Title: Qualitative profiles of 
disability. 
 
This study identified 
profiles of functional 
disability paralleled by 
Explain what this study has 
defined disability as.  
 
Disability can be defined as difficulty or inability to 
perform basic activities essential for daily and 
independent living. Functional disability is specifically 






No.  Bibliography Details Aim  Disability areas discussed Overall Disability Conclusions  Disability 
Measuremen
t Discussed 
Authors: Annicchiarico R, 
Gilbert K, Cortés U, Campana 
F, Caltagirone C.  
 
JRehabil Res  Dev 
2004;41(6):835-45. 
increasing levels of 
disability.  
 
This study developed 
four definitions for 
different classes of 
disability.  
Described the sample 
population measured and the 
analysis.  
which interact to cause disability. Personal and 
environmental factors are also discussed. 
 
The scientific community lacks consensus on the best 
way to measure disability.   
Assessment 
Schedule 2.0  
4.   Title: Exploring Disability; 
second edition.  
 
Author: Barnes C  
 
Cambridge CB2 1UR, UK 
Polity Press; 2010; 341 pages. 
The aim of this book was 
to provide an up to date, 
wide-ranging and critical 
review of key issues and 
debates relevant to 
sociology studies of 
disability.  
This book aims to introduce 
disability, look at different 
models, and different 
theories of disability as well 
as looking at barriers. 
Additionally, routes to 
independent living and the 
politics of disability are 
discussed in this book.  
The individual medical model defines impairment as 
lacking part of a limb or having a defective bodily 
mechanism, disablement as the loss or reduction in 
functional ability and handicap as the disadvantage or 
restriction of activity caused by disability.  
 
Impairment is lacking part a limb or having a defective 
mechanism of the body and disability is the 
disadvantage or restriction of activity caused by a 
contemporary social organisation which takes little 
account of people with impairments.  
 
5.  Title: Exploring Disability. 
 
Barnes C & Mercer G  
 
UK Polity Press; 2010; 341 
pages. 
The main aim of this 
book is to describe 
disability, to describe the 
development of disability 
models.  
Chapter 2 discusses various 
models of disability.  
In the medical model of disability this can be viewed 
as impairment which means having a defective part of 
the body, disablement which is the loss or reduction 
of functional ability and handicap which is the 
disadvantage or restriction of activity caused by 
disability.  
Alternatively, the social model of disability sees 
impairment as having a defection affecting function 
and disability is the disadvantage or restriction of 
activities in society due to society excluding those 
who are different.  
 
6.  Title: Beyond (Models of) 
Disability? 
 
Author: Beaudry J 
 
J Med Philos 2016;41(2):210-
28. 
The aim of this paper 
was to discuss disability, 
the social and medical 
models and critique these 
models.  
Begin by discussing the 
various models of disability.  
Following this critique of the 
models are discussed.  
The concept of disability is better left open-ended and 
broad in scope to encompass various ethical issues.  
 
The social model of disability took off in the 70s in 
response to the medical model. The social model of 
disability portrays disability as a social phenomenon 
caused by social oppression and prejudices rather 








A key criticism of the social model of disability is that it 
separates impairment from the individual and some 
people experience disability as an individual rather 
than it being a social problem.  
7. Title: Implications for public 
health research of models and 
theories of disability: a scoping 
study and evidence synthesis. 
 
Berghs M, Atkin K, Graham H, 
Hatton C, Thomas C 
2016; 195 pages.  
The aim of this source 
was to examine the 
literature of theories and 
models of disability.  
This study completed a 
scoping review of disability.  
Models of disability include the medical model which 
views impairment as the problem of the individual. 
Following this, the human rights model assesses 
fundamental human rights of individuals with 
disabilities. The social model which differs impairment 
(physical/mental/sensory) and disability (oppression 
causes socially). 
 
8.  Title: Models of disablement, 
universalism and the 
international classification of 
impairments, disabilities and 
handicaps. 
 
Authors: Bickenbach J, 
Chatterji S, Badley E, Ustun T 
 
Soc Sci Med. 
1999;48(9):1173-87. 
This study aimed to 
review and critique 
models of disability and 
trace the development of 





and Handicaps (ICIDH).  
Disablement models and 
strategies for advocacy has 
been discussed.  
Minority groups are 
discussed as is the ICIDH.  
This source discusses the social and medical models 
of disability.  
 
In the 1980s the ICIDH began which acted as an 
international classification of disablement. This 
models disablement as a sequence of levels. The 
pathological issue is known as impairment and if this 
limits an individual ability to perform activities to what 
is considered as “normal” this is disability. Handicap is 
defined as a disadvantage due to impairment or 
disability that prevents fulfilment of the role that is 
considered normal for that individual. 
 
9.  Title: Reflection on the 
definition of impairment and 
disability as defined by the 
World Health Organization. 
 
Authors: Brandsma J, 
Lakerveld-Heyl K, Van 




ICIDH is gaining 
worldwide acceptance 
inside and outside of 
medicine. This article 
analyses the definitions 
of disability and 
impairment.  
Describes ICIDH 
development. Following, this 
the WHO definition of 
impairment, disability is 
explained in various context 
such as health experience, 
abnormality, structure and 
function.   
 
This article concludes that 
there needs to be re-wording 
of the WHO definitions and it 
Since the introduction of the ICIDH the concepts 
‘impairment’, ‘disability’ and ‘handicap’ have become 
increasingly accepted to monitor health status. ICIDH 
has been criticised for its overlap with the 
International Classification of Diseases (ICD).  
 
Consensus on definitions is mandatory for 
communication, research and educational process.  
 
Impairment “in the context of health, an impairment 




No.  Bibliography Details Aim  Disability areas discussed Overall Disability Conclusions  Disability 
Measuremen
t Discussed 
is necessary to harmonize 
various characteristics of a 
definition.  
structure or a physiological or psychological function 
taking into consideration the age of the person.”  
Disability “in the context of health, a disability can be 
defined as a loss or deviation, in both qualitative and 
quantitative way, of expected or desired activity 
performance or behaviour of a person, taking into 
consideration age, gender, physical, and social, and 
cultural environment.”  
10.  Title: Disability/Postmodernity 
 
Authors: Mairian C, 
Shakespeare T 
 
New York, NY 10038: Mairian 
Corker, Tom Shakespeare and 
the contributors 2002; 2002. 
This book aims to explore 
the theoretical 
perspectives of disability. 
The second section 
discusses culture and 
lastly it concludes with 
disabled children’s 
perspectives.  
This book describes the 
social model, the model of 
impairment and various 
cultures of disability.  
It is believed that disability studies can only benefit 
from the critical, reflexive exchange of ideas between 
those who bring different theoretical perspectives and 
different biographies.  
 
11.  Title: The utility of the 
International Classification of 
Functioning, Disability and 
Health checklist for evaluating 
disability in a community-
dwelling geriatric population 
sample. 
 
Authors: Dernek B, 
Esmaeilzadeh S, Oral A 
 
Int JRehab Res. 
2015;38(2):144-55. 
The main aim was to 
investigate disability in 
community dwelling 
individuals aged 65 years 
and over through using 
the ICF and WHODAS II 
schedule to compare how 
these measures and see 
if ICF checklist can be 
used to describe 
disability.  
Disability as measured by 
the ICF and WHODAS II was 
compared as measures in 
older populations.  
They concluded that the “ICF checklist has the 
potential to be used in a field setting, provided that 




12.   Title: Prospective outcomes of 
injury study. 
 
Authors: Derrett S, Langley J, 
Hokowhitu B, Ameratunga S, 
Hansen P, Davie G, et al. 
 
The aim was to quantify 
factors leading to 
disability outcomes after 
an injury in New Zealand. 
This paper discusses the 
concept of disability. It 
discusses disability in NZ, 
the financial costs of injury, 
injury-related disability 
research and outcomes.   
Definitions and conceptions of disability have 
continuously been contested. Originally disability was 
seen to be about individuals, however from the 1960s 
disability began to be viewed as an issue of the 
environment and social perceptions of it. Individuals 
with disabilities helped develop the ICF model. 
However, the ICF does not consider the subjective 











13.  Title: World Health 
Organization disability 




Authors: Federici S, Bracalenti 




This systematic review 
aimed to examine 
research and the 
practical applications of 
WHODAS 2.0. 
Provided a background 
about what disability is, and 
the methods and results of 
the systematic review.  
WHODAS 2.0 is useful to use alongside other 
measures and has been translated into 47 languages 
and used in 27 different areas of research.  
 
WHODAS 2.0 was developed from pooling together 
ICF items together to gain the areas of cognition, 
mobility, self-care, getting along, life activities and 
participation.  
 
WHODAS 2.0 has proven to be useful globally.  
 
No minimal clinically important difference (MCID) has 
been created for WHODAS 2.0 as of yet.  
WHODAS2.0  
14.  Title: World Health 
Organization Disability 
Assessment Schedule II: 
contribution to the Italian 
validation. 
 
Authors: Federici S, Meloni F, 





The aim of this study was 
to provide an assessment 
of the usefulness of 
WHODAS 2.0 in Italy.  
This source discusses the 
different models of disease 
and the developments of the 
ICF and ICIDH. This study 
has participants and looks at 
the reliability of the 
measurement.  
WHODAS 2.0 is useful for measuring disability in both 
normal and disabled people. The strengths of 
WHODAS 2.0 is that it rates a person’s disability from 
the patient’s perspective rather than from a clinician’s 
point of view.  
 
The study acts to confirm that the six main 
dimensions measured are the most valid measures of 
disability.  
WHODAS 2.0  
15.  Title: Disability identity 
development model: Voices 
from the ADA-generation.  
 
Authors: Forber-Pratt A, Zape 
M. 
 
A qualitative study was 
completed to explore how 
disability identity was 
developed in college 
students with disability.  
This article discusses 
important landmarks in 
developing disability 
decisions. This study also 
describes the results of 
interviewing 17 college 
students qualitatively to 
Understanding what disability means is important and 
could enable families of those who are disabled be 
better equipped.   
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Disab Health J 
2017;10(2):350-5. 
describe how they view their 
disability.  
16.  Title: Description of the 
person-environment 
interaction: methodological 
issues and empirical results of 
an Italian large-scale disability 
assessment study using an 
ICF-based protocol. 
 
Authors: Francescutti C, 
Gongolo F, Simoncello A, 
Frattura L 
 
BMC public health. 2011;11 
Suppl 4:S11. 
To define disability and to 
develop a way to use a 
theoretical model of 
disability empirical.   
This study aimed to define 
disability, and then break 
down this definition of 
disability, before developing 
an ICF protocol. This study 
concluded that it is possible 
to plan empirical studies in 
which theoretical advances 
and operative goals on 
disability in a person-
environment framework.  
Disability can be defined as the result of an interaction 
between a person and the environment directly.  
 
The ICF model shows the links between the relevant 
“health components” and allows information related to 
health conditions to be collected which included 
participation, environment and personal factors.  
 
The UN definition stated that “persons with disabilities 
include those who have long-term physical, mental, 
intellectual or sensory impairments which in 
interaction with various barriers may hinder their full 
and effective participation in society on an equal basis 
with others.”  
 
Disability should always be considered as a dynamic 
process.  
 
17.  Title: A new social perspective 
on disability and its 
implications for rehabilitation. 
 
Author: Gill C 
 
Occup ther in health care. 
1987;4(1):49-55. 
The aim of this study was 
to contrast the traditional 
medical model with the 
new interactional or 
socio-political model of 
disability. Disability is 
also experienced from 
the view of those in the 
disability minority group.  
This paper discusses how 
those with disability have 
become increasingly able to 
describe or define disability 
for themselves.  
Traditionally disability has been conceptualised by the 
medical model. The socio-political model defined 
disability as influenced by the social environment.  
 
Disabled people regardless of their medical diagnosis 





18.  Title: DSM-5 and the 
assessment of functioning: the 
World Health Organization 
Disability Assessment 
Schedule 2.0 (WHODAS 2.0).  
 
Author: Gold L 
 
The article aimed to 
review the implications 
for forensic psychiatric 
evaluations and 
assessed the DSM-5. 
Describes the DSM-5 and 
gives and introduction into 
WHODAS 2.0  
 
WHODAS 2.0 is the best measure of disability for 
routine clinical use.  
 
WHO makes a distinction between medical and 
psychiatric disorders and the term disability 
encompasses impairments, activity limitations and 
participation restrictions.  
 
WHODAS 2.0  
128 
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t Discussed 
J Am AcadPsychiatry and the 
Law Online. 2014;42(2):173-
81. 
WHODAS 2.0 is designed to be applicable to all 
health conditions. It can also be self-administered. 
 
WHODAS 2.0 is reliable, responsive to change and 
applicable globally.   
19.  Title: Perspectives on disability 








This book aims to expose 
ideologies and power that 
have been essential to 
rehabilitation 
professionals.  
This book discusses the 
assumptions of rehabilitation, 
the theoretical model of 
disability, it describes 
impairment.  
There are many models of disability including the 
moral/religious model of disability, followed by the 
individual/medical model, the social/political model of 
disability and the rehabilitation model.  
 
20.   Title: Is there a coherent social 
conception of disability? 
 
Author: Harris J 
 
J Med Ethics. 2000;26(2):95-
100. 
The aim is to examine 
and reject different 
conceptions of disability 
based on social factors, 
but it also analyses 
physical and mental 
conditions.  
The social model of disability 
is discussed, additionally 
disability and discrimination 
are discussed as is 
reproductive freedom and 
congenital deafness.  
A major weakness of seeing the social model of 
disability as completely floored is that if all the issues 
of society causing disability are removed are there in 
fact no disabling features remaining.  
 
Disability is caused by prior choices of the agent or of 
the agent’s parents. Disabling elements are harmful to 
the person and consequently that person has strong 
rational preference not to be in such condition.  
 
Most disabilities fall far short of something that awful 
that life is not worth living.  
 
21.   Title: Counting disability: 
global and national estimation. 
 
Authors: Kostanjsek N, Good 
A, Madden R, Üstün T, 




The purpose of this paper 
was to determine the 
number of individuals 
with disabilities, how 
disabilities are defined, 
and how it can be 
measured.  
Disability is difficult to count 
and measure as it is so 
broad. This source discusses 
methodology of the world 
report for multinational 
measurements of disability 
prevalence.  
To improve the quality of disability information it is 
recommended that concepts of disability are based on 
the ICF.  
 
Measuring and counting those with disability is difficult 
as it is multidimensional and a continuum.  
 
ICF definitions of disability are used to estimate the 





No.  Bibliography Details Aim  Disability areas discussed Overall Disability Conclusions  Disability 
Measuremen
t Discussed 
About 1 billion people have disabilities with extreme 
difficulties being experience by 110-190 million.  
 
Environmental factors play a considerable role in 
causing disability.  
 
The ICF acknowledges that every human can 
experience some level of disability.  
22.   Title: The definition of 
disability: what is in a name? 
 
Author: Leonardi M, 
Bickenbach J, Ustun T, 
Kostanjsek N, Chatterji S. 
 
Lancet. 2006;368 North 
American Edition(9543);1219-
2. 
To discuss the need for a 
global, all-inclusive 
definition for disability.  
Acknowledgement of the 
need for a common 
agreement of disability.  
When a common definition of disability is reached it 
should be applicable to all people and should not 
stipulate what causes this disability. Only when 
disability is defined can issues of health and social 
policy be tackled.  
 
The ICF provides a consistent conceptualisation of 
disability.  
 
The current UN Convention does not defined disability 
but rather people with disabilities.  
 
When defining disability, we should be careful to 
distinguish objective descriptions of disability from an 
individual’s satisfaction with that experience. 
 
ICF conceptualisation of disability is useful for 
bringing everyone closer to a goal of defining 
disability equally.  
 
23.   Title: Comparing the Disability 
Creation Process and 
International Classification of 
Functioning, Disability and 
Health models. 
 
Authors: Levasseur M, 
Desrosiers J, St-Cyr Tribble D. 
 
The aim of this paper 
was to compare the 
disability creation 




and Health (ICF).  
This source described the 
DCP model and the ICF 
model. Following this it goes 
on to describe the similarities 
between the DCP and the 
ICF models.  
The DCP model is an explanatory model of the 
causes and consequences of disease and is based 
on the interaction between individuals and their 
environment. 
 
The ICF model dates to the 1980s when the ICIDH 
was published. The terms impairment, disabilities and 
handicap were introduced to combat the medical 
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t Discussed 




Both the ICF and DCP are universal and they attempt 
to describe the complex phenomenon of human 
functioning.  
 
The DCP is based on the anthropological model of 
human development and disability which maintains 
that disability is dynamic and interactive between 
personal and environmental factors. Whereas the ICF 
is an integration of the medical and social models. 
24.   Title: Understanding how 
disability is defined and 
conceptualized in the 
literature. 
 
Authors: Lutz B, Bowers B 
 
RNJ 2003;28(3):74-8. 
To know how to define 
disability it is important 
that it is understood how 
people with disability 
perceive their lives.  
The rehabilitation and the 
social model of disabilities 
are explored. This source 
then goes on to define 
disability.  
The rehabilitation model takes the approach that 
human beings need to be able to function at a level 
that is considered optimal.  
 
The social perspective began to arise in the 1960s, 
the goal was to shift disability from the burden on the 
individual to a burden on society.  
 
25.   Title: Measuring disability and 
monitoring the UN Convention 
on the Rights of Persons with 
Disabilities: the work of the 
Washington Group on 
Disability Statistics. 
 
Authors: Madans J, Loeb M, 
Altman B 
 
BMC public health. 2011;11 
Suppl 4:S4. 
The paper describes the 
work completed by the 
Washington Group who 
are investigating 
disability.  
The Washington group is 
described as is, their view on 
disability statistics.  
Ways of measuring disability 
were discussed. The 
Washington Short Set was 
also discussed, and it’s 
testing and uses were 
analysed.  
There is a need for a comparable population-based 
measure of disability to be used for individual 
countries for international comparisons.  
The main purpose of the Washington Group is to 
promote and co-ordinate international co-operation in 
the area of health statistics.  
 
Disability is complex to measure as it is complex 
process and not a static state.  
 
They conclude that the short set of questions which 
has been tested in many countries provides a 







with ICF.  
26.   Title: From disablement to 
enablement: conceptual 
models of disability in the 20th 
century. 
 
Authors: Masala C, Petretto D 
The purpose of this 
article is to describe 
conceptualisations of 
disability.  
This was a review of the 
literature and describes the 
various ideas of disability 
that have contributed to 
different developments of 
disability.  
The current ICF model of WHO has been recognised 
and translated in 191 countries.  
 
In the 1960s there became a major reflection on the 












The ICIDH aimed to analyse, describe and classify 
the consequences of diseases, and distinguished 
between impairments, disabilities and handicaps. This 
was the first internationally shared issue.  
 
The environment-disabled model is when the 
environment is the largest contributor to disability.  
 
From the 1990s the idea of disablement became 
enablement.  
 
The National Centre for Medical Rehabilitation 
Research (NCMRR) developed a model that focused 
on individuals and the way they adapt in their own 
families.  
 
The ICF is used world-wide, and further analysis is 
needed to clarify the concept of functioning and its 
link with the environment and personal characteristics 
to identify the individual, the environment and the 
individual-environment interaction.  
27.   Title: Disability, nursing 
research and the importance 
of reflexivity. 
 
Author: Northway R 
 
J Adv Nurs. 2000;32(2):391-7. 
This source discusses 
the importance of 
reflexivity in disability 
research.  
This source discusses 
reflexivity and the need for 
reflexivity in disability 
research. This source 
discusses why reflexivity is 
important for disability 
researchers and definitions 
of disability.  
Disabled people challenged the individual model of 
disability. The social model argues that people with 
impairments are prevented from social life due to 
physical, social and economic barriers, so it is society 
rather than the individual causing disability.  
 
If nurses view disability in a non-reflexive manner this 
will lead to a very limited understanding of what is 
meant by disability.  
 
Self-reflection of nurses is necessary to allow nurses 
to enhance the care of disabled people rather than 
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28.   Title: Models and 
measurement in disability: an 
international review.  
 
Authors: Palmer M, Harley D 
 
Health Policy and Plann. 
2011;27(5):357-64. 
The article describes the 
theoretical basis and 
methods of disability 
measurement.  
This source discusses the 
medical and social models of 
disability, the ICF and how 
disability is measured.  
Social model of disability is important for assessing 
the equalisation of opportunities.  
 
The measurement of disability has important 
implications for law and policy. Different models serve 
different purposes.  
 
The social model has been criticised for failing to 
address impairment.   
 












daily living.  
29.   Title: The problem of disability 
definition: Commentary.  
 
Author: Pfeiffer D 
 
J Disab Policy Stud. 
1993;4(2):77-82. 
The aim of this article is 
to discuss disability 
definitions.  
This source discusses the 
weaknesses of having 
disability definitions.  
The ICIDH has become very popular in research and 
public health.  
 
There are different terms for disabled and 
handicapped, and these terms mean different things 
to different people.  
 
Disability should be defined on a case-by-case basis 
because the discrimination occurs on an individual 
basis.  
 
The conclusion was that there is little chance that the 
oppression of disability community will remain if the 
disability definition remains.  
 
 
30.   Title: The problem of disability 
definition: Again. 
 





This source aims to 
discuss the problem of 
disability definitions 
again.  
This source describes the 
progression of disability.  
In the 1970s disability was a chronic condition which 
prevented a person from working. In the 1980s this 
became an issue as those working disabled people 
were not included but still needed protection. In 1973 
the Rehabilitation act amended this by saying 
disability is when a person with a physical or mental 
impairment which limited a major life activity, however 
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Measuremen
t Discussed 
Simply stating the definition used does not give the 
analyst the license to make recommendations and 
conclusions for all people with disabilities, but only 
those included in the specific definition used.  
31.   Title: Models of disability: A 
brief overview.  
 
Authors: Retief M, Letšosa R. 
 
HTS 2018;74(1):8. 
This article sought to 
provide a brief overview 
of the nine most 
dominant models of 
disability.  
This source talks about 
disability theology in a 
church setting and describes 
the purposes of various 
models of disability. This 
source describes the nine 
most common models that 
exist.  
Models of disability provide definitions, explanations 
of the causes, provide information on perceived 
needs, they guide the formulation and implementation 
of policy, they are not neutral, they determine how 
academics may study disability, they shape self-
identity and can cause prejudice and discrimination.  
 
The models that are most common include the 
religious model, the medical model, the social model, 
the identity model, the human rights model, the 
charity model, and the economic model.  
 
32.   Title: Disability reconsidered: 
the paradox of physical 
therapy. 
 
Authors: Roush S, Sharby N 
PT. 2011;91(12):1715-27. 
The aim of this article is 
to explore models of 
disability from the 
perspective of the 
academic discipline and 
to look at how to improve 
functioning with such a 
diverse disability 
background.  
First disability and the 
paradox of physical therapy 
is described followed by 
descriptions of the moral 
model, medical model and 
the social model of disability.  
The moral model of disability equates disability with 
sin, loss of faith or a test of faith.  
 
The medical model places disability in anatomy or 
physiological departures from what is considered 
normal. The idea is to ‘fix’ the problem.  
 
The social model shifts the perspective from the 
individual to the environment and its role in amplifying 
impairments.  
 
33.   Title: Models of disability: their 
influence in nursing and 
potential role in challenging 
discrimination.  
 
Author: Scullion P 
 
J Adv Nurs . 2010;66(3):697-
707. 
The aim of this paper 
was to discuss the 
medical and social 
models of disability 
associated with the 
experience of disabled 
people as citizens and 
patients.  
This paper discusses 
background to disability, how 
the search was completed 
before a discussion around 
disability.  
WHO 2001 set out to provide international language 
for disability: a multidimensional phenomenon 
resulting from the interaction between people and 
their physical and social environment.  
 
Disability in nursing has traditionally been viewed as 
the medical model, this can lead to disability be seen 
as a personal problem, and can cause undermining 
and alienating effects, can lead to invalidation and 





No.  Bibliography Details Aim  Disability areas discussed Overall Disability Conclusions  Disability 
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The social model of disability allows the discriminatory 
way disability is looked at to be challenged. In NZ the 
social model guides nursing education.  
34.   Title: Disability Rights and 
Wrongs.  
 
Author: Shakespeare T  
 
New York, NY 100016: 
Routledge. 2006. 
This book aims to 
conceptualise disability, 
to describe disability and 
bioethics, to describe the 
social relations of 
disability.  
This book conceptualises 
disability.  
Agreeing with a certain model of disability often 
influences the way in which one treats disability. 
Disability is complex and is an interaction between 
individual and structural factors. Disability is a 
complex set of intrinsic and extrinsic factors are at 
play.  
 
35.   Title: Debating disability. 
 
Author: Shakespeare T 
 
J Med Ethics. 2008;34(1):11-4. 
 
This study explores the 
political nature of 
disability research. 
Disability is an emerging 
field of enquiry and 
constructive debate is 
welcomed.  
This source discusses the 
medical and social models of 
disability primarily.  
Disability is a complex, scalar and multi-dimensional 
phenomenon.  
 
There can be an unhelpful focus on the social model.  
 
It is necessary for the structural approach of disability 
to be understood.  
 
36.   Title: Measuring health and 
disability: Manual for WHO 
disability assessment 
schedule WHODAS 2.0.  
 
Author: Üstün T 
 
World Health Organization; 
2010. 
 
The aim of this source 
was to describe the 
reasons for WHODAS 
2.0, the development and 
testing of this measure.  
This source describes why 
disability is important to 
measure and the 
development and testing of 
WHODAS 2.0.  
WHODAS 2.0 is a generic assessment for measuring 
health and disability across cultures. It was developed 
from the ICF.  
 
It is difficult to define and measure disability.  
 
WHODAS 2.0 was needed to address the need for a 
standardised way to measure health and disability 
across cultures.  
WHODAS 2.0  
37  Title: Exploring the role of 
contextual factors in disability 
models.  
 





The aim of this was to 
define and categorise the 
types of relationships that 
contextual factors have 
within models of disability 
according to the WHO 
ICF.  
Various contextual factors 
are analyses to determine 
how they affect the disability 
process.  
A mediating factor occurs when an issue arises from 
an activity limitation which in turn affects the level of 
participation.  
 
A moderating factor is when the effect of activity 
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38.   Title: International 
Classification of Functioning, 
Disability and Health Geneva 
World Health Organization. 
 








and Health known as the 
ICF and its aim is to 
provide a unified and 
standard of describing 
health and health status.  
This book describes the aims 
of the ICF and the different 
components, has detailed 
classification and definitions 
of body functions, structures, 
activities and participation 
and environmental factors.  
The ICF aimed to provide a scientific basis for 
understanding and studying health states, to establish 
a common language, to permit comparison across 
countries and to provide a systematic coding scheme 
for health information systems.  
 
Impairments: are problems in body function or 
structure as a significant deviation or loss. 
ICF joins both the social and medical model.   
 
 
Table I (4): Overview of the Rapid Review of literature discussing disability in Māori  
No.  Bibliography Details Aim  Disability areas discussed Overall Disability Conclusions  Disability 
Measurement 
Discussed 
1.  Title: Rehabilitation and 
indigenous peoples: the Maori 
experience. 
 
Author: Harwood M 
 
Disab & Rehab. 
2010;32(12):972-7. 
This article aimed to 
present perspectives of 
Māori on rehabilitation 
services for Māori.  
He Korowai Oranga is 
discussed in the context of 
rehabilitation.  
He Korowai Oranga overall aim is for Māori 
families to achieve their maximum health and well-
being.  
 
Māori have a right to equal access of health care 
and outcomes as non-Māori.  
 
Whānau is very important for Māori families. A 
safe, supportive environment is important for full 
participation, in order to gain the most out of 
rehabilitation.  
 
2.  Title: Replacing medical and 
social models of disability by a 
communities-based model of 
equal access for people of 
differing abilities: A Maori 
perspective. 
 
Author: Hickey H 
 
This paper aims to 
discuss how the social 
model of disability should 
be replaced with a 
communities-based 
model were equal access 
is provided for those with 
differing abilities. In NZ 
this should further be 
Disabled Māori treatment is 
discussed, as is the medical 
model of disability and how it 
has progressed into a model 
as with the social model. It 
also discusses the limitations 
of the social model of 
disability.  
Three Māori models of 
health are examined to 
Disabled Māori are often treated less favourably 
than non-Māori, thus leaving their whānau being 
obliged to accept approaches to providing 
culturally sensitive care. The issue of 
appropriateness and equity needs to be 
addressed. However, this is impossible without a 
Māori model of disability.  
 
The limitations of the social model of disability is 
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He Puna Korero: J Maori and 
Pacific Develop. 2006;7(1):35. 
informed by Te Whare 
Tapa Whā.  
inform disability. The 
different models are then 
compared.  
people with different values, so it is difficult to 
make them all feel accepted.  
 
Te Whare Tapa Whā included four dimensions 
which are taha wairua (spiritual), taha hinengaro 
(thoughts and feelings), taha tinana (the physical 
dimensions) and taha whanau (family).  
 
Te Wheke represents the family and eight 
tentacles to show eight different important 
dimensions of life.  
 
Ngā Pou Mana has four pillars which include 
family (whanaungatanga), cultural heritage 
(taonga tuku iho), the physical presence (tea o 
turoa) and the indisputable land based 
(turangawaewae).  
 
The concepts of wairua, hinengaro, taha tinana 
and whānau could underpin the development of a 
communities-based model of equal access for 
people with differing abilities. This will allow for 
equity.  
 
3.  Title: "Whānau Hauā: 
Reframing Disability From an 
Indigenous Perspective."  
 
Authors: Hickey, H. and D. 
Wilson (2017) 
 
Mai Journal 2017; 6(1): 82-94. 
 
To critically examine 
current approaches to 
working with disabled 
Māori and the 
experiences of these 
disabled persons.   
The social and medical and 
ICF models of disability were 
discussed.  
Disabled persons have a range of barriers to face. 
In NZ Māori experience very high disability with 
33% being disabled.  
 
Introduce Whānau Hauā as an alternative 
indigenous framework.  
 
Indigenous disabled persons have experiences 
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Disability was not always acknowledged by Māori. 
Despite Māori having higher levels of disability 
they are more likely to have unmet needs.  
 
Whānau Hauā is informed by Te ao Māori and it 
provides a Māori perspective on disability This 
acts as an umbrella term suitable for disabled 
Māori. It adds a cultural dimension to restore 
meaning to people’s lives.     
4.  Title: Maori Concepts of 
Disability. 
 
Authors: Kingi J, Bray A  
 
Dunedin Donald Beasley 
Institute Incorporated 2000. 29 
pages. 
To explore a Māori world 
view of disability.   
This source explores 
qualitative interviews of 
Māori individuals to gain their 
view and understanding of 
disability.  
Issues surrounding power, control and equity are 
needed to be addressed to help develop services 
that achieve good outcomes for Māori and issues 
surrounding power, control and equity are needed 
to develop this relationship with Māori people.  
 
Disability is a symptom of wider and broader 
concepts within the Māori society.  
 
The loss of land, unhelpful government policies 
and loss of knowledge of whakapapa and identify 
and the ongoing effects of colonisation has 
continued to have a disabling effect on them as 
the Tangata Whenua.  
 
The dominant model of disability in NZ is the 
biomedical model of health and Tangata Whenua 
needs are not met when the needs differ from 
dominant culture. Tangata Whenua must manage 
their own initiatives and develop their own 
services so that they have the dignity of choice 
between mainstream or kaupapa Tangata 
Whenua services to support persons with 
disabilities and their whanau.            
 
5.  Title: Maori Experience of 
Disability and Disability 
Support Services. 
 
The aim of this chapter 
was to describe Māori 
understanding of 
This source discussed Māori 
understanding of disability 
and disability support, data 
issues, impairment among 
The NZ disability strategy distinguished between 
disabilities and impairments with individuals not 
having disabilities but rather physical, sensory, 
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Authors: Ratima K, Ratima M 
 
Haoura: Maori Standards of 
Health IV A study of the years 
2000-2005 [Internet]. 
Wellington Te Rōpū Rangahau 
Hauora a Eru Pōmare. 
 
disability and disability 
support services.  
Māori, the evolution of 
disability support services for 
Māori.  
impairments and disability is the process which 
happens when one group of people create barriers 
that don’t take into account the way others live.  
 
Māori experience wide disparities when it comes 
to disability.  
 
For Māori a secure cultural identity is key for 
having good health.  
 
Māori experience a lot more impairment than non-
Māori and have a lot more unmet need.  
 
Māori have distinctive needs when it comes to 
disability which include social and cultural 
requirements.  
6.  Title: At a cultural crossroads: 
lessons on culture and policy 
from the New Zealand 
DISABILITY STRATEGY.  
 
Author: Wiley A 
 
Disab & Rehab. 
2009;31(14):1205-14. 
The aim of this article 
was to determine if there 
has been a promotion of 
participation of disabled 
Māori.  
It also looks at culturally 
appropriate resources of 
disabled Māori.  
This source discusses the 
NZ disability strategy, the 
methodology of this study, 
and the findings and 
recommendations from the 
various groups of people 
interviewed as well as 
discussing recommendations 
for the future.  
Disabled Māori in NZ experience less employment 
and less income, which can have a direct and 
profound impact on people’s lives.  
Objective 11 of the New Zealand disability 
strategy aims to promote participation of disabled 
Māori. This model is based off the social model of 
disability, so society rather than the individual 
needs to adapt.  
 
There is a lack of collaboration between ministries 
regarding disability policy and Māori with 
disabilities. Most service providers were providing 
some sort of training to advance cultural 
awareness and sensitivity among staff.  
 
Consumers painted a different picture as extreme 
pro-activeness was needed to access services 






No.  Bibliography Details Aim  Disability areas discussed Overall Disability Conclusions  Disability 
Measurement 
Discussed 
Most caregivers felt very unsatisfied with the 
services provided. Unless covered by ACC 
caregivers are not actively funded.  
 
Society is not homogenous therefore disability 
should not be either, disability needs to be both 
effective and culturally appropriate.  
7.  Title: Prevalence and 
predictors of disability for 
Māori 24 months after injury. 
 
Authors: Wyeth EH, 
Samaranayaka A, Davie G, 
Derrett S 
 
Aust NZ J Publ Heal. 
2017;41(3):262-8. 
The study aimed to 
investigate post injury 
disability and predictors 
in Māori Prospective 
Outcomes of Injury Study 
Participants.  
Describes the issue of 
disability in the Māori 
population. This paper then 
describes the prospective 
outcomes injury study.  
There are large disparities between Māori and 
non-Māori disability outcomes and there is little 
research into disability in Māori or indigenous 
people post injury.  
 
Disabled Māori have difficulties accessing health 





Table I (5): Overview of the Rapid Review literature discussing both HRQoL and disability  
No Bibliography Details Aim  HRQoL and Disability Concepts  HRQoL and Disability Conclusions  
1.  Title: Disability in older adults 
3: Policy implications. 
 
Authors: Chiriboga DA, 
Ottenbacher K, Haber DA 
 
J. Behav. Med. 
1999;24(4):171-80. 
This source sought to determine if 
the concept of disability was 
important from a public policy 
perspective.  
 
Additionally, it discusses the 
importance of physical activity in 
reducing disability. 
The extent to which an individual’s 
capability are improved influences both 
the medical quality of life (QoL) and 




No Bibliography Details Aim  HRQoL and Disability Concepts  HRQoL and Disability Conclusions  
2.  Title: The contribution and 
impact of the International 
Classification of Functioning, 
Disability and Health on 
quality of life in 
communication disorders.  
 
Author: Cruice M   
 
Int J Speech Lang Pathol. 
2008; 10(1/2):38-49. 
The aim of this source is to evaluate 
the contribution of the impact of the 
International Classification of 
Functioning, Disability and Health 
on quality of life in communication 
disorders.  
It was recommended that HRQoL be 
linked to other models.  
 
HRQoL is the final outcome wherein 
impairments give rise to disabilities 
which result in handicaps which 
influence overall HRQoL. The 
characteristics of individuals and 
environments are also important. 
 
HRQoL can also be viewed as an 
umbrella concept, encompassing 
impairments, disablement and 
handicap.  
 
Modelling quality of life alongside the 
ICF disablement framework has not 
come without its concerns. Disablement 
frameworks need further development.  
 
The ICF focused on the individual 
person therefore encouraging clinicians 
and researchers to think beyond their 
own discipline.   
QoL and HRQoL and wellbeing or subjective 
experience has not been focused on evaluation 
and intervention.  
 
Overall quality of life is seen in some way as 
representing an aggregate of components of 
functioning, activity and participation.  
 
QoL is not another level of the ICF, the ICF 
framework helps to structure what individuals can 
and cannot do, QoL reminds us to consider who 
the individual is and what he or she wants to be. 
 
These concepts are separate, and the ultimate 
goal is to allow an individual to dictate there 
personal and environmental lifestyles and go 
from there.   
3.  Title: Clinical and public 
health perspectives and 
applications of health-related 
quality of life measurement.  
 




The purpose was to look at HRQoL 
measures and the specific purposes 
of HRQoL measurement are 
considered in detail and an 
alternative approached using 
impairment, disability and handicap 
model of disease consequence is 
proposed.  
HRQoL is the value assigned to 
duration of life as modified by the 
impairments, functional states, 
perceptions and social opportunities 
that are influenced by disease, injury, 
treatment or policy.  
 
A strength of HRQoL it allows for a 
patient centred view of disease.  
 
HRQoL is an umbrella concept that 
encompasses impairment, disability and 
handicap, HRQoL is a less clear 
concept.  
Impairment, disability and handicap provide a 
model of the consequences of diseases which 
has considerable advantages over the HRQoL 




Appendix II: Tables to Support the Scoping Review 
Table II (1): Overview of Scoping Review of literature discussing ‘HRQoL and CKD’ 
No.NNNo
.   
Bibliography 
Details 
Aim Study Design 
  
Key findings and 
conclusions  










1.  Apostolou T 
(2007). Quality 














noted as a 
key 
determinan
t of QoL.  
Literature Review, 
the number of 
papers was not 
identified, and the 
inclusion/exclusion 
criteria was not 
detailed.  
  
QoL data suggests that 
older patients have 
similar levels of social 
functioning and mental 
health as younger 
dialysis patients usually 

















was mentioned.  










of factors that 
influence 
HRQoL and 
how this acts to 
predict CKD 
outcomes.  
2.  Balogun, S. A,   


























Literature Review of 
23 papers.  
Pubmed: January 
1994 to December 
2014. Human, 65+ 




Older adults should not 
be excluded from renal 
replacement therapy 
based on age. Older 
adults had a lower 
physical functioning of 
HRQoL scores.  
Little is known about QoL 
perceptions in elderly 
with cognitive or 
functional or terminal 
impairment due to being 
excluded from the 
studies.  
Frequently 




















A limitation is 
that this paper 
did not clearly 
define what 
HRQoL was, 
despite using it 
as a key 
measure and 
refereeing to 
QoL and HRQoL 
numerous times.  
Systematic, 
accurate 
reporting of the 
data. A good 
synthesis of the 
overall findings 




to base claims 
off, but a 
thorough 
synthesis of the 
papers 
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3.  Brown, E. A., 







































quantitative scales.  
140 Participants 
Inclusion: 65+, had 
been on dialysis for 
at least 90 days, 
had not been 





or with a life 
expectancy of less 
than 6 months were 
excluded.  
Quite similar QoL scores, 
if not slightly better in PD 
patients. Greater PD 
should be available to 
older patients.  
Improved education 
would allow for the 
correct choice by 
patients, as they will 
know what suits them 
best to maintain the 
































of study, sick PD 
patients can 
transfer to HD. 
















used to gain an 
appropriate 
idea of HRQoL 
in these 
patients.  
4.  de Jonge, P., 
et al. (2003). 
"A simple risk 
score predicts 
poor quality of 
life and non-


























December 1999.  
Age, diabetes as a 
comorbid condition and a 
high INTERMED score 
was associated with a 
poorer QoL.   
QoL in CKD 










which is a 
baseline survey 











There was no 
baseline QoL 
score, and since 
this is a powerful 
predictor of QoL 





for well in 
INTERMED.  
Limited number 
of patients. Also, 
not strictly 65+ 
INTERMED 
more objective 
so not reliant 
on patients’ 
temporal views.  
Patients who 
refused  follow 
up were 
compared to 
those who did 
not refuse and 
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quality of life: 
people living 
with dialysis." 












interviews at a 
cross-sectional point 
in time in Minnesota.  
31 interviews, 20 
dialysis patients who 
had been on dialysis 
for at least 6 
months, and 11 with 
family members.  
When QoL was poor 
those on dialysis 
reconsidered if it was 
even worth it. Initially 
thrived on dialysis before 
just surviving.  
























evolving QoL.  
Qualitative 
interviews add 
insights into the 
patients QoL 
experiences.  
6. Finkelstein, F. 


















Narrative review, the 
number of papers 
was not described 




Assessment of HRQoL 
gives key information 
about CKD patients and 
routine assessment of 
patient reported 
outcomes should begin.  
HRQoL can be 
defined as the 






affected by a 
medical condition 




36 and the 
Health Utility 
Service. KDQoL 
is a specific 
measurement.  
A large limitation 
is the methods 
of the review, 
the inclusion 
and exclusion 
criteria of the 
papers and the 
number was not 
included.  
Provide a great 
summary that 
defines HRQoL 
in the context 
of CKD.  
7.  Finkelstein, F. 
O., et al. 
(2009). 
"Health related 
quality of life 











that can be 
used to 
Mini Review, the 
number of papers 





Increasing interest in 
assessing HRQoL in 
CKD patients and it is 
now mandated in the 
United States. Focus 
needs to be on 
developing strategies to 
improve HRQoL.  
HRQoL can be 
defined as the 
extent to which 





affected by a 
Use of HRQoL 
has become an 
important 




Once again this 




the number of 
papers included 





list of various 
studies that 
could be used 
to improve the 
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or treatment.  
8.  Ghiasi, B., et 
al. (2018). 
"Quality of Life 

























from May 2005-May 
2017.  
17,200 individuals in 












“CKD” and “Quality 




insufficient data and 
statistical population 
other than in 
patients with CKD.  
Mean QoL score of SF-
36, HRQoL and KDQoL-
SF was 60.31, 51.60 and 
50.37% respectively. QoL 
was poorer compared to 
other diseases.  
CKD patients had a lower 
mean QoL score 
compared normal people.  
Intervention measures 
should take place to 














Due to the 
differences in 
scores of 
HRQoL criteria it 
was not possible 
to come up with 
an average 
HRQoL score in 
CKD patients.   
Provided meta-




about QoL.  
























The SF-36 which is often 
seen as the gold 
standard measure does 
not cover all the issues 
important in the CKD 
stage five population.  




mental and social 
wellbeing if the 
WHO definition of 
health is used and 
it is often thought 












was not clear.  
Great logical 
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quality of life: a 
systematic 





used to assess 
health-related 







included is not clear. 
WHOQoL appears 
to be most valid in 
terms of the content 
validity.  
Searched terms in 
English, terms that 
were searched 
included words such 
as CKD stage five, 
HRQoL and 
measures. Articles 
relating to oncology 
and paediatrics 
were excluded.  
and is suggested to be 
used.  
The EQ-5D does not 
include treatment specific 
issues, sleep, sex, 
cognitive function, body 
image and finances but 
can be self-administered 
and is quick.  
setting the health 
state is what is 
impacting an 
individual’s QoL.   
disease specific 
measures of 











Griva, K., et al. 








































Study with 201 
patients from the 
Peritoneal Dialysis 
Centre in Singapore 





PD for a minimum of 
three months, aged 




hospitalised at time 
of assessment or 
preceding 3 weeks 
and able to 
communicate in 
Older patients had better 
QoL compared to 
younger patients despite 
worse clinical findings.  
All patients regardless of 
age can do well on PD.  
QoL plays an 
important role in 
healthcare and 
plays an important 
role in treatment 
decisions and 
similar endpoints.  
KDQoL, 
WHOQoL and 








Not strictly 65+ 
but splits the 
sample into 
those over and 





sample size.  
May be 
selection bias in 
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English, Mandarin or 
Malay.  
Excluded based on 
stroke, dementia, 




Harris, S. A., 
et al. (2002). 
"Clinical 
outcomes and 













and QoL in 
elderly 
patients on 









174 patients that 




70 years older and 
90 days of 
uninterrupted 
dialysis that defines 
chronic dialysis. 
Recruited from May 
1995 and December 
1996. Excluded if 
terminal ill with life 
expectancy less 
than 6 months, 
psychosis, 
cognitively impaired.  
Clinical outcomes of QoL 
are similar in elderly 
people on PD and HD. 
The apparent advantage 
of PD is often misleading 
and may be contributed 
to residual renal function 
not assessed when 
looking at adequacy of 
HD.   PD is useful in 
older patients as well as 
HD.  
The way HRQoL 
is measured was 
described but 
what it is and what 
it means for this 
















36 and KDQoL.   
Non-participants 
were more likely 






selection bias in 












on dialysis and 








Iyasere, O. U., 
et al. (2016). 




















sectional study.  
251 (129 PD and 
122HD) from 
England and 
Northern Ireland.  
PD patients were 
required to have 
assistance and HD 
No differences between 
QoL and physical 
function between older 
patients on assisted PD 
compared to HD, expect 
for treatment satisfaction 
which is higher in PD 
patients. QoL in these 

















means it is 
limited to 
association and 





Has a larger 
sample size, 
and has many 
good measures 
and predictors 
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Clin J Am Soc 
Nephrol 11(3): 
423-430. 
patients eligible if 
they required 
hospital transport to 
attend dialysis 
sessions. 60 years 
old, dialysis for more 
than 3 months, free 
of hospitalisation for 





than 6 months were 
excluded from the 
study.  
dialysis factors including 
frailty.  PD should be 
considered as an 
alternative to in-centre 
HD for older patients, at 
least from the viewpoint 






of health care 
resources and 
overall costs.  
1
3.  
Kutner, N. G. 
and S. V. 
Jassal (2002). 





























This paper does not 
describe the number 
of papers nor how 
they were selected.   
  
Ideally individuals decline 
can be slowed by 
screening, rehabilitation 
therapy and maintenance 
care. Elderly patient’s 
mental health has been 
shown to be better 
compared to their 
younger peers. 
Preventive and 
rehabilitation models are 
important for prompting 
healthy aging and patient 
QoL on dialysis and will 
help the cost burden.  






to as HRQoL.  
SIP and SF-36 A limitation is 




on criteria was 
not available.  
The main 
advantage of 
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quality of life, 

























study of 221 
participants with 
CKD stage five and 
at 12 months there 
was 125 participants 
who survived to 12 
months. Recruited 
from May 1996 to 
December 1996 in 
the UK.  
Patients 70+ with 
CKD, who started 
dialysis during the 
recruitment period 
and patients who 
had been on dialysis 
for at least 90 days 
were included.  
Age alone should not be 
used as a barrier to 
referral and treatment 
and dialysis should be 
used as a barrier to 
referral and treatment. 
Indicators rather than 
chronological age should 
be used to see if they 
benefit from treatment. 
Mental QoL of patients 
was the same as non-
dialysis peers but 
physical ability was 
lower.  
Again, HRQoL 
was not defined 
















not in detail. 
Additionally, 
HRQoL was not 
defined for this 
paper.  







the disease.  
1
5. 




on the quality 











sectional study.  
169 CKD patients 
who started dialysis 
and 169 sex 
matched non-CKD 
controls. Sampled 
between 1997 and 
2001 from France.   
70 + and with CKD 




clearance less than 
15 mL/min.  
If dialysis initiation was 
planned this led to QoL 
being no worse than 
other diseases, however 
for unplanned dialysis 
this led to severely 
impaired QoL. Pre-
dialysis care is important 





how QoL in this 
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The number of 
papers was not 
discussed nor was 
the 
inclusion/exclusion 
criteria.   
  
Those unable to 
complete the HRQoL 
forms had a substantially 
higher risk of death.  
WHO defines 
HRQoL as the 
state of one’s 
well-being in the 
areas of physical 
health, mental 
health and a 
global sense of 
one’s health. It is 
subjective and 
often dependent 
on how a person 
views their health.  
KDQoL, SF-12 A significant 
limitation of this 




selected into this 
study or the 
number of 





the history of 




Phillips, L., et 
al. (2001). 
"Health-related 










ed QoL in 
patients 
with CKD 







and it also 
presents 
Review article, likely 
a rapid review. The 
number of papers 
reviewed, and the 
inclusion/exclusion 
criteria was not 
discussed.  
  
There is much debate 
over how QoL should be 
defined and measured.  
HRQoL is more 
than just an 
assessment of 
health status. 





assess the impact 





have all been 
used as well as 












of this review 





type of review it 
is, or the 
inclusion/exclusi
on criteria of the 





















.   
Bibliography 
Details 
Aim Study Design 
  
Key findings and 
conclusions  

































used to assess 
HRQoL in CKD 




et al. (2005). 
"Renal 
replacement 



























survey between 1 
Jan 1994 and 31 
December 2003 in 
Scotland.  
465 patients 
received dialysis. 62 
were aged 80 years 
or over. 39 of these 
completed the 
questionnaire and 6 
did not. Controls 
had lung cancer and 
MI.  
.  
Included those over 
the age of 80 who 
were on dialysis or 
who had lung 
cancer or an MI as 
the control group.  
Age is no longer seen as 
a contraindication to 
treatment. QoL in older 
dialysis patients have 
similar social functioning 
and mental health but 
poorer physical function 
than their younger 
dialysis counterparts.  
HRQoL was 
described as a 
measure however 






using the SF38 
questionnaire.  
The sample size 
in this study was 





































of 51 outpatients 
from France 
receiving dialysis. 
Almost half the 
cognitively impaired 
patients were depressed.  
HRQoL should be 
monitored in elderly 




QoL based on 
QoL 
assessment of 
NHP, also used 
depression 
It was not clear 
whether poor 
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and March 2000. 
HD or PD. 70+. 
Excluded patients 
not fluent in French 
and those who had 
marked visual or 
hearing impairment 
(5 of 56).  
dialysis patients using 
sale report measures, as 
this will improve our 
understanding of how 
dialysis affects life.  
their subjective 
experience.  
scale and two 



















Unruh, M. L. 









C K D 14(4): 
345-352. 























Review, likely a 
systematic narrative 
review. The number 
of papers and 
inclusion/exclusion 
criteria was not 
described.   
  
Translating the 
knowledge from HRQoL 
research that this is often 
impaired in the CKD 
patients into clinical 
practise would be useful 
for including outcomes. It 
is often difficult to know 
what measure to analysis 
HRQoL in.  
HRQoL pertains 
to the health 
demands that are 
related to health 
or disease. 
Provide a useful 
figure of HRQoL 
in CKD patients.  
Generic 
measures like 




This paper does 
not have the 
number of 
papers included 
or the methods 
of how papers 
were included or 




HRQoL in CKD 
patients. This 
paper assesses 
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Unruh, M. L., 
et al. (2008). 
"The influence 
of age on 
changes in 
health-related 
quality of life 
over three 
























1813 (98%) of HD 
patients completed 
baseline surveys. 
This study occurred 
in the United States.  
15 clinics, included 
people 70+ years 
and under 70 years 
as a comparison 
group, who were on 
HD.  
HRQoL scores in HD 
patients over the age of 
70 years were better than 
in the younger patients. 
There was no substantial 
decline in relationship 
between age and 
average HRQoL decline 












Not strictly 65+, 
but only uses 
younger patients 
as a comparison 
group. May be 
survivor bias 








the period of 
three years. 
This study also 
collected a 




Unruh, M. L., 

























t in the 
ESRD 
population.   
Narrative review, the 
number of papers 
reviewed, and the 
inclusion/exclusion 
criteria was not 
discussed,  
  
HRQoL is a useful 
assessment of how one’s 
life is going and how it 
would be best to assess 
or decide on treatment 
and improving this 
treatment.  
HRQoL assess 
the QoL of a 
person that refers 
to their health and 
is highly 
dependent on 
what an individual 
thinks HRQoL is. 
It is important to 
understand the 
conceptual model 
of HRQoL when 






CHOICE.   
The number of 




in this study was 
not discussed.  
This paper 
once again has 

















Boateng, E. A. 






26 of the 574 
studies were 
There is no simple 
understanding about 
which dialysis modality 
HRQoL was not 
strictly defined. 




The limitation of 
this review is 
only 
This study has 
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quality of life: a 
systematic 




















searched from their 
inception to July 
2010 for studies that 
compared QoL in 
both HD and PD 
patients. Studies 
were selected if they 
involved adults 
ESRD patients on 
dialysis, papers that 
compared HD and 
PD, papers that 
evaluated QoL as a 
primary or 
secondary outcome 
with a validated tool 
and reported QoL 
separately for HD 
and PD. Excluded if 
they reported on just 
a component of 
QoL, did not specify 
the QoL toll and did 
not separate QoL 
measures for HD 
and PD patients.  
improves QoL, HD and 
PD are comparable to 
each other in terms of 
QoL.  
multidimensional 



















studies could be 






not be used.  
cohort studies 
are the best for 
understanding 
information, 
this study also 
provided 
methods and 













quality of life in 
haemodialysis 
patients 










study follow.  211 
HD patients (72 
elderly and 139 non-
elderly patients). 20 
patients excluded 
No difference in VAS 
scores between elderly 
and non-elderly patients. 
They had to be on HD. 
There were no issues in 
the elderly patients with 
HRQoL.  
HRQoL was not 
distinctly defined 
however it has 
been found that 
there are many 
different elements 
of disability.  
Used the visual 
analogue scale, 
participants 
were asked to 
rate each 
indicator from 0-
100, 10 items 
were assessed 
A limitation of 
this paper is it 
wasn’t strictly 
65+ and they 
found no real 
association in 
any of the 
HRQoL issues 
The strengths 
of this study 
are it was 
prospective 
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t of their 
psychosoci
al status 


























daily life and 
happiness.  
in the elderly 
patients. 
Although this 
may be an 
important result. 
Also, the sample 
size was 
relatively small.  
different 
elements of 
QoL that are 
important.  
 
Table II (2): Overview of Scoping Review of literature discussing ‘Disability and CKD’ 
No.NNNo
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5479 long term 
(incident patients) 
on dialysis units in 
Lazio (1/1/2008 and 
31/12/2013) (Italy). 
Followed until 31 
December 2015.  
Excluded if less than 
18, residency 
outside Lazio, renal 
transplantation or 
Functional impairment is 
a highly prevalent 
condition in 
haemodialysis patients 
and that it is associated 
with reduced survival. 
Functional impairment 
may be prevented or 
reversed in elderly 
patients. Identify patients 
who benefit from 
treatment early.  
Functional ability 
refers to a 









also collected.  
Not exclusively 





were not asked. 
Some 
participants 
follow up was 
very short if they 
were enrolled at 
The strengths 
of this paper 
include the fact 
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death within the first 
3 months of dialysis, 
duration of HD or 
hemodiafiltration 
less than 9 weeks.  
the end of the 
study.  





































Review, the number 
of papers was not 
reviewed, and the 
inclusion/exclusion 
criteria were not 
described.  
 
Further work is needed to 
categorise the 
relationship between 
kidney disease and frailty 
and to identify 
opportunities to 
intervene. The concept of 
frailty is highly important 
for CKD patients, 
especially those on the 
end stages. High 
disability burden in those 
with CKD and is linked to 
increased mortality. Fall 
incidence is higher in 
older adults.  






























The limitation of 
this paper is the 








It was positive 
to see that they 
mentioned that 










A great section 
specifically 
focusing on 
older adults.  
3. 3.  Cook, W. L. 















168 Participants.  
Of 182 
haemodialysis 
eligible patients, 3 
excluded due to no 
Factors associated with 
having disability is one or 
more ADL, including the 
inability to perform a TUG 
test within 10s, abnormal 
cognition, polypharmacy 
Disability was not 
strictly defined 








activities in daily 
living (ADL and 
IADL, 
respectively): 
A limitation is it 
is a cross-
sectional study 
do we can only 
understand 
information 
The strength of 
this study is it 
outlines which 
elements are 
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with one or 
more 
disabilities 





















interpreter, due to 
death (n=4), with-
drawn consent (n=1) 
and prolonged 
hospitalisation 
(n=1). All patients 
were aged 65+.  
  
and having fewer years 
of education.  




cause no disability.  
and dependence 
(is requiring help 




















dressing etc.  
happening at a 









Seminars in dialysis, 
the number of 
patients reviewed 
Rehabilitation can delay 
or prevent the onset of 
disability and 
Disability was not 
strictly defined by 
the article alluded 
Disability was 
not strictly 
discussed but a 
The main 
limitation of the 
paper is that 
The strengths 
of this paper 
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was not discussed, 





describes the utility of 
rehabilitation in practise. 
There are often subtle 
hints in functional decline 
that would be useful to be 
noticed.  
to disability 
frequently in the 
way that the aim 















although it uses 





disability is not 
defined and the 
number of 




used a case 
example to talk 
through how 




and how this 
case by case 
scenario may 












































Cohort Study of 167 
participants. 
Patients were 65 
years or older and 
had been receiving 
chronic 
maintenance HD 
over 12 months, 
followed 
prospectively for at 
least 2 years.   
  
The 4-item scale is a 
simple, valid screening 
test for disability, it could 
be used as a screening 
tool. Although stair 
climbing may be 
overlooked. Previous 
studies show that dialysis 
leads to disability. 
Patients with severe 
disability had significantly 
higher risk of death after 
correlation for age, 
comorbidity and dialysis 
vintage.  




measure it were 
discussed.  
Activities of daily 
living (ADL), the 
Falls Efficacy 
Scale (FES). 4 
item scale was 
validated 
against the 
Barthel Index.   
A limitation of 





A strength of 
the study is that 
it is a cohort, it 
has 167 
participants 
and it has used 
a measure to 





















CKD is associated with 












CKD stage five 
but does split 
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contacted every 6 
months. 
Included participants 
aged 7—79 with no 
difficulty in 
performing activities 
of daily living, in 
walking a quarter 
mile, and upstairs, 
no plans to move 
and no cancer in 
prior three years. No 
criteria based on 
kidney function. 
Participants 
excluded if they had 
coronary heart 
disease, low ankle 
arm index, 
depressed, arthritis 
and diabetes.  
 
comorbidity, body 
composition and tests of 
strength and physical 
performance, this may be 
due to the inflammatory 
state in CKD.  
functional 















severities.   
Additionally, 
they had no 
inclusion/exclusi





were more likely 
to be excluded if 
they were older, 
black, lower 
education. The 





CKD stage five.  
could look at 
incident cases. 
Could adjust for 






at ways to 
reduce this 
disability.  
6666f   7 
7.   





exercise in the 
aging process 















Narrative review, the 
number of papers 
reviewed, and the 
inclusion/exclusion 
criteria was not 
discussed.  
  
Physical exercise has 
been found to be 
effective in preventing 
frailty and disability in this 
population. Elderly and 
CKD patients are both 
affected by an impaired 
physical performance 
that may be reversed by 
physical exercise with an 
Frailty is a state of 
vulnerability to 
poor resolution of 
homoeostasis 
after a stressor 













could help CKD 
patients.   
The major 
limitation of this 
paper is that it 
did not include 
the 
inclusion/exclusi
on criteria or list 
the number of 
papers include 










.   
Bibliography 
Details 
Aim Study Design 
  























improvement of the 
survival rate.  
systems during a 
lifetime.  
       8.  Intiso, D. 
(2014). "The 
rehabilitation 















on in CKD 
patients.  
Narrative review. 




criteria was not 
discussed.  
  
It is recommended that 
exercise training should 
be implemented in CKD 
patients to help reduce 
disability occurrence. 
Age, hypertension and 
diabetes are key 
predictors of secondary 
CKD.  CKD associated 
with increased risk of 
functional impairment.  
Rehabilitation is 
the use of means 
aimed at reducing 





with disability to 
achieve optimal 






of how disability 
is caused is well 
discussed.  
The major 
limitation of this 
paper is the 
number of 
papers and the 
inclusion/exclusi
on criteria of the 
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criteria was not 
discussed.   
  
Older dialysis patients 
were at higher risk than 
usual of accidental falls 
and subclinical spinal 
fractures both of which 
lead to mobility limitations 
and functional disability 
or death. Rehabilitation 




defined as the 
inability to perform 
daily tasks. 
Disability is 
defined as a 
restriction or lack 
of ability to 
perform an activity 







The review did 





on criteria of the 
papers was not 
described.  
This paper has 
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113 Prevalent renal 
failure patients on 
in-centre 
haemodialysis and 
286 controls across 
a period of three 
years.  
All patients were 
older than 60 years. 
Cases had been 
receiving dialysis at 
the baseline 
interview in 1988. 
Had to be living in 
Georgia. They could 
not be living in a 
nursing home, not 
receive a transplant 
or experienced 
return of renal 
function.  
Dialysis patients 
compared to controls 
reported more functional 
impairment at baseline 
and at follow-yup after 
adjusting for baseline 
impairment and 
covariates. Older 
patient’s life satisfaction 
at 3-year follow-up was 
similar to life satisfaction 
of those not on dialysis.  
Disability as a 
definition is not 
specifically 
discussed, 
however it is 
alluded to and 
measured through 
the physical 
impairment index.  
Disability was 
measured with a 
functional 
impairment 






life satisfaction.   
This paper is not 
exclusively 65+ 
although is 64-
88 in the dialysis 
cohort and 59-
88 in the non-
CKD cohort.  
High response 
rate of cases of 
95% at 
baseline. Only 
80% of controls 
were sampled 
at baseline.  
10. 10  
11.  
Lam, M. and 

















nt in the 
CKD 
population.   
Review. The 
number of papers 
and the 
inclusion/exclusion 
criteria was not 
described.  
  
Elderly patients with CKD 
have a higher prevalence 
of frailty compared to 
those with normal renal 
function. Key factors 
were unintentional weight 
loss, weak grip strength, 
self-reported exhaustion, 
and slow gait speed and 
low energy expenditure. 
Social vulnerability can 
cause fragility. No simple 






Comorbidity is an 
etiologic risk 
factor for frailty, 
and disability is an 
outcome of this 
condition.  
The frailty score 
index is a score 
based upon the 
total number of 
deficits from a 
list of 70 
components of 
health, this list 
excludes renal 
disease.   
A limitation of 
this paper is 





for his review, 
additionally 




A strength of 
this study is 
that they 
describe how 
the presence of 
frailty in CKD 
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12.  
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"The Presence 





















the elderly.  
Cross-sectional 
analysis in a cohort 
fashion of 5,888 
community-dwelling 
adults.   
5,888 community-
dwelling adults. 
Aged 65 or older in 
four clinical centres 
in the United States. 
Not institutionalised, 
expected to remain 
in current 
community for more 
than three years, not 
under active cancer 
treatment and 
informed consent.  
Elderly patients with CKD 
have a high prevalence 
of frailty, which may 
signal their risk for 
progression to adverse 
health outcomes. Those 
with CKD are three times 
as likely to be frail 
compared to those with 
normal renal function. 
Fatigue, weakness and 
weight loss may be 
subtle pre-uremic 
consequences of even 
mild chronic kidney 
disease.  
Disability is 






and low physical 
activity. It is also 
defined as any 
difficulty in ADLs, 
including eating, 
transferring from 
bed to chair, 
mobility inside the 
home, dressing, 
bathing and using 







CKD stage 5, 
actually there 
wasn’t enough 
of these patients 










leads to frailty 
and disability 
on the CKD 
population.  
































were read. Only 14 
of the articles 
contained 
information about 
CKD stage five and 
the ability to work.  
27 databases were 
included, from the 




selected based on 
exclusively focusing 
on CKD stage five, 
Employment was 
significantly less likely 
among patients with 
peripheral vascular 
disease, pulmonary 
disease, limitations in 
performing at least one 
activity of daily living and 
HIV or AIDs. Not enough 
information to allow for 
conclusion above 
whether the disability 
criteria should be 
changed.  
The law describes 
disability as the 
inability to perform 
any substantial 
gainful activity by 
reason of any 
medically 
determinable 
physical or mental 
impairment that 
can be expected 
to result in death 
or that has lasted 
or can be 
expected to last 
for a continuous 
period of not less 
than 12 months.  
Disability was 
measured with a 
performance of 




split the results 
into 65+ and 
those not 65+. 
The study was 
never able to 
identify what 
ability meant.  It 






status as an 
outcome 
measure.  
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Review, the number 
of papers reviewed, 
and the 
inclusion/exclusion 
criteria was not 
discussed.  
  
Patients with CKD are 
still encumbered by 
physical limitations in 
numerous daily activities, 
which combine to reduce 
patient QoL. There is a 
need for rehabilitative 
interventions to restore or 
rehabilitate individuals 














and cause the 
inability to perform 
usual takes, which 
leads to disability 
which is the 
inability to perform 
social roles.  
The paper 




of this paper is it 
did not include 





define the type 
of review it was.  
This paper 
identifies some 
key factors for 
the 
disablement 






Overall this is a 
fantastic paper.  
 
Table II (3): Overview of Scoping Review of literature discussing ‘HRQoL and Disability in those with CKD’ 
No.NNNo
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Bibliography 
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Key findings and 
conclusions 












11 1.  Fidan, F., et al. 
(2016). 













study of 50 patients 
Exclusion were the 
presence of chronic 
conditions such as 
cancer, amaurosis, 
chronic hearing loss, 




mainly on the age, 
severity of comorbid 
conditions, depression, 
This paper doesn’t 
detail how HRQoL 
or disability can 
be described but 
explains 
measures used to 




scale (VAS) and 
beck depression 
inventory (BDI). 
Limitation is it is 
not strictly 65+ 
and it’s a 
relevantly small 
sample size.  
The strength of 
this study is it is 
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Key findings and 
conclusions 
































HIV or neurological 
diseases.   
locomotor findings and 
hand disability of HD 
patients. The KDQoL is 
related to the clinical 
status and functional 
ability of HD patients and 
it can be used as a 
sensitive health status 
measure of clinical 
evaluation. Patients over 
65 had poorer KDQoL-36 
than those under 65. 
Physical functioning 




problems and hand 
disability.  
measure HRQoL 
and disability.  
Also collected 
demographic  































study of Korean 
dialysis patients in 
27 hospitals or 
dialysis centres in 
Daegu/Kyungsangp
ook.  
1,616 patients were 
recruited. 1250 were 
HD patients and 366 
were PD patients 
between July and 
December 2012.  
Excluded if under 20 
years old, receiving 
dialysis for less than 
6 months, having a 
No significant difference 
in frailty between patients 
treated with the two 
dialysis modalities, 
disability was more 
common in PD than HD 
patients. This is 
regardless of physical 
functional status. Type of 
PD may influence the 
outcome.  
These were not 
defined however 














activities of daily 
living (ADLs) 
scores.  








of this study 
were the large 
sample size 
and the ability 
to measure a 
large range of 
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being unable to 
walk, unable to 




Table II (4): Overview of Scoping Review of literature discussing ‘HRQoL and Disability in Māori with CKD’ 
No.NNNo
.   
Bibliography 
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Aim Study Design 
  
Key findings and 
conclusions 
















affect the lives 
of rural Maori 
patients?" Kai 
Tiaki Nursing 
NZ   16(10): 
12-14. 








care.   
Qualitative 
Interviews. 
7 Māori HD patients, 
were chosen from 
the 26 patient’s 
receiving dialysis at 
the units. 
Consent forms were 
sent to patients who 
had been on dialysis 
for more than three 
months and who 
had no other major 
health issues that 
would impede the 
interview process 
like deafness. 
CKD management for 
Māori should consider 
individuals, families and 
communities holistically. 
The strength of Māori 
communities is built on 
the well-being of each 
family. There were four 
main themes from the 
study were facing fear, 
stress from requiring 
dialysis, having to learn, 
adjust and change your 
attitude and family 









detail however it 

























65 Māori and Pacific 
patients with either 
The main findings are 
that the unique benefits 
found were that the 
community-based 
Once again, a 








of this study are 
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year follow up 


























CKD stage 3 or 4, 
33 received 
community-based 
intervention of home 
visits and 32  









CKD stage 3 or 4.  
intervention did not 
translate to longer term 
community based 
benefits. 
disability in detail 
however it was 
still important to 
include this paper 
as it specifically 
looks at long term 
outcomes from a 
potential 
intervention. 
65+, or CKD 
stage five and it 





BP and CKD 
outcomes 4 
years post trial 
in the Maori 
and Pacific 
communities 
which is a 
unique study 
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13 Māori patients 
with CKD and who 
were either nearing 
the need for dialysis 
or had started 
dialysis within the 










whakamana (sense of 
self-esteem and self-




patients with CKD 
experienced 
marginalisation within the 
NZ healthcare system. 
This was not 
described in detail 
however still an 
important concept 
are discussed that 










information.   
The limitation of 




HRQoL.    
This study 
again provides 
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Appendix III: Tables to Support the Results 
 
Table III (1) Multivariable analysis of variables predicting WHODAS 2.0 ≥10 
representing ‘considerable disability’ at 12 months (n=156) with age, sex, ethnicity 
and the EQ-5D-3L variables fixed.  
Variable  Relative 
Risk  
95% CI  P-value Overall P 
Sex 
    
  Male Ref 
   
  Female  1.27 0.99-1.62 0.052 
 
Age group 
    
  <75 years Ref 
   
  75+ years 1.06 0.80-1.39 0.694 
 
Ethnicity  
    





  Māori  1.01 0.73-1.38 0.975 
 
  Pacific 1.08 0.75-1.55 0.696 
 
Dialysis vintage  
    
  Non-dialysis Ref 
  
0.015 
  <2 years 0.53 0.25-1.14 0.103 
 
  ≥2 years 0.38 0.18-0.83 0.015 
 
Dialysis location 
    
  Non-dialysis Ref 
  
0.061 
  Home (HD+PD) 2.25 1.03-4.94 0.042 
 
  In centre  1.65 0.77-3.56 0.201 
 
EQ-5D mobility  
    
  No problems Ref 
   
  Moderate-severe 
problems 
1.31 0.93-1.86 0.126 
 
EQ-5D-3L self-care 
    
  No problems Ref 
   
  Moderate-severe 
problems 




    
  No problems Ref 
   
  Moderate-severe 
problems 




    
  No problems Ref 
   
  Moderate-severe 
problems 




    
  No problems Ref 
   
  No problems 1.00 0.75-1.33 0.994 
 
Disability at baseline 
(WHODAS 2.0) 
    
168 
 
  WHODAS <10 Ref 
   
  WHODAS ≥10 1.73 1.25-2.40 0.001 
 
Variables included but not retained; number of comorbidities, living arrangements and cognitive function 
Table III (2): Multivariable analysis of variables predicting WHODAS 2.0≥ 10 
representing ‘considerable disability’ at 12 months (n=156) with the EQ-5D-3L 
variables fixed. 
Variable  Relative 
Risk  
95% CI Lower  95% CI Upper P 
 
Sex 
     
  Male 1 
    
  Female  1.28 0.96 1.55 0.107 
 
Age group 
     
  >75 years 1 
    
  75+ years 1.08 0.83 1.41 0.547 
 
Ethnicity  
     
  Non-Māori, Non-Pacific  1 
    
  Māori  0.89 0.64 1.24 0.508 
 
  Pacific 0.98 0.69 1.40 0.904 
 
EQ-5D-3L mobility  
     
  No problems 1 
    
  Moderate-severe problems 1.36 0.94 1.96 0.104 
 
EQ-5D-3L self-care 
     
  No problems 1 
    
  Moderate-severe problems 1.19 0.95 1.48 0.135 
 
EQ-5D-3L usual activities  
     
  No problems 1 
    
  Moderate-severe problems 1.26 0.88 1.81 0.207 
 
EQ-5D-3L pain  
     
  No problems 1 
    
  Moderate-severe problems 1.06 0.82 1.37 0.650 
 
EQ-5D-3L anxiety  
     
  No problems 1 
    
  Moderate-severe problems 0.98 0.73 1.32 0.912 
 
Disability at baseline 
(WHODAS 2.0) 
     
  WHODAS <10 1 
    
  WHODAS ≥10) 1.69 1.20 2.39 0.003 
 









Table III (3) Characteristics of Māori participants followed up to 12 months 
(n=37) compared to baseline only participants (n=12) 
Variable Baseline(n=12) % Followed till 12 
months (n=37) 
% P value  
Sex 
    
0.035 
  Male 10 36 18 64 
 
  Female  2 10 19 90 
 
Age group 
    
0.861 
  <75 years 10 25 30 75 
 
  75+ years 2 22 7 78 
 
Dialysis vintage  
    
0.656 
  Non-dialysis  2 20 8 80 
 
  <2 years 6 32 13 68 
 
  ≥2 years 4 20 16 80 
 
Dialysis location  
    
0.744 
  Non-dialysis  2 17 10 83 
 
  Home (HD+PD) 3 30 7 70 
 




    
0.200 
  0-2 3 15 17 85 
 
  3+  9 31 20 69 
 
Living arrangements 
    
0.890 
  With others 9 25 27 75 
 
  Alone  3 23 10 77 
 
EQ-5D-3L mobility 
    
0.656 
  No problems 4 21 15 79 
 
  Moderate-severe 
problems 
8 27 22 73 
 
EQ-5D-3L self-care  
    
0.962 
  No problems 9 24 28 76 
 
  Moderate-severe 
problems 




    
0.807 
  No problems 6 26 17 74 
 
  Moderate-severe 
problems 




    
0.456 
  No problems 7 29 17 71 
 
  Moderate-severe 
problems 




    
0.179 
  No problems 12 27 32 73 
 
  Moderate-severe 
problems 
0 0 5 1 
 
Disability at baseline 
(WHODAS 2.0) 
    
0.456 
  WHODAS <10 5 20 20 80 
 




Variable Baseline(n=12) % Followed till 12 
months (n=37) 
% P value  
Treatment type  
    
0.900 
  Non-dialysis 2 20 8 80 
 
  Haemodialysis 8 27 22 73 
 
  Peritoneal Dialysis  2 22 7 78 
 
Cognitive function  
    
0.909 
  No problems 8 25 24 75 
 
  Moderate-severe 
problems 
4 24 13 76 
 
*Row percentages have been presented.  
 
 
 
